id	sid	tid	token	lemma	pos
iajs-2806	1	1	ibn	ibn	PROPN
iajs-2806	1	2	al	al	PROPN
iajs-2806	1	3	-	-	PUNCT
iajs-2806	1	4	haitham	haitham	PROPN
iajs-2806	1	5	jour	jour	X
iajs-2806	1	6	.	.	PROPN
iajs-2806	1	7	for	for	ADP
iajs-2806	1	8	pure	pure	ADJ
iajs-2806	1	9	&	&	CCONJ
iajs-2806	1	10	appl	appl	PROPN
iajs-2806	1	11	.	.	PUNCT
iajs-2806	2	1	sci	sci	PROPN
iajs-2806	2	2	.	.	PROPN
iajs-2806	3	1	34	34	NUM
iajs-2806	3	2	(	(	PUNCT
iajs-2806	3	3	1	1	NUM
iajs-2806	3	4	)	)	PUNCT
iajs-2806	3	5	2021	2021	NUM
iajs-2806	3	6	1	1	NUM
iajs-2806	3	7	sera	sera	NOUN
iajs-2806	3	8	level	level	NOUN
iajs-2806	3	9	and	and	CCONJ
iajs-2806	3	10	polymorphism	polymorphism	NOUN
iajs-2806	3	11	of	of	ADP
iajs-2806	3	12	interleukin-33	interleukin-33	ADJ
iajs-2806	3	13	gene	gene	NOUN
iajs-2806	3	14	in	in	ADP
iajs-2806	3	15	iraqi	iraqi	ADJ
iajs-2806	3	16	females	female	NOUN
iajs-2806	3	17	patients	patient	NOUN
iajs-2806	3	18	with	with	ADP
iajs-2806	3	19	breast	breast	NOUN
iajs-2806	3	20	cancer	cancer	NOUN
iajs-2806	3	21	abstract	abstract	NOUN
iajs-2806	3	22	interleukin-33	interleukin-33	PROPN
iajs-2806	3	23	[	[	X
iajs-2806	3	24	il-33	il-33	NUM
iajs-2806	3	25	]	]	PUNCT
iajs-2806	3	26	is	be	AUX
iajs-2806	3	27	a	a	DET
iajs-2806	3	28	specific	specific	ADJ
iajs-2806	3	29	ligand	ligand	NOUN
iajs-2806	3	30	for	for	ADP
iajs-2806	3	31	the	the	DET
iajs-2806	3	32	st2	st2	NOUN
iajs-2806	3	33	receptor	receptor	NOUN
iajs-2806	3	34	,	,	PUNCT
iajs-2806	3	35	and	and	CCONJ
iajs-2806	3	36	a	a	DET
iajs-2806	3	37	member	member	NOUN
iajs-2806	3	38	of	of	ADP
iajs-2806	3	39	the	the	DET
iajs-2806	3	40	il-1	il-1	X
iajs-2806	3	41	family	family	NOUN
iajs-2806	3	42	.	.	PUNCT
iajs-2806	4	1	it	it	PRON
iajs-2806	4	2	is	be	AUX
iajs-2806	4	3	a	a	DET
iajs-2806	4	4	dual	dual	ADJ
iajs-2806	4	5	-	-	PUNCT
iajs-2806	4	6	function	function	NOUN
iajs-2806	4	7	protein	protein	NOUN
iajs-2806	4	8	that	that	PRON
iajs-2806	4	9	acts	act	VERB
iajs-2806	4	10	both	both	PRON
iajs-2806	4	11	as	as	ADP
iajs-2806	4	12	an	an	DET
iajs-2806	4	13	extracellular	extracellular	ADJ
iajs-2806	4	14	alarmin	alarmin	NOUN
iajs-2806	4	15	cytokine	cytokine	NOUN
iajs-2806	4	16	,	,	PUNCT
iajs-2806	4	17	and	and	CCONJ
iajs-2806	4	18	an	an	PRON
iajs-2806	4	19	as	as	ADP
iajs-2806	4	20	an	an	DET
iajs-2806	4	21	intracellular	intracellular	ADJ
iajs-2806	4	22	nuclear	nuclear	ADJ
iajs-2806	4	23	factor	factor	NOUN
iajs-2806	4	24	participates	participate	VERB
iajs-2806	4	25	in	in	ADP
iajs-2806	4	26	maintaining	maintain	VERB
iajs-2806	4	27	barrier	barrier	NOUN
iajs-2806	4	28	function	function	NOUN
iajs-2806	4	29	by	by	ADP
iajs-2806	4	30	regulating	regulate	VERB
iajs-2806	4	31	gene	gene	NOUN
iajs-2806	4	32	expression	expression	NOUN
iajs-2806	4	33	of	of	ADP
iajs-2806	4	34	il-33	il-33	NOUN
iajs-2806	4	35	modulating	modulate	VERB
iajs-2806	4	36	tumor	tumor	NOUN
iajs-2806	4	37	growth	growth	NOUN
iajs-2806	4	38	and	and	CCONJ
iajs-2806	4	39	anti	anti	ADJ
iajs-2806	4	40	-	-	ADJ
iajs-2806	4	41	tumor	tumor	ADJ
iajs-2806	4	42	immunity	immunity	NOUN
iajs-2806	4	43	in	in	ADP
iajs-2806	4	44	cancer	cancer	NOUN
iajs-2806	4	45	patients	patient	NOUN
iajs-2806	4	46	.	.	PUNCT
iajs-2806	5	1	the	the	DET
iajs-2806	5	2	present	present	ADJ
iajs-2806	5	3	study	study	NOUN
iajs-2806	5	4	aimed	aim	VERB
iajs-2806	5	5	to	to	PART
iajs-2806	5	6	investigate	investigate	VERB
iajs-2806	5	7	the	the	DET
iajs-2806	5	8	role	role	NOUN
iajs-2806	5	9	of	of	ADP
iajs-2806	5	10	il-33	il-33	PUNCT
iajs-2806	5	11	serum	serum	NOUN
iajs-2806	5	12	level	level	NOUN
iajs-2806	5	13	and	and	CCONJ
iajs-2806	5	14	gene	gene	NOUN
iajs-2806	5	15	polymorphism	polymorphism	NOUN
iajs-2806	5	16	in	in	ADP
iajs-2806	5	17	iraqi	iraqi	ADJ
iajs-2806	5	18	women	woman	NOUN
iajs-2806	5	19	with	with	ADP
iajs-2806	5	20	breast	breast	NOUN
iajs-2806	5	21	cancer	cancer	NOUN
iajs-2806	5	22	.	.	PUNCT
iajs-2806	6	1	materials	material	NOUN
iajs-2806	6	2	and	and	CCONJ
iajs-2806	6	3	methods	method	NOUN
iajs-2806	6	4	:	:	PUNCT
iajs-2806	6	5	blood	blood	NOUN
iajs-2806	6	6	samples	sample	NOUN
iajs-2806	6	7	were	be	AUX
iajs-2806	6	8	collected	collect	VERB
iajs-2806	6	9	from	from	ADP
iajs-2806	6	10	66	66	NUM
iajs-2806	6	11	iraqi	iraqi	ADJ
iajs-2806	6	12	patient	patient	ADJ
iajs-2806	6	13	women	woman	NOUN
iajs-2806	6	14	diagnosed	diagnose	VERB
iajs-2806	6	15	with	with	ADP
iajs-2806	6	16	breast	breast	NOUN
iajs-2806	6	17	cancer	cancer	NOUN
iajs-2806	6	18	,	,	PUNCT
iajs-2806	6	19	which	which	PRON
iajs-2806	6	20	were	be	AUX
iajs-2806	6	21	divided	divide	VERB
iajs-2806	6	22	into	into	ADP
iajs-2806	6	23	two	two	NUM
iajs-2806	6	24	groups	group	NOUN
iajs-2806	6	25	:	:	PUNCT
iajs-2806	6	26	pre	pre	ADJ
iajs-2806	6	27	-	-	NOUN
iajs-2806	6	28	treatment	treatment	ADJ
iajs-2806	6	29	[	[	X
iajs-2806	6	30	pt	pt	X
iajs-2806	6	31	]	]	X
iajs-2806	6	32	and	and	CCONJ
iajs-2806	6	33	under	under	ADP
iajs-2806	6	34	treatment	treatment	NOUN
iajs-2806	6	35	with	with	ADP
iajs-2806	6	36	chemotherapy	chemotherapy	NOUN
iajs-2806	6	37	[	[	X
iajs-2806	6	38	utc	utc	X
iajs-2806	6	39	]	]	X
iajs-2806	6	40	patients	patient	NOUN
iajs-2806	6	41	in	in	ADP
iajs-2806	6	42	addition	addition	NOUN
iajs-2806	6	43	to	to	ADP
iajs-2806	6	44	34	34	NUM
iajs-2806	6	45	apparently	apparently	ADV
iajs-2806	6	46	healthy	healthy	ADJ
iajs-2806	6	47	women	woman	NOUN
iajs-2806	6	48	who	who	PRON
iajs-2806	6	49	were	be	AUX
iajs-2806	6	50	matched	match	VERB
iajs-2806	6	51	with	with	ADP
iajs-2806	6	52	patients	patient	NOUN
iajs-2806	6	53	as	as	ADP
iajs-2806	6	54	a	a	DET
iajs-2806	6	55	control	control	NOUN
iajs-2806	6	56	.	.	PUNCT
iajs-2806	7	1	elisa	elisa	NOUN
iajs-2806	7	2	technique	technique	NOUN
iajs-2806	7	3	was	be	AUX
iajs-2806	7	4	used	use	VERB
iajs-2806	7	5	to	to	PART
iajs-2806	7	6	determine	determine	VERB
iajs-2806	7	7	the	the	DET
iajs-2806	7	8	il-33	il-33	ADJ
iajs-2806	7	9	serum	serum	NOUN
iajs-2806	7	10	level	level	NOUN
iajs-2806	7	11	.	.	PUNCT
iajs-2806	8	1	the	the	DET
iajs-2806	8	2	pcr	pcr	PROPN
iajs-2806	8	3	-	-	PUNCT
iajs-2806	8	4	rflp	rflp	NOUN
iajs-2806	8	5	technique	technique	NOUN
iajs-2806	8	6	was	be	AUX
iajs-2806	8	7	performed	perform	VERB
iajs-2806	8	8	to	to	PART
iajs-2806	8	9	determine	determine	VERB
iajs-2806	8	10	il-33	il-33	VERB
iajs-2806	8	11	gene	gene	NOUN
iajs-2806	8	12	polymorphisms	polymorphism	NOUN
iajs-2806	8	13	at	at	ADP
iajs-2806	8	14	single	single	ADJ
iajs-2806	8	15	nucleotide	nucleotide	ADJ
iajs-2806	8	16	polymorphism	polymorphism	NOUN
iajs-2806	8	17	snp	snp	NOUN
iajs-2806	9	1	[	[	X
iajs-2806	9	2	rs1929992	rs1929992	ADJ
iajs-2806	9	3	]	]	PUNCT
iajs-2806	9	4	.	.	PUNCT
iajs-2806	10	1	results	result	NOUN
iajs-2806	10	2	:	:	PUNCT
iajs-2806	10	3	il-33	il-33	VERB
iajs-2806	10	4	serum	serum	NOUN
iajs-2806	10	5	level	level	NOUN
iajs-2806	10	6	recorded	record	VERB
iajs-2806	10	7	lower	low	ADJ
iajs-2806	10	8	significant	significant	ADJ
iajs-2806	10	9	in	in	ADP
iajs-2806	10	10	pt	pt	NOUN
iajs-2806	11	1	[	[	X
iajs-2806	11	2	182.22	182.22	NUM
iajs-2806	11	3	±	±	NUM
iajs-2806	11	4	29.86pg	29.86pg	NUM
iajs-2806	11	5	/	/	SYM
iajs-2806	11	6	ml	ml	ADP
iajs-2806	11	7	]	]	PUNCT
iajs-2806	11	8	and	and	CCONJ
iajs-2806	11	9	utc	utc	X
iajs-2806	11	10	[	[	X
iajs-2806	11	11	129.87	129.87	NUM
iajs-2806	11	12	±	±	NUM
iajs-2806	11	13	45.11pg	45.11pg	NUM
iajs-2806	11	14	/	/	SYM
iajs-2806	11	15	ml	ml	ADP
iajs-2806	11	16	]	]	PUNCT
iajs-2806	11	17	patients	patient	NOUN
iajs-2806	11	18	compared	compare	VERB
iajs-2806	11	19	with	with	ADP
iajs-2806	11	20	control	control	NOUN
iajs-2806	11	21	[	[	X
iajs-2806	11	22	258.08	258.08	NUM
iajs-2806	11	23	±	±	NOUN
iajs-2806	11	24	39.54	39.54	NUM
iajs-2806	11	25	pg	pg	NOUN
iajs-2806	11	26	/	/	SYM
iajs-2806	11	27	ml	ml	ADP
iajs-2806	11	28	]	]	PUNCT
iajs-2806	11	29	under	under	ADP
iajs-2806	11	30	[	[	X
iajs-2806	11	31	p<0.05	p<0.05	NOUN
iajs-2806	11	32	]	]	PUNCT
iajs-2806	11	33	.	.	PUNCT
iajs-2806	12	1	in	in	ADP
iajs-2806	12	2	a	a	DET
iajs-2806	12	3	polymorphism	polymorphism	NOUN
iajs-2806	12	4	study	study	NOUN
iajs-2806	12	5	on	on	ADP
iajs-2806	12	6	il-33	il-33	ADJ
iajs-2806	12	7	snp	snp	NOUN
iajs-2806	12	8	[	[	X
iajs-2806	12	9	rs1929992	rs1929992	ADV
iajs-2806	12	10	]	]	PUNCT
iajs-2806	12	11	showed	show	VERB
iajs-2806	12	12	ag	ag	PROPN
iajs-2806	12	13	genotype	genotype	NOUN
iajs-2806	12	14	recorded	record	VERB
iajs-2806	12	15	the	the	DET
iajs-2806	12	16	high	high	ADJ
iajs-2806	12	17	frequency	frequency	NOUN
iajs-2806	12	18	in	in	ADP
iajs-2806	12	19	control	control	NOUN
iajs-2806	12	20	than	than	ADP
iajs-2806	12	21	in	in	ADP
iajs-2806	12	22	patients	patient	NOUN
iajs-2806	12	23	[	[	X
iajs-2806	12	24	76.47	76.47	NUM
iajs-2806	12	25	,	,	PUNCT
iajs-2806	12	26	58.46	58.46	NUM
iajs-2806	12	27	]	]	PUNCT
iajs-2806	12	28	compared	compare	VERB
iajs-2806	12	29	to	to	ADP
iajs-2806	12	30	other	other	ADJ
iajs-2806	12	31	genotypes	genotype	NOUN
iajs-2806	12	32	aa	aa	NOUN
iajs-2806	12	33	,	,	PUNCT
iajs-2806	12	34	gg	gg	NOUN
iajs-2806	12	35	with	with	ADP
iajs-2806	12	36	no	no	DET
iajs-2806	12	37	significant	significant	ADJ
iajs-2806	12	38	difference	difference	NOUN
iajs-2806	12	39	according	accord	VERB
iajs-2806	12	40	to	to	ADP
iajs-2806	12	41	fisher	fisher	PROPN
iajs-2806	12	42	’s	’s	PART
iajs-2806	12	43	exact	exact	ADJ
iajs-2806	12	44	probability	probability	NOUN
iajs-2806	12	45	.	.	PUNCT
iajs-2806	13	1	in	in	ADP
iajs-2806	13	2	conclusion	conclusion	NOUN
iajs-2806	13	3	:	:	PUNCT
iajs-2806	13	4	il-33	il-33	VERB
iajs-2806	13	5	serum	serum	NOUN
iajs-2806	13	6	level	level	NOUN
iajs-2806	13	7	decreased	decrease	VERB
iajs-2806	13	8	after	after	ADP
iajs-2806	13	9	performing	perform	VERB
iajs-2806	13	10	surgery	surgery	NOUN
iajs-2806	13	11	on	on	ADP
iajs-2806	13	12	breast	breast	NOUN
iajs-2806	13	13	cancer	cancer	NOUN
iajs-2806	13	14	patients	patient	NOUN
iajs-2806	13	15	.	.	PUNCT
iajs-2806	14	1	there	there	PRON
iajs-2806	14	2	was	be	VERB
iajs-2806	14	3	no	no	DET
iajs-2806	14	4	association	association	NOUN
iajs-2806	14	5	between	between	ADP
iajs-2806	14	6	breast	breast	NOUN
iajs-2806	14	7	cancer	cancer	NOUN
iajs-2806	14	8	development	development	NOUN
iajs-2806	14	9	and	and	CCONJ
iajs-2806	14	10	il-33	il-33	ADJ
iajs-2806	14	11	snp	snp	NOUN
iajs-2806	14	12	[	[	X
iajs-2806	14	13	rs1929992	rs1929992	ADJ
iajs-2806	14	14	]	]	PUNCT
iajs-2806	14	15	.	.	PUNCT
iajs-2806	15	1	the	the	DET
iajs-2806	15	2	heterozygous	heterozygous	ADJ
iajs-2806	15	3	genotype	genotype	NOUN
iajs-2806	15	4	ag	ag	PROPN
iajs-2806	15	5	was	be	AUX
iajs-2806	15	6	a	a	DET
iajs-2806	15	7	common	common	ADJ
iajs-2806	15	8	genotype	genotype	NOUN
iajs-2806	15	9	in	in	ADP
iajs-2806	15	10	the	the	DET
iajs-2806	15	11	iraqi	iraqi	ADJ
iajs-2806	15	12	population	population	NOUN
iajs-2806	15	13	.	.	PUNCT
iajs-2806	16	1	allele	allele	PROPN
iajs-2806	16	2	g	g	PROPN
iajs-2806	16	3	had	have	VERB
iajs-2806	16	4	an	an	DET
iajs-2806	16	5	environmental	environmental	ADJ
iajs-2806	16	6	fraction	fraction	NOUN
iajs-2806	16	7	,	,	PUNCT
iajs-2806	16	8	while	while	SCONJ
iajs-2806	16	9	allele	allele	NOUN
iajs-2806	16	10	a	a	PRON
iajs-2806	16	11	had	have	VERB
iajs-2806	16	12	preventive	preventive	ADJ
iajs-2806	16	13	fraction	fraction	NOUN
iajs-2806	16	14	,	,	PUNCT
iajs-2806	16	15	which	which	PRON
iajs-2806	16	16	related	relate	VERB
iajs-2806	16	17	ibn	ibn	PROPN
iajs-2806	16	18	al	al	PROPN
iajs-2806	16	19	haitham	haitham	PROPN
iajs-2806	16	20	journal	journal	PROPN
iajs-2806	16	21	for	for	ADP
iajs-2806	16	22	pure	pure	ADJ
iajs-2806	16	23	and	and	CCONJ
iajs-2806	16	24	applied	apply	VERB
iajs-2806	16	25	science	science	NOUN
iajs-2806	16	26	journal	journal	PROPN
iajs-2806	16	27	homepage	homepage	NOUN
iajs-2806	16	28	:	:	PUNCT
iajs-2806	16	29	http://jih.uobaghdad.edu.iq/index.php/j/index	http://jih.uobaghdad.edu.iq/index.php/j/index	NOUN
iajs-2806	16	30	doi	doi	NOUN
iajs-2806	16	31	:	:	PUNCT
iajs-2806	16	32	10.30526/34.1.2547	10.30526/34.1.2547	PROPN
iajs-2806	16	33	article	article	NOUN
iajs-2806	16	34	history	history	NOUN
iajs-2806	16	35	:	:	PUNCT
iajs-2806	16	36	received	receive	VERB
iajs-2806	16	37	29may	29may	NOUN
iajs-2806	16	38	2020	2020	NUM
iajs-2806	16	39	,	,	PUNCT
iajs-2806	16	40	accepted	accept	VERB
iajs-2806	16	41	31august	31august	NUM
iajs-2806	16	42	2020	2020	NUM
iajs-2806	16	43	,	,	PUNCT
iajs-2806	16	44	published	publish	VERB
iajs-2806	16	45	in	in	ADP
iajs-2806	16	46	january	january	PROPN
iajs-2806	16	47	2021	2021	NUM
iajs-2806	17	1	asmaa	asmaa	PROPN
iajs-2806	17	2	m.	m.	PROPN
iajs-2806	17	3	salih	salih	PROPN
iajs-2806	17	4	almohaidi	almohaidi	PROPN
iajs-2806	17	5	hazima	hazima	PROPN
iajs-2806	17	6	mossa	mossa	PROPN
iajs-2806	17	7	al	al	PROPN
iajs-2806	17	8	-	-	PROPN
iajs-2806	17	9	abassi	abassi	PROPN
iajs-2806	17	10	zainab	zainab	PROPN
iajs-2806	17	11	jalil	jalil	PROPN
iajs-2806	17	12	abdulkareem	abdulkareem	PROPN
iajs-2806	17	13	department	department	PROPN
iajs-2806	17	14	of	of	ADP
iajs-2806	17	15	biology	biology	NOUN
iajs-2806	17	16	,	,	PUNCT
iajs-2806	17	17	collage	collage	NOUN
iajs-2806	17	18	of	of	ADP
iajs-2806	17	19	science	science	NOUN
iajs-2806	17	20	for	for	ADP
iajs-2806	17	21	women	woman	NOUN
iajs-2806	17	22	,	,	PUNCT
iajs-2806	17	23	university	university	PROPN
iajs-2806	17	24	of	of	ADP
iajs-2806	17	25	baghdad	baghdad	PROPN
iajs-2806	17	26	department	department	PROPN
iajs-2806	17	27	of	of	ADP
iajs-2806	17	28	biology	biology	NOUN
iajs-2806	17	29	/	/	SYM
iajs-2806	17	30	college	college	NOUN
iajs-2806	17	31	of	of	ADP
iajs-2806	17	32	education	education	NOUN
iajs-2806	17	33	for	for	ADP
iajs-2806	17	34	pure	pure	ADJ
iajs-2806	17	35	science	science	NOUN
iajs-2806	17	36	ibn	ibn	PROPN
iajs-2806	17	37	al	al	PROPN
iajs-2806	17	38	-	-	PUNCT
iajs-2806	17	39	haitham	haitham	PROPN
iajs-2806	17	40	/	/	SYM
iajs-2806	17	41	university	university	PROPN
iajs-2806	17	42	of	of	ADP
iajs-2806	17	43	baghdad	baghdad	PROPN
iajs-2806	17	44	,	,	PUNCT
iajs-2806	17	45	iraq	iraq	PROPN
iajs-2806	17	46	ministry	ministry	PROPN
iajs-2806	17	47	of	of	ADP
iajs-2806	17	48	education	education	PROPN
iajs-2806	17	49	,	,	PUNCT
iajs-2806	17	50	iraq	iraq	PROPN
iajs-2806	17	51	zainabjalil30@gmail.com	zainabjalil30@gmail.com	PROPN
iajs-2806	17	52	maha	maha	PROPN
iajs-2806	17	53	mhammed	mhamme	VERB
iajs-2806	17	54	al	al	PROPN
iajs-2806	17	55	-	-	PUNCT
iajs-2806	17	56	sayyid	sayyid	NOUN
iajs-2806	17	57	oncology	oncology	NOUN
iajs-2806	17	58	teaching	teach	VERB
iajs-2806	17	59	hospital	hospital	NOUN
iajs-2806	17	60	of	of	ADP
iajs-2806	17	61	the	the	DET
iajs-2806	17	62	medical	medical	ADJ
iajs-2806	17	63	city	city	NOUN
iajs-2806	17	64	2806280628062806	2806280628062806	NUM
iajs-2806	18	1	mailto:zainabjalil30@gmail.com	mailto:zainabjalil30@gmail.com	PROPN
iajs-2806	19	1	mailto:zainabjalil30@gmail.com	mailto:zainabjalil30@gmail.com	PROPN
iajs-2806	20	1	ibn	ibn	PROPN
iajs-2806	20	2	al	al	PROPN
iajs-2806	20	3	-	-	PUNCT
iajs-2806	20	4	haitham	haitham	PROPN
iajs-2806	20	5	jour	jour	X
iajs-2806	20	6	.	.	PROPN
iajs-2806	21	1	for	for	ADP
iajs-2806	21	2	pure	pure	ADJ
iajs-2806	21	3	&	&	CCONJ
iajs-2806	21	4	appl	appl	PROPN
iajs-2806	21	5	.	.	PUNCT
iajs-2806	22	1	sci	sci	PROPN
iajs-2806	22	2	.	.	PROPN
iajs-2806	23	1	34	34	NUM
iajs-2806	23	2	(	(	PUNCT
iajs-2806	23	3	1	1	NUM
iajs-2806	23	4	)	)	PUNCT
iajs-2806	23	5	2021	2021	NUM
iajs-2806	23	6	2	2	NUM
iajs-2806	24	1	to	to	ADP
iajs-2806	24	2	increasing	increase	VERB
iajs-2806	24	3	the	the	DET
iajs-2806	24	4	level	level	NOUN
iajs-2806	24	5	of	of	ADP
iajs-2806	24	6	il-33	il-33	ADJ
iajs-2806	24	7	with	with	ADP
iajs-2806	24	8	both	both	PRON
iajs-2806	24	9	genotypes	genotype	NOUN
iajs-2806	24	10	aa	aa	NOUN
iajs-2806	24	11	,	,	PUNCT
iajs-2806	24	12	ag	ag	PROPN
iajs-2806	24	13	in	in	ADP
iajs-2806	24	14	the	the	DET
iajs-2806	24	15	healthy	healthy	ADJ
iajs-2806	24	16	control	control	NOUN
iajs-2806	24	17	group	group	NOUN
iajs-2806	24	18	,	,	PUNCT
iajs-2806	24	19	in	in	ADP
iajs-2806	24	20	contrast	contrast	NOUN
iajs-2806	24	21	with	with	ADP
iajs-2806	24	22	gg	gg	NOUN
iajs-2806	24	23	genotype	genotype	NOUN
iajs-2806	24	24	which	which	PRON
iajs-2806	24	25	showed	show	VERB
iajs-2806	24	26	the	the	DET
iajs-2806	24	27	highest	high	ADJ
iajs-2806	24	28	level	level	NOUN
iajs-2806	24	29	in	in	ADP
iajs-2806	24	30	the	the	DET
iajs-2806	24	31	patients	patient	NOUN
iajs-2806	24	32	’	'	PUNCT
iajs-2806	24	33	group	group	NOUN
iajs-2806	24	34	.	.	PUNCT
iajs-2806	25	1	keywords	keyword	NOUN
iajs-2806	25	2	:	:	PUNCT
iajs-2806	25	3	breast	breast	NOUN
iajs-2806	25	4	cancer	cancer	NOUN
iajs-2806	25	5	,	,	PUNCT
iajs-2806	25	6	il-33	il-33	NUM
iajs-2806	25	7	,	,	PUNCT
iajs-2806	25	8	il-33	il-33	ADJ
iajs-2806	25	9	gene	gene	NOUN
iajs-2806	25	10	,	,	PUNCT
iajs-2806	25	11	il-33	il-33	VERB
iajs-2806	25	12	polymorphism	polymorphism	NOUN
iajs-2806	25	13	.	.	PUNCT
iajs-2806	26	1	1	1	X
iajs-2806	26	2	.	.	X
iajs-2806	26	3	introduction	introduction	NOUN
iajs-2806	26	4	breast	breast	NOUN
iajs-2806	26	5	cancer	cancer	NOUN
iajs-2806	26	6	is	be	AUX
iajs-2806	26	7	considered	consider	VERB
iajs-2806	26	8	the	the	DET
iajs-2806	26	9	most	most	ADV
iajs-2806	26	10	important	important	ADJ
iajs-2806	26	11	and	and	CCONJ
iajs-2806	26	12	frequently	frequently	ADV
iajs-2806	26	13	cancer	cancer	NOUN
iajs-2806	26	14	among	among	ADP
iajs-2806	26	15	women	woman	NOUN
iajs-2806	26	16	worldwide	worldwide	ADV
iajs-2806	26	17	and	and	CCONJ
iajs-2806	26	18	the	the	DET
iajs-2806	26	19	leading	lead	VERB
iajs-2806	26	20	cause	cause	NOUN
iajs-2806	26	21	of	of	ADP
iajs-2806	26	22	cancer	cancer	NOUN
iajs-2806	26	23	-	-	PUNCT
iajs-2806	26	24	related	relate	VERB
iajs-2806	26	25	deaths	death	NOUN
iajs-2806	26	26	in	in	ADP
iajs-2806	26	27	developing	develop	VERB
iajs-2806	26	28	countries	country	NOUN
iajs-2806	26	29	[	[	X
iajs-2806	26	30	1	1	NUM
iajs-2806	26	31	]	]	PUNCT
iajs-2806	26	32	.	.	PUNCT
iajs-2806	27	1	in	in	ADP
iajs-2806	27	2	iraq	iraq	PROPN
iajs-2806	27	3	breast	breast	NOUN
iajs-2806	27	4	cancer	cancer	NOUN
iajs-2806	27	5	was	be	AUX
iajs-2806	27	6	considered	consider	VERB
iajs-2806	27	7	the	the	DET
iajs-2806	27	8	most	most	ADV
iajs-2806	27	9	common	common	ADJ
iajs-2806	27	10	cancer	cancer	NOUN
iajs-2806	27	11	and	and	CCONJ
iajs-2806	27	12	there	there	PRON
iajs-2806	27	13	were	be	VERB
iajs-2806	27	14	4529	4529	NUM
iajs-2806	27	15	cases	case	NOUN
iajs-2806	27	16	in	in	ADP
iajs-2806	27	17	2013	2013	NUM
iajs-2806	27	18	considered	consider	VERB
iajs-2806	27	19	4422	4422	NUM
iajs-2806	27	20	females	female	NOUN
iajs-2806	27	21	and	and	CCONJ
iajs-2806	27	22	107	107	NUM
iajs-2806	27	23	males	male	NOUN
iajs-2806	27	24	,	,	PUNCT
iajs-2806	27	25	the	the	DET
iajs-2806	27	26	percentage	percentage	NOUN
iajs-2806	27	27	of	of	ADP
iajs-2806	27	28	total	total	ADJ
iajs-2806	27	29	constitute	constitute	NOUN
iajs-2806	27	30	around	around	ADP
iajs-2806	27	31	18.84	18.84	NUM
iajs-2806	27	32	%	%	NOUN
iajs-2806	27	33	with	with	ADP
iajs-2806	27	34	rate	rate	NOUN
iajs-2806	27	35	12.9	12.9	NUM
iajs-2806	27	36	for	for	ADP
iajs-2806	27	37	each	each	DET
iajs-2806	27	38	100000	100000	NUM
iajs-2806	27	39	populations	population	NOUN
iajs-2806	27	40	,	,	PUNCT
iajs-2806	27	41	and	and	CCONJ
iajs-2806	27	42	considered	consider	VERB
iajs-2806	27	43	the	the	DET
iajs-2806	27	44	commonest	commonest	NOUN
iajs-2806	27	45	ten	ten	NUM
iajs-2806	27	46	cancers	cancer	NOUN
iajs-2806	27	47	in	in	ADP
iajs-2806	27	48	iraq	iraq	PROPN
iajs-2806	27	49	for	for	ADP
iajs-2806	27	50	the	the	DET
iajs-2806	27	51	year	year	NOUN
iajs-2806	27	52	2013	2013	NUM
iajs-2806	28	1	[	[	X
iajs-2806	28	2	2	2	NUM
iajs-2806	28	3	]	]	PUNCT
iajs-2806	28	4	.	.	PUNCT
iajs-2806	29	1	a	a	DET
iajs-2806	29	2	few	few	ADJ
iajs-2806	29	3	recent	recent	ADJ
iajs-2806	29	4	studies	study	NOUN
iajs-2806	29	5	indicated	indicate	VERB
iajs-2806	29	6	a	a	DET
iajs-2806	29	7	potential	potential	ADJ
iajs-2806	29	8	role	role	NOUN
iajs-2806	29	9	of	of	ADP
iajs-2806	29	10	il-33	il-33	ADJ
iajs-2806	29	11	in	in	ADP
iajs-2806	29	12	cancer	cancer	NOUN
iajs-2806	29	13	by	by	ADP
iajs-2806	29	14	tumor	tumor	NOUN
iajs-2806	29	15	growth	growth	NOUN
iajs-2806	29	16	and	and	CCONJ
iajs-2806	29	17	modulating	modulate	VERB
iajs-2806	29	18	anti	anti	ADJ
iajs-2806	29	19	-	-	ADJ
iajs-2806	29	20	tumor	tumor	ADJ
iajs-2806	29	21	immunity	immunity	NOUN
iajs-2806	29	22	in	in	ADP
iajs-2806	29	23	breast	breast	NOUN
iajs-2806	29	24	cancer	cancer	NOUN
iajs-2806	29	25	patients	patient	NOUN
iajs-2806	29	26	[	[	X
iajs-2806	29	27	3	3	NUM
iajs-2806	29	28	]	]	PUNCT
iajs-2806	29	29	.	.	PUNCT
iajs-2806	30	1	il-33	il-33	ADJ
iajs-2806	30	2	is	be	AUX
iajs-2806	30	3	a	a	DET
iajs-2806	30	4	member	member	NOUN
iajs-2806	30	5	of	of	ADP
iajs-2806	30	6	the	the	DET
iajs-2806	30	7	il-1	il-1	X
iajs-2806	30	8	family	family	NOUN
iajs-2806	30	9	,	,	PUNCT
iajs-2806	30	10	playing	play	VERB
iajs-2806	30	11	important	important	ADJ
iajs-2806	30	12	roles	role	NOUN
iajs-2806	30	13	in	in	ADP
iajs-2806	30	14	inflammation	inflammation	NOUN
iajs-2806	30	15	,	,	PUNCT
iajs-2806	30	16	immune	immune	ADJ
iajs-2806	30	17	regulation	regulation	NOUN
iajs-2806	30	18	,	,	PUNCT
iajs-2806	30	19	host	host	NOUN
iajs-2806	30	20	defense	defense	NOUN
iajs-2806	30	21	and	and	CCONJ
iajs-2806	30	22	neuronal	neuronal	ADJ
iajs-2806	30	23	injury	injury	NOUN
iajs-2806	30	24	[	[	X
iajs-2806	30	25	4	4	NUM
iajs-2806	30	26	]	]	PUNCT
iajs-2806	30	27	.	.	PUNCT
iajs-2806	31	1	the	the	DET
iajs-2806	31	2	human	human	PROPN
iajs-2806	31	3	il-33	il-33	ADJ
iajs-2806	31	4	gene	gene	NOUN
iajs-2806	31	5	was	be	AUX
iajs-2806	31	6	located	locate	VERB
iajs-2806	31	7	on	on	ADP
iajs-2806	31	8	chromosome	chromosome	NOUN
iajs-2806	31	9	9p24.1	9p24.1	NUM
iajs-2806	31	10	[	[	X
iajs-2806	31	11	5	5	NUM
iajs-2806	31	12	]	]	PUNCT
iajs-2806	31	13	.	.	PUNCT
iajs-2806	32	1	including	include	VERB
iajs-2806	32	2	10	10	NUM
iajs-2806	32	3	introns	intron	NOUN
iajs-2806	32	4	and	and	CCONJ
iajs-2806	32	5	11	11	NUM
iajs-2806	32	6	exons	exon	NOUN
iajs-2806	32	7	[	[	X
iajs-2806	32	8	seven	seven	NUM
iajs-2806	32	9	coding	code	VERB
iajs-2806	32	10	exons	exon	NOUN
iajs-2806	32	11	]	]	PUNCT
iajs-2806	32	12	,	,	PUNCT
iajs-2806	32	13	which	which	PRON
iajs-2806	32	14	produced	produce	VERB
iajs-2806	32	15	protein	protein	NOUN
iajs-2806	32	16	of	of	ADP
iajs-2806	32	17	270	270	NUM
iajs-2806	32	18	amino	amino	NOUN
iajs-2806	32	19	acids	acid	NOUN
iajs-2806	32	20	with	with	ADP
iajs-2806	32	21	a	a	DET
iajs-2806	32	22	weight	weight	NOUN
iajs-2806	32	23	of	of	ADP
iajs-2806	32	24	31	31	NUM
iajs-2806	32	25	kda	kda	NOUN
iajs-2806	32	26	.	.	PUNCT
iajs-2806	33	1	the	the	DET
iajs-2806	33	2	il-33	il-33	ADJ
iajs-2806	33	3	n	n	CCONJ
iajs-2806	33	4	-	-	PUNCT
iajs-2806	33	5	terminal	terminal	ADJ
iajs-2806	33	6	domains	domain	NOUN
iajs-2806	33	7	required	require	VERB
iajs-2806	33	8	for	for	ADP
iajs-2806	33	9	nuclear	nuclear	ADJ
iajs-2806	33	10	localization	localization	NOUN
iajs-2806	33	11	,	,	PUNCT
iajs-2806	33	12	encode	encode	ADJ
iajs-2806	33	13	by	by	ADP
iajs-2806	33	14	exons	exon	NOUN
iajs-2806	33	15	1–3	1–3	PROPN
iajs-2806	33	16	,	,	PUNCT
iajs-2806	33	17	whereas	whereas	SCONJ
iajs-2806	33	18	the	the	DET
iajs-2806	33	19	c	c	NOUN
iajs-2806	33	20	-	-	PUNCT
iajs-2806	33	21	terminal	terminal	ADJ
iajs-2806	33	22	il-1	il-1	NOUN
iajs-2806	33	23	-	-	PUNCT
iajs-2806	33	24	like	like	ADJ
iajs-2806	33	25	cytokine	cytokine	NOUN
iajs-2806	33	26	domain	domain	NOUN
iajs-2806	33	27	encode	encode	ADJ
iajs-2806	33	28	by	by	ADP
iajs-2806	33	29	exons	exon	NOUN
iajs-2806	33	30	4–7	4–7	PROPN
iajs-2806	33	31	.	.	PUNCT
iajs-2806	34	1	recently	recently	ADV
iajs-2806	34	2	,	,	PUNCT
iajs-2806	34	3	a	a	DET
iajs-2806	34	4	number	number	NOUN
iajs-2806	34	5	of	of	ADP
iajs-2806	34	6	the	the	DET
iajs-2806	34	7	il-33	il-33	ADJ
iajs-2806	34	8	gene	gene	NOUN
iajs-2806	34	9	polymorphisms	polymorphism	NOUN
iajs-2806	34	10	have	have	AUX
iajs-2806	34	11	been	be	AUX
iajs-2806	34	12	identified	identify	VERB
iajs-2806	34	13	,	,	PUNCT
iajs-2806	34	14	and	and	CCONJ
iajs-2806	34	15	the	the	DET
iajs-2806	34	16	relationships	relationship	NOUN
iajs-2806	34	17	between	between	ADP
iajs-2806	34	18	some	some	DET
iajs-2806	34	19	diseases	disease	NOUN
iajs-2806	34	20	and	and	CCONJ
iajs-2806	34	21	the	the	DET
iajs-2806	34	22	il-33	il-33	ADJ
iajs-2806	34	23	gene	gene	NOUN
iajs-2806	34	24	polymorphisms	polymorphism	NOUN
iajs-2806	34	25	,	,	PUNCT
iajs-2806	34	26	such	such	ADJ
iajs-2806	34	27	as	as	ADP
iajs-2806	34	28	rheumatoid	rheumatoid	NOUN
iajs-2806	34	29	arthritis	arthritis	NOUN
iajs-2806	34	30	and	and	CCONJ
iajs-2806	34	31	systemic	systemic	ADJ
iajs-2806	34	32	sclerosis	sclerosis	NOUN
iajs-2806	34	33	have	have	AUX
iajs-2806	34	34	been	be	AUX
iajs-2806	34	35	reported	report	VERB
iajs-2806	34	36	[	[	X
iajs-2806	34	37	6	6	NUM
iajs-2806	34	38	,	,	PUNCT
iajs-2806	34	39	7	7	NUM
iajs-2806	34	40	,	,	PUNCT
iajs-2806	34	41	8	8	NUM
iajs-2806	34	42	]	]	PUNCT
iajs-2806	34	43	.	.	PUNCT
iajs-2806	35	1	in	in	ADP
iajs-2806	35	2	2003	2003	NUM
iajs-2806	35	3	il-33	il-33	NUM
iajs-2806	35	4	was	be	AUX
iajs-2806	35	5	identified	identify	VERB
iajs-2806	35	6	as	as	ADP
iajs-2806	35	7	a	a	DET
iajs-2806	35	8	nuclear	nuclear	ADJ
iajs-2806	35	9	protein	protein	NOUN
iajs-2806	35	10	,	,	PUNCT
iajs-2806	35	11	highly	highly	ADV
iajs-2806	35	12	expressed	express	VERB
iajs-2806	35	13	in	in	ADP
iajs-2806	35	14	high	high	ADJ
iajs-2806	35	15	endothelial	endothelial	ADJ
iajs-2806	35	16	venules	venule	NOUN
iajs-2806	35	17	[	[	X
iajs-2806	35	18	hev	hev	X
iajs-2806	35	19	]	]	PUNCT
iajs-2806	35	20	,	,	PUNCT
iajs-2806	35	21	and	and	CCONJ
iajs-2806	35	22	initially	initially	ADV
iajs-2806	35	23	named	name	VERB
iajs-2806	35	24	nf	nf	NOUN
iajs-2806	35	25	-	-	PUNCT
iajs-2806	35	26	hev	hev	NOUN
iajs-2806	36	1	[	[	PUNCT
iajs-2806	36	2	nuclear	nuclear	ADJ
iajs-2806	36	3	factor	factor	NOUN
iajs-2806	36	4	from	from	ADP
iajs-2806	36	5	hev	hev	PROPN
iajs-2806	36	6	]	]	X
iajs-2806	37	1	[	[	X
iajs-2806	37	2	9	9	NUM
iajs-2806	37	3	]	]	PUNCT
iajs-2806	37	4	,	,	PUNCT
iajs-2806	37	5	and	and	CCONJ
iajs-2806	37	6	identified	identify	VERB
iajs-2806	37	7	as	as	ADP
iajs-2806	37	8	a	a	DET
iajs-2806	37	9	ligand	ligand	NOUN
iajs-2806	37	10	for	for	ADP
iajs-2806	37	11	st2	st2	NOUN
iajs-2806	37	12	the	the	DET
iajs-2806	37	13	orphan	orphan	NOUN
iajs-2806	37	14	il-1	il-1	ADP
iajs-2806	37	15	family	family	NOUN
iajs-2806	37	16	receptor	receptor	NOUN
iajs-2806	37	17	in	in	ADP
iajs-2806	37	18	2005	2005	NUM
iajs-2806	37	19	[	[	X
iajs-2806	37	20	5	5	NUM
iajs-2806	37	21	]	]	PUNCT
iajs-2806	37	22	.	.	PUNCT
iajs-2806	38	1	il-33	il-33	ADJ
iajs-2806	38	2	was	be	AUX
iajs-2806	38	3	released	release	VERB
iajs-2806	38	4	upon	upon	SCONJ
iajs-2806	38	5	cell	cell	NOUN
iajs-2806	38	6	necrosis	necrosis	NOUN
iajs-2806	38	7	and	and	CCONJ
iajs-2806	38	8	it	it	PRON
iajs-2806	38	9	drives	drive	VERB
iajs-2806	38	10	inflammation	inflammation	NOUN
iajs-2806	38	11	as	as	ADP
iajs-2806	38	12	a	a	DET
iajs-2806	38	13	damp	damp	ADJ
iajs-2806	39	1	[	[	X
iajs-2806	39	2	damage	damage	NOUN
iajs-2806	39	3	associated	associate	VERB
iajs-2806	39	4	molecular	molecular	ADJ
iajs-2806	39	5	pattern	pattern	NOUN
iajs-2806	39	6	]	]	PUNCT
iajs-2806	39	7	;	;	PUNCT
iajs-2806	39	8	il-33	il-33	NUM
iajs-2806	39	9	is	be	AUX
iajs-2806	39	10	expressed	express	VERB
iajs-2806	39	11	by	by	ADP
iajs-2806	39	12	many	many	ADJ
iajs-2806	39	13	cell	cell	NOUN
iajs-2806	39	14	types	type	NOUN
iajs-2806	39	15	and	and	CCONJ
iajs-2806	39	16	precursor	precursor	NOUN
iajs-2806	39	17	form	form	NOUN
iajs-2806	39	18	is	be	AUX
iajs-2806	39	19	enzymatically	enzymatically	ADV
iajs-2806	39	20	processed	process	VERB
iajs-2806	39	21	and	and	CCONJ
iajs-2806	39	22	can	can	AUX
iajs-2806	39	23	regulate	regulate	VERB
iajs-2806	39	24	gene	gene	NOUN
iajs-2806	39	25	transcription	transcription	NOUN
iajs-2806	39	26	[	[	X
iajs-2806	39	27	10	10	NUM
iajs-2806	39	28	]	]	PUNCT
iajs-2806	39	29	.	.	PUNCT
iajs-2806	40	1	it	it	PRON
iajs-2806	40	2	is	be	AUX
iajs-2806	40	3	released	release	VERB
iajs-2806	40	4	from	from	ADP
iajs-2806	40	5	producing	produce	VERB
iajs-2806	40	6	cells	cell	NOUN
iajs-2806	40	7	upon	upon	SCONJ
iajs-2806	40	8	cellular	cellular	ADJ
iajs-2806	40	9	stress	stress	NOUN
iajs-2806	40	10	or	or	CCONJ
iajs-2806	40	11	cellular	cellular	ADJ
iajs-2806	40	12	damage	damage	NOUN
iajs-2806	40	13	,	,	PUNCT
iajs-2806	40	14	and	and	CCONJ
iajs-2806	40	15	appears	appear	VERB
iajs-2806	40	16	to	to	PART
iajs-2806	40	17	function	function	VERB
iajs-2806	40	18	as	as	ADP
iajs-2806	40	19	an	an	DET
iajs-2806	40	20	alarm	alarm	NOUN
iajs-2806	40	21	signal	signal	VERB
iajs-2806	40	22	rapidly	rapidly	ADV
iajs-2806	40	23	.	.	PUNCT
iajs-2806	41	1	it	it	PRON
iajs-2806	41	2	is	be	AUX
iajs-2806	41	3	constitutively	constitutively	ADV
iajs-2806	41	4	expressed	express	VERB
iajs-2806	41	5	in	in	ADP
iajs-2806	41	6	lymphoid	lymphoid	ADJ
iajs-2806	41	7	organs	organ	NOUN
iajs-2806	41	8	and	and	CCONJ
iajs-2806	41	9	epithelial	epithelial	ADJ
iajs-2806	41	10	barrier	barrier	NOUN
iajs-2806	41	11	tissues	tissue	NOUN
iajs-2806	41	12	.	.	PUNCT
iajs-2806	42	1	it	it	PRON
iajs-2806	42	2	plays	play	VERB
iajs-2806	42	3	an	an	DET
iajs-2806	42	4	important	important	ADJ
iajs-2806	42	5	role	role	NOUN
iajs-2806	42	6	in	in	ADP
iajs-2806	42	7	innate	innate	ADJ
iajs-2806	42	8	immunity	immunity	NOUN
iajs-2806	42	9	[	[	X
iajs-2806	42	10	11	11	NUM
iajs-2806	42	11	]	]	PUNCT
iajs-2806	42	12	.	.	PUNCT
iajs-2806	43	1	it	it	PRON
iajs-2806	43	2	is	be	AUX
iajs-2806	43	3	a	a	DET
iajs-2806	43	4	dual	dual	ADJ
iajs-2806	43	5	-	-	PUNCT
iajs-2806	43	6	function	function	NOUN
iajs-2806	43	7	protein	protein	NOUN
iajs-2806	43	8	that	that	PRON
iajs-2806	43	9	acts	act	VERB
iajs-2806	43	10	both	both	PRON
iajs-2806	43	11	as	as	ADP
iajs-2806	43	12	an	an	DET
iajs-2806	43	13	extracellular	extracellular	ADJ
iajs-2806	43	14	alarming	alarming	ADJ
iajs-2806	43	15	cytokine	cytokine	NOUN
iajs-2806	43	16	that	that	PRON
iajs-2806	43	17	has	have	VERB
iajs-2806	43	18	a	a	DET
iajs-2806	43	19	crucial	crucial	ADJ
iajs-2806	43	20	role	role	NOUN
iajs-2806	43	21	in	in	ADP
iajs-2806	43	22	the	the	DET
iajs-2806	43	23	regulation	regulation	NOUN
iajs-2806	43	24	of	of	ADP
iajs-2806	43	25	adaptive	adaptive	ADJ
iajs-2806	43	26	and	and	CCONJ
iajs-2806	43	27	innate	innate	ADJ
iajs-2806	43	28	immune	immune	ADJ
iajs-2806	43	29	responses	response	NOUN
iajs-2806	43	30	,	,	PUNCT
iajs-2806	43	31	wound	wound	ADJ
iajs-2806	43	32	healing	healing	NOUN
iajs-2806	43	33	,	,	PUNCT
iajs-2806	43	34	tissue	tissue	NOUN
iajs-2806	43	35	repair	repair	NOUN
iajs-2806	43	36	.	.	PUNCT
iajs-2806	44	1	as	as	ADV
iajs-2806	44	2	well	well	ADV
iajs-2806	44	3	as	as	ADP
iajs-2806	44	4	the	the	DET
iajs-2806	44	5	initiation	initiation	NOUN
iajs-2806	44	6	of	of	ADP
iajs-2806	44	7	the	the	DET
iajs-2806	44	8	acute	acute	ADJ
iajs-2806	44	9	local	local	ADJ
iajs-2806	44	10	inflammation	inflammation	NOUN
iajs-2806	44	11	,	,	PUNCT
iajs-2806	44	12	and	and	CCONJ
iajs-2806	44	13	other	other	ADJ
iajs-2806	44	14	function	function	NOUN
iajs-2806	44	15	as	as	ADP
iajs-2806	44	16	intracellular	intracellular	ADJ
iajs-2806	44	17	nuclear	nuclear	ADJ
iajs-2806	44	18	factor	factor	NOUN
iajs-2806	44	19	participates	participate	VERB
iajs-2806	44	20	in	in	ADP
iajs-2806	44	21	maintaining	maintain	VERB
iajs-2806	44	22	barrier	barrier	NOUN
iajs-2806	44	23	function	function	NOUN
iajs-2806	44	24	by	by	ADP
iajs-2806	44	25	regulating	regulate	VERB
iajs-2806	44	26	gene	gene	NOUN
iajs-2806	44	27	expression	expression	NOUN
iajs-2806	45	1	[	[	X
iajs-2806	45	2	12	12	NUM
iajs-2806	45	3	]	]	PUNCT
iajs-2806	45	4	.	.	PUNCT
iajs-2806	46	1	il-33	il-33	VERB
iajs-2806	46	2	binding	bind	VERB
iajs-2806	46	3	to	to	ADP
iajs-2806	46	4	its	its	PRON
iajs-2806	46	5	heterodimeric	heterodimeric	ADJ
iajs-2806	46	6	receptor	receptor	NOUN
iajs-2806	46	7	st2	st2	NOUN
iajs-2806	46	8	and	and	CCONJ
iajs-2806	46	9	il-33	il-33	VERB
iajs-2806	46	10	accessory	accessory	ADJ
iajs-2806	46	11	protein	protein	NOUN
iajs-2806	46	12	,	,	PUNCT
iajs-2806	46	13	induces	induce	VERB
iajs-2806	46	14	synthesis	synthesis	NOUN
iajs-2806	46	15	of	of	ADP
iajs-2806	46	16	various	various	ADJ
iajs-2806	46	17	cytokines	cytokine	NOUN
iajs-2806	46	18	such	such	ADJ
iajs-2806	46	19	as	as	ADP
iajs-2806	46	20	il-5	il-5	PROPN
iajs-2806	46	21	and	and	CCONJ
iajs-2806	46	22	il-13	il-13	NUM
iajs-2806	46	23	.	.	PUNCT
iajs-2806	47	1	il-33	il-33	PROPN
iajs-2806	47	2	plays	play	VERB
iajs-2806	47	3	various	various	ADJ
iajs-2806	47	4	but	but	CCONJ
iajs-2806	47	5	important	important	ADJ
iajs-2806	47	6	roles	role	NOUN
iajs-2806	47	7	in	in	ADP
iajs-2806	47	8	immunemediated	immunemediate	VERB
iajs-2806	47	9	diseases	disease	NOUN
iajs-2806	47	10	such	such	ADJ
iajs-2806	47	11	as	as	ADP
iajs-2806	47	12	autoimmune	autoimmune	ADJ
iajs-2806	47	13	diseases	disease	NOUN
iajs-2806	47	14	,	,	PUNCT
iajs-2806	47	15	infection	infection	NOUN
iajs-2806	47	16	and	and	CCONJ
iajs-2806	47	17	allergy	allergy	NOUN
iajs-2806	47	18	[	[	X
iajs-2806	47	19	13	13	NUM
iajs-2806	47	20	]	]	PUNCT
iajs-2806	47	21	.	.	PUNCT
iajs-2806	48	1	il-33	il-33	VERB
iajs-2806	48	2	contributes	contribute	VERB
iajs-2806	48	3	to	to	ADP
iajs-2806	48	4	enhanced	enhance	VERB
iajs-2806	48	5	immunosuppressive	immunosuppressive	ADJ
iajs-2806	48	6	function	function	NOUN
iajs-2806	48	7	and	and	CCONJ
iajs-2806	48	8	the	the	DET
iajs-2806	48	9	abnormal	abnormal	ADJ
iajs-2806	48	10	expansion	expansion	NOUN
iajs-2806	48	11	of	of	ADP
iajs-2806	48	12	mdscs	mdsc	NOUN
iajs-2806	48	13	[	[	X
iajs-2806	48	14	myeloidderived	myeloidderive	VERB
iajs-2806	48	15	suppressor	suppressor	NOUN
iajs-2806	48	16	cells	cell	NOUN
iajs-2806	48	17	]	]	PUNCT
iajs-2806	48	18	within	within	ADP
iajs-2806	48	19	the	the	DET
iajs-2806	48	20	microenvironment	microenvironment	NOUN
iajs-2806	48	21	of	of	ADP
iajs-2806	48	22	tumor	tumor	NOUN
iajs-2806	48	23	,	,	PUNCT
iajs-2806	48	24	which	which	PRON
iajs-2806	48	25	can	can	AUX
iajs-2806	48	26	be	be	AUX
iajs-2806	48	27	probably	probably	ADV
iajs-2806	48	28	targeted	target	VERB
iajs-2806	48	29	to	to	PART
iajs-2806	48	30	reverse	reverse	VERB
iajs-2806	48	31	mdsc	mdsc	ADV
iajs-2806	48	32	-	-	PUNCT
iajs-2806	48	33	mediated	mediate	VERB
iajs-2806	48	34	tumor	tumor	NOUN
iajs-2806	48	35	immune	immune	ADJ
iajs-2806	48	36	evasion	evasion	NOUN
iajs-2806	48	37	,	,	PUNCT
iajs-2806	48	38	mdscs	mdsc	NOUN
iajs-2806	48	39	mediated	mediate	VERB
iajs-2806	48	40	immune	immune	ADJ
iajs-2806	48	41	dysfunction	dysfunction	NOUN
iajs-2806	48	42	is	be	AUX
iajs-2806	48	43	an	an	DET
iajs-2806	48	44	important	important	ADJ
iajs-2806	48	45	mechanism	mechanism	NOUN
iajs-2806	48	46	that	that	PRON
iajs-2806	48	47	leads	lead	VERB
iajs-2806	48	48	to	to	ADP
iajs-2806	48	49	tumor	tumor	NOUN
iajs-2806	48	50	immune	immune	ADJ
iajs-2806	48	51	escape	escape	NOUN
iajs-2806	48	52	and	and	CCONJ
iajs-2806	48	53	the	the	DET
iajs-2806	48	54	inefficacy	inefficacy	NOUN
iajs-2806	48	55	of	of	ADP
iajs-2806	48	56	cancer	cancer	NOUN
iajs-2806	48	57	immunotherapy	immunotherapy	NOUN
iajs-2806	49	1	[	[	X
iajs-2806	49	2	14	14	NUM
iajs-2806	49	3	]	]	PUNCT
iajs-2806	49	4	.	.	PUNCT
iajs-2806	50	1	the	the	DET
iajs-2806	50	2	il-33	il-33	PRON
iajs-2806	50	3	/	/	SYM
iajs-2806	50	4	st2	st2	NOUN
iajs-2806	50	5	axis	axis	NOUN
iajs-2806	50	6	has	have	AUX
iajs-2806	50	7	been	be	AUX
iajs-2806	50	8	implicated	implicate	VERB
iajs-2806	50	9	in	in	ADP
iajs-2806	50	10	numerous	numerous	ADJ
iajs-2806	50	11	disease	disease	NOUN
iajs-2806	50	12	states	state	NOUN
iajs-2806	50	13	,	,	PUNCT
iajs-2806	50	14	including	include	VERB
iajs-2806	50	15	cancer	cancer	NOUN
iajs-2806	50	16	and	and	CCONJ
iajs-2806	50	17	asthma	asthma	NOUN
iajs-2806	51	1	[	[	X
iajs-2806	51	2	15	15	NUM
iajs-2806	51	3	,	,	PUNCT
iajs-2806	51	4	16	16	NUM
iajs-2806	51	5	]	]	PUNCT
iajs-2806	51	6	,	,	PUNCT
iajs-2806	51	7	alzheimer	alzheimer	PROPN
iajs-2806	51	8	’s	’s	PART
iajs-2806	51	9	disease	disease	NOUN
iajs-2806	51	10	[	[	X
iajs-2806	51	11	17	17	NUM
iajs-2806	51	12	]	]	PUNCT
iajs-2806	51	13	and	and	CCONJ
iajs-2806	51	14	inflammatory	inflammatory	ADJ
iajs-2806	51	15	bowel	bowel	NOUN
iajs-2806	51	16	diseases	disease	NOUN
iajs-2806	51	17	[	[	X
iajs-2806	51	18	18	18	NUM
iajs-2806	51	19	]	]	PUNCT
iajs-2806	51	20	.	.	PUNCT
iajs-2806	52	1	some	some	DET
iajs-2806	52	2	evidence	evidence	NOUN
iajs-2806	52	3	is	be	AUX
iajs-2806	52	4	supportive	supportive	ADJ
iajs-2806	52	5	of	of	ADP
iajs-2806	52	6	a	a	DET
iajs-2806	52	7	critical	critical	ADJ
iajs-2806	52	8	role	role	NOUN
iajs-2806	52	9	for	for	ADP
iajs-2806	52	10	the	the	DET
iajs-2806	52	11	il-33	il-33	PRON
iajs-2806	52	12	/	/	SYM
iajs-2806	52	13	st2	st2	NOUN
iajs-2806	52	14	axis	axis	NOUN
iajs-2806	52	15	in	in	ADP
iajs-2806	52	16	the	the	DET
iajs-2806	52	17	initiation	initiation	NOUN
iajs-2806	52	18	and	and	CCONJ
iajs-2806	52	19	ibn	ibn	PROPN
iajs-2806	52	20	al	al	PROPN
iajs-2806	52	21	-	-	PUNCT
iajs-2806	52	22	haitham	haitham	PROPN
iajs-2806	52	23	jour	jour	X
iajs-2806	52	24	.	.	PROPN
iajs-2806	53	1	for	for	ADP
iajs-2806	53	2	pure	pure	ADJ
iajs-2806	53	3	&	&	CCONJ
iajs-2806	53	4	appl	appl	PROPN
iajs-2806	53	5	.	.	PUNCT
iajs-2806	54	1	sci	sci	PROPN
iajs-2806	54	2	.	.	PROPN
iajs-2806	55	1	34	34	NUM
iajs-2806	55	2	(	(	PUNCT
iajs-2806	55	3	1	1	NUM
iajs-2806	55	4	)	)	PUNCT
iajs-2806	55	5	2021	2021	NUM
iajs-2806	55	6	3	3	NUM
iajs-2806	55	7	maintenance	maintenance	NOUN
iajs-2806	55	8	of	of	ADP
iajs-2806	55	9	wound	wound	ADJ
iajs-2806	55	10	healing	healing	NOUN
iajs-2806	55	11	responses	response	NOUN
iajs-2806	55	12	[	[	X
iajs-2806	55	13	19	19	NUM
iajs-2806	55	14	]	]	PUNCT
iajs-2806	55	15	.	.	PUNCT
iajs-2806	56	1	initially	initially	ADV
iajs-2806	56	2	the	the	DET
iajs-2806	56	3	link	link	NOUN
iajs-2806	56	4	between	between	ADP
iajs-2806	56	5	cancer	cancer	NOUN
iajs-2806	56	6	and	and	CCONJ
iajs-2806	56	7	il33	il33	PROPN
iajs-2806	56	8	/	/	SYM
iajs-2806	56	9	st2	st2	NOUN
iajs-2806	56	10	axis	axis	NOUN
iajs-2806	56	11	was	be	AUX
iajs-2806	56	12	identified	identify	VERB
iajs-2806	56	13	in	in	ADP
iajs-2806	56	14	breast	breast	NOUN
iajs-2806	56	15	cancer	cancer	NOUN
iajs-2806	56	16	[	[	X
iajs-2806	56	17	20	20	NUM
iajs-2806	56	18	]	]	PUNCT
iajs-2806	56	19	.	.	PUNCT
iajs-2806	57	1	il-33	il-33	VERB
iajs-2806	57	2	/	/	SYM
iajs-2806	57	3	st2	st2	NOUN
iajs-2806	57	4	signaling	signal	VERB
iajs-2806	57	5	inducing	induce	VERB
iajs-2806	57	6	the	the	DET
iajs-2806	57	7	protumorigenic	protumorigenic	ADJ
iajs-2806	57	8	cytokine	cytokine	NOUN
iajs-2806	57	9	il-6	il-6	NOUN
iajs-2806	57	10	,	,	PUNCT
iajs-2806	57	11	possibly	possibly	ADV
iajs-2806	57	12	contributes	contribute	VERB
iajs-2806	57	13	to	to	ADP
iajs-2806	57	14	intestinal	intestinal	ADJ
iajs-2806	57	15	tumorigenesis	tumorigenesis	NOUN
iajs-2806	57	16	in	in	ADP
iajs-2806	57	17	mice	mouse	NOUN
iajs-2806	57	18	[	[	X
iajs-2806	57	19	21	21	NUM
iajs-2806	57	20	]	]	PUNCT
iajs-2806	57	21	.	.	PUNCT
iajs-2806	58	1	il33	il33	PROPN
iajs-2806	58	2	/	/	SYM
iajs-2806	58	3	st2	st2	NOUN
iajs-2806	58	4	pathway	pathway	NOUN
iajs-2806	58	5	facilitated	facilitate	VERB
iajs-2806	58	6	expression	expression	NOUN
iajs-2806	58	7	of	of	ADP
iajs-2806	58	8	pro	pro	ADJ
iajs-2806	58	9	angiogenic	angiogenic	ADJ
iajs-2806	58	10	vascular	vascular	ADJ
iajs-2806	58	11	endothelial	endothelial	NOUN
iajs-2806	58	12	growth	growth	NOUN
iajs-2806	58	13	factor	factor	NOUN
iajs-2806	58	14	[	[	X
iajs-2806	58	15	vegf	vegf	X
iajs-2806	58	16	]	]	PUNCT
iajs-2806	58	17	in	in	ADP
iajs-2806	58	18	tumor	tumor	NOUN
iajs-2806	58	19	cells	cell	NOUN
iajs-2806	58	20	and	and	CCONJ
iajs-2806	58	21	attenuating	attenuate	VERB
iajs-2806	58	22	tumor	tumor	NOUN
iajs-2806	58	23	necrosis	necrosis	NOUN
iajs-2806	58	24	and	and	CCONJ
iajs-2806	58	25	that	that	SCONJ
iajs-2806	58	26	critically	critically	ADV
iajs-2806	58	27	involved	involve	VERB
iajs-2806	58	28	in	in	ADP
iajs-2806	58	29	the	the	DET
iajs-2806	58	30	growth	growth	NOUN
iajs-2806	58	31	of	of	ADP
iajs-2806	58	32	breast	breast	NOUN
iajs-2806	58	33	tumor	tumor	NOUN
iajs-2806	59	1	[	[	X
iajs-2806	59	2	22	22	NUM
iajs-2806	59	3	]	]	PUNCT
iajs-2806	59	4	.	.	PUNCT
iajs-2806	60	1	the	the	DET
iajs-2806	60	2	aim	aim	NOUN
iajs-2806	60	3	of	of	ADP
iajs-2806	60	4	the	the	DET
iajs-2806	60	5	present	present	ADJ
iajs-2806	60	6	study	study	NOUN
iajs-2806	60	7	is	be	AUX
iajs-2806	60	8	the	the	DET
iajs-2806	60	9	association	association	NOUN
iajs-2806	60	10	of	of	ADP
iajs-2806	60	11	il-33	il-33	PROPN
iajs-2806	60	12	serum	serum	NOUN
iajs-2806	60	13	level	level	NOUN
iajs-2806	60	14	and	and	CCONJ
iajs-2806	60	15	polymorphism	polymorphism	NOUN
iajs-2806	60	16	with	with	ADP
iajs-2806	60	17	breast	breast	NOUN
iajs-2806	60	18	cancer	cancer	NOUN
iajs-2806	60	19	in	in	ADP
iajs-2806	60	20	iraqi	iraqi	ADJ
iajs-2806	60	21	women	woman	NOUN
iajs-2806	60	22	suffers	suffer	VERB
iajs-2806	60	23	from	from	ADP
iajs-2806	60	24	breast	breast	NOUN
iajs-2806	60	25	cancer	cancer	NOUN
iajs-2806	60	26	.	.	PUNCT
iajs-2806	61	1	2	2	X
iajs-2806	61	2	.	.	X
iajs-2806	61	3	materials	material	NOUN
iajs-2806	61	4	and	and	CCONJ
iajs-2806	61	5	methods	method	NOUN
iajs-2806	61	6	blood	blood	NOUN
iajs-2806	61	7	samples	sample	NOUN
iajs-2806	61	8	were	be	AUX
iajs-2806	61	9	collected	collect	VERB
iajs-2806	61	10	from	from	ADP
iajs-2806	61	11	66	66	NUM
iajs-2806	61	12	iraqi	iraqi	ADJ
iajs-2806	61	13	patient	patient	ADJ
iajs-2806	61	14	women	woman	NOUN
iajs-2806	61	15	diagnosed	diagnose	VERB
iajs-2806	61	16	with	with	ADP
iajs-2806	61	17	breast	breast	NOUN
iajs-2806	61	18	cancer	cancer	NOUN
iajs-2806	61	19	[	[	X
iajs-2806	61	20	underwent	underwent	ADJ
iajs-2806	61	21	surgery	surgery	NOUN
iajs-2806	61	22	]	]	PUNCT
iajs-2806	61	23	from	from	ADP
iajs-2806	61	24	the	the	DET
iajs-2806	61	25	oncology	oncology	NOUN
iajs-2806	61	26	teaching	teaching	NOUN
iajs-2806	61	27	hospital	hospital	NOUN
iajs-2806	61	28	of	of	ADP
iajs-2806	61	29	the	the	DET
iajs-2806	61	30	medical	medical	ADJ
iajs-2806	61	31	city	city	NOUN
iajs-2806	61	32	.	.	PUNCT
iajs-2806	62	1	samples	sample	NOUN
iajs-2806	62	2	divided	divide	VERB
iajs-2806	62	3	into	into	ADP
iajs-2806	62	4	two	two	NUM
iajs-2806	62	5	groups	group	NOUN
iajs-2806	62	6	pre	pre	ADJ
iajs-2806	62	7	-	-	NOUN
iajs-2806	62	8	treatment	treatment	ADJ
iajs-2806	62	9	[	[	X
iajs-2806	62	10	pt	pt	X
iajs-2806	62	11	]	]	X
iajs-2806	62	12	and	and	CCONJ
iajs-2806	62	13	under	under	ADP
iajs-2806	62	14	treatment	treatment	NOUN
iajs-2806	62	15	with	with	ADP
iajs-2806	62	16	chemotherapy	chemotherapy	NOUN
iajs-2806	62	17	[	[	X
iajs-2806	62	18	utc	utc	X
iajs-2806	62	19	]	]	X
iajs-2806	62	20	patients	patient	NOUN
iajs-2806	62	21	[	[	X
iajs-2806	62	22	surgery	surgery	NOUN
iajs-2806	62	23	was	be	AUX
iajs-2806	62	24	performed	perform	VERB
iajs-2806	62	25	to	to	PART
iajs-2806	62	26	remove	remove	VERB
iajs-2806	62	27	the	the	DET
iajs-2806	62	28	tumor	tumor	NOUN
iajs-2806	62	29	]	]	PUNCT
iajs-2806	62	30	,	,	PUNCT
iajs-2806	62	31	during	during	ADP
iajs-2806	62	32	the	the	DET
iajs-2806	62	33	period	period	NOUN
iajs-2806	62	34	from	from	ADP
iajs-2806	62	35	september	september	PROPN
iajs-2806	62	36	2017	2017	NUM
iajs-2806	62	37	to	to	ADP
iajs-2806	62	38	december	december	PROPN
iajs-2806	62	39	2017	2017	NUM
iajs-2806	62	40	,	,	PUNCT
iajs-2806	62	41	and	and	CCONJ
iajs-2806	62	42	34	34	NUM
iajs-2806	62	43	healthy	healthy	ADJ
iajs-2806	62	44	women	woman	NOUN
iajs-2806	62	45	were	be	AUX
iajs-2806	62	46	matched	match	VERB
iajs-2806	62	47	with	with	ADP
iajs-2806	62	48	patients	patient	NOUN
iajs-2806	62	49	in	in	ADP
iajs-2806	62	50	age	age	NOUN
iajs-2806	62	51	and	and	CCONJ
iajs-2806	62	52	gender	gender	NOUN
iajs-2806	62	53	.	.	PUNCT
iajs-2806	63	1	the	the	DET
iajs-2806	63	2	volume	volume	NOUN
iajs-2806	63	3	of	of	ADP
iajs-2806	63	4	5	5	NUM
iajs-2806	63	5	ml	ml	NOUN
iajs-2806	63	6	of	of	ADP
iajs-2806	63	7	whole	whole	ADJ
iajs-2806	63	8	blood	blood	NOUN
iajs-2806	63	9	samples	sample	NOUN
iajs-2806	63	10	was	be	AUX
iajs-2806	63	11	collected	collect	VERB
iajs-2806	63	12	under	under	ADP
iajs-2806	63	13	sterilized	sterilize	VERB
iajs-2806	63	14	condition	condition	NOUN
iajs-2806	63	15	by	by	ADP
iajs-2806	63	16	using	use	VERB
iajs-2806	63	17	disposable	disposable	ADJ
iajs-2806	63	18	syringe	syringe	NOUN
iajs-2806	63	19	then	then	ADV
iajs-2806	63	20	distributed	distribute	VERB
iajs-2806	63	21	to	to	ADP
iajs-2806	63	22	two	two	NUM
iajs-2806	63	23	parts	part	NOUN
iajs-2806	63	24	2	2	NUM
iajs-2806	63	25	ml	ml	NOUN
iajs-2806	63	26	in	in	ADP
iajs-2806	63	27	edta	edta	NOUN
iajs-2806	63	28	tube	tube	NOUN
iajs-2806	63	29	and	and	CCONJ
iajs-2806	63	30	3	3	NUM
iajs-2806	63	31	ml	ml	NOUN
iajs-2806	63	32	in	in	ADP
iajs-2806	63	33	gel	gel	NOUN
iajs-2806	63	34	tube	tube	NOUN
iajs-2806	63	35	left	leave	VERB
iajs-2806	63	36	for	for	ADP
iajs-2806	63	37	half	half	DET
iajs-2806	63	38	an	an	DET
iajs-2806	63	39	hour	hour	NOUN
iajs-2806	63	40	,	,	PUNCT
iajs-2806	63	41	then	then	ADV
iajs-2806	63	42	centrifuged	centrifuge	VERB
iajs-2806	63	43	for	for	ADP
iajs-2806	63	44	15	15	NUM
iajs-2806	63	45	minutes	minute	NOUN
iajs-2806	63	46	at	at	ADP
iajs-2806	63	47	3000	3000	NUM
iajs-2806	63	48	rpm	rpm	NOUN
iajs-2806	63	49	serum	serum	NOUN
iajs-2806	63	50	was	be	AUX
iajs-2806	63	51	transferred	transfer	VERB
iajs-2806	63	52	into	into	ADP
iajs-2806	63	53	2ml	2ml	NOUN
iajs-2806	63	54	eppendorf	eppendorf	PROPN
iajs-2806	63	55	tubes	tube	NOUN
iajs-2806	63	56	and	and	CCONJ
iajs-2806	63	57	stored	store	VERB
iajs-2806	63	58	at	at	ADP
iajs-2806	63	59	-20	-20	PROPN
iajs-2806	63	60	c	c	NOUN
iajs-2806	63	61	for	for	ADP
iajs-2806	63	62	further	further	ADJ
iajs-2806	63	63	analysis	analysis	NOUN
iajs-2806	63	64	.	.	PUNCT
iajs-2806	64	1	the	the	DET
iajs-2806	64	2	serum	serum	NOUN
iajs-2806	64	3	level	level	NOUN
iajs-2806	64	4	of	of	ADP
iajs-2806	64	5	il-33	il-33	ADV
iajs-2806	64	6	measured	measure	VERB
iajs-2806	64	7	by	by	ADP
iajs-2806	64	8	using	use	VERB
iajs-2806	64	9	an	an	DET
iajs-2806	64	10	elisa	elisa	NOUN
iajs-2806	64	11	kit	kit	NOUN
iajs-2806	64	12	[	[	X
iajs-2806	64	13	human	human	NOUN
iajs-2806	64	14	il-33	il-33	ADJ
iajs-2806	64	15	elisa	elisa	NOUN
iajs-2806	64	16	.	.	PUNCT
iajs-2806	65	1	2.1	2.1	NUM
iajs-2806	65	2	.	.	PUNCT
iajs-2806	65	3	dna	dna	PROPN
iajs-2806	65	4	extraction	extraction	NOUN
iajs-2806	65	5	and	and	CCONJ
iajs-2806	65	6	polymorphism	polymorphism	NOUN
iajs-2806	65	7	genotyping	genotype	VERB
iajs-2806	65	8	total	total	ADJ
iajs-2806	65	9	genomic	genomic	NOUN
iajs-2806	65	10	dna	dna	PROPN
iajs-2806	65	11	extracted	extract	VERB
iajs-2806	65	12	from	from	ADP
iajs-2806	65	13	the	the	DET
iajs-2806	65	14	whole	whole	ADJ
iajs-2806	65	15	blood	blood	NOUN
iajs-2806	65	16	was	be	AUX
iajs-2806	65	17	applied	apply	VERB
iajs-2806	65	18	using	use	VERB
iajs-2806	65	19	genomic	genomic	ADJ
iajs-2806	65	20	dna	dna	PROPN
iajs-2806	65	21	extraction	extraction	NOUN
iajs-2806	65	22	kits	kit	NOUN
iajs-2806	66	1	[	[	X
iajs-2806	66	2	geneaid	geneaid	PROPN
iajs-2806	66	3	,	,	PUNCT
iajs-2806	66	4	taiwan	taiwan	PROPN
iajs-2806	66	5	]	]	PUNCT
iajs-2806	66	6	.	.	PUNCT
iajs-2806	67	1	then	then	ADV
iajs-2806	67	2	,	,	PUNCT
iajs-2806	67	3	dna	dna	PROPN
iajs-2806	67	4	concentration	concentration	NOUN
iajs-2806	67	5	and	and	CCONJ
iajs-2806	67	6	purity	purity	NOUN
iajs-2806	67	7	were	be	AUX
iajs-2806	67	8	measured	measure	VERB
iajs-2806	67	9	by	by	ADP
iajs-2806	67	10	nanodrop	nanodrop	NOUN
iajs-2806	67	11	.	.	PUNCT
iajs-2806	68	1	dna	dna	PROPN
iajs-2806	68	2	bands	band	NOUN
iajs-2806	68	3	were	be	AUX
iajs-2806	68	4	visualized	visualize	VERB
iajs-2806	68	5	using	use	VERB
iajs-2806	68	6	uv	uv	NOUN
iajs-2806	68	7	light	light	NOUN
iajs-2806	68	8	after	after	ADP
iajs-2806	68	9	electrophoresis	electrophoresis	NOUN
iajs-2806	68	10	in	in	ADP
iajs-2806	68	11	a	a	DET
iajs-2806	68	12	1	1	NUM
iajs-2806	68	13	%	%	NOUN
iajs-2806	68	14	agarose	agarose	NOUN
iajs-2806	68	15	gel	gel	NOUN
iajs-2806	68	16	in	in	ADP
iajs-2806	68	17	75	75	NUM
iajs-2806	68	18	volts	volt	NOUN
iajs-2806	68	19	for	for	ADP
iajs-2806	68	20	1	1	NUM
iajs-2806	68	21	hour	hour	NOUN
iajs-2806	68	22	.	.	PUNCT
iajs-2806	69	1	extracted	extract	VERB
iajs-2806	69	2	dna	dna	NOUN
iajs-2806	69	3	samples	sample	NOUN
iajs-2806	69	4	were	be	AUX
iajs-2806	69	5	stored	store	VERB
iajs-2806	69	6	at	at	ADP
iajs-2806	69	7	-20ْc	-20ْc	PROPN
iajs-2806	69	8	for	for	SCONJ
iajs-2806	69	9	furthered	further	VERB
iajs-2806	69	10	used	use	VERB
iajs-2806	69	11	.	.	PUNCT
iajs-2806	70	1	the	the	DET
iajs-2806	70	2	polymerase	polymerase	NOUN
iajs-2806	70	3	chain	chain	NOUN
iajs-2806	70	4	reaction	reaction	NOUN
iajs-2806	70	5	[	[	X
iajs-2806	70	6	pcr	pcr	NOUN
iajs-2806	70	7	]	]	PUNCT
iajs-2806	70	8	performed	perform	VERB
iajs-2806	70	9	in	in	ADP
iajs-2806	70	10	a	a	DET
iajs-2806	70	11	25µl	25µl	ADJ
iajs-2806	70	12	reaction	reaction	NOUN
iajs-2806	70	13	mixture	mixture	NOUN
iajs-2806	70	14	,	,	PUNCT
iajs-2806	70	15	pre	pre	ADJ
iajs-2806	70	16	-	-	NOUN
iajs-2806	70	17	mix	mix	VERB
iajs-2806	70	18	5µl	5µl	NOUN
iajs-2806	71	1	[	[	X
iajs-2806	71	2	bioneer	bioneer	NOUN
iajs-2806	71	3	,	,	PUNCT
iajs-2806	71	4	korea	korea	PROPN
iajs-2806	71	5	]	]	PUNCT
iajs-2806	71	6	,	,	PUNCT
iajs-2806	71	7	2µl	2µl	ADJ
iajs-2806	71	8	dna	dna	NOUN
iajs-2806	71	9	,	,	PUNCT
iajs-2806	71	10	2µl	2µl	NOUN
iajs-2806	71	11	of	of	ADP
iajs-2806	71	12	each	each	DET
iajs-2806	71	13	primer	primer	NOUN
iajs-2806	71	14	and	and	CCONJ
iajs-2806	71	15	11µl	11µl	NOUN
iajs-2806	71	16	of	of	ADP
iajs-2806	71	17	distilled	distilled	ADJ
iajs-2806	71	18	water	water	NOUN
iajs-2806	71	19	.	.	PUNCT
iajs-2806	72	1	the	the	DET
iajs-2806	72	2	primer	primer	NOUN
iajs-2806	72	3	sequence	sequence	NOUN
iajs-2806	72	4	of	of	ADP
iajs-2806	72	5	il-33	il-33	ADJ
iajs-2806	72	6	snp	snp	NOUN
iajs-2806	72	7	[	[	X
iajs-2806	72	8	rs1929992	rs1929992	X
iajs-2806	72	9	]	]	PUNCT
iajs-2806	72	10	was	be	AUX
iajs-2806	72	11	shown	show	VERB
iajs-2806	72	12	in	in	ADP
iajs-2806	72	13	table	table	NOUN
iajs-2806	72	14	1	1	NUM
iajs-2806	72	15	.	.	PUNCT
iajs-2806	73	1	the	the	DET
iajs-2806	73	2	program	program	NOUN
iajs-2806	73	3	of	of	ADP
iajs-2806	73	4	pcr	pcr	ADJ
iajs-2806	73	5	reaction	reaction	NOUN
iajs-2806	73	6	was	be	AUX
iajs-2806	73	7	shown	show	VERB
iajs-2806	73	8	in	in	ADP
iajs-2806	73	9	table	table	NOUN
iajs-2806	73	10	2	2	NUM
iajs-2806	73	11	.	.	PUNCT
iajs-2806	74	1	the	the	DET
iajs-2806	74	2	length	length	NOUN
iajs-2806	74	3	of	of	ADP
iajs-2806	74	4	pcr	pcr	ADJ
iajs-2806	74	5	products	product	NOUN
iajs-2806	74	6	was	be	AUX
iajs-2806	74	7	217bp	217bp	NOUN
iajs-2806	74	8	.	.	PUNCT
iajs-2806	75	1	the	the	DET
iajs-2806	75	2	polymerase	polymerase	NOUN
iajs-2806	75	3	chain	chain	NOUN
iajs-2806	75	4	reactionrestriction	reactionrestriction	NOUN
iajs-2806	75	5	fragment	fragment	NOUN
iajs-2806	75	6	length	length	NOUN
iajs-2806	75	7	polymorphism	polymorphism	NOUN
iajs-2806	75	8	[	[	X
iajs-2806	75	9	pcr	pcr	NOUN
iajs-2806	75	10	-	-	PUNCT
iajs-2806	75	11	rflp	rflp	NOUN
iajs-2806	75	12	]	]	PUNCT
iajs-2806	75	13	method	method	NOUN
iajs-2806	75	14	was	be	AUX
iajs-2806	75	15	performed	perform	VERB
iajs-2806	75	16	to	to	PART
iajs-2806	75	17	determine	determine	VERB
iajs-2806	75	18	il-33	il-33	VERB
iajs-2806	75	19	gene	gene	NOUN
iajs-2806	75	20	polymorphisms	polymorphism	NOUN
iajs-2806	75	21	at	at	ADP
iajs-2806	75	22	rs1929992	rs1929992	ADJ
iajs-2806	75	23	.	.	PUNCT
iajs-2806	76	1	the	the	DET
iajs-2806	76	2	product	product	NOUN
iajs-2806	76	3	of	of	ADP
iajs-2806	76	4	pcr	pcr	NOUN
iajs-2806	76	5	restricted	restrict	VERB
iajs-2806	76	6	with	with	ADP
iajs-2806	76	7	restriction	restriction	NOUN
iajs-2806	76	8	enzyme	enzyme	NOUN
iajs-2806	76	9	sspi	sspi	NOUN
iajs-2806	76	10	[	[	X
iajs-2806	76	11	new	new	ADJ
iajs-2806	76	12	england	england	PROPN
iajs-2806	76	13	biolabs	biolabs	PROPN
iajs-2806	76	14	,	,	PUNCT
iajs-2806	76	15	england	england	PROPN
iajs-2806	76	16	]	]	PUNCT
iajs-2806	76	17	.	.	PUNCT
iajs-2806	77	1	the	the	DET
iajs-2806	77	2	results	result	NOUN
iajs-2806	77	3	observed	observe	VERB
iajs-2806	77	4	,	,	PUNCT
iajs-2806	77	5	three	three	NUM
iajs-2806	77	6	genotypes	genotype	NOUN
iajs-2806	77	7	were	be	AUX
iajs-2806	77	8	in	in	ADP
iajs-2806	77	9	the	the	DET
iajs-2806	77	10	homozygote	homozygote	NOUN
iajs-2806	78	1	[	[	X
iajs-2806	78	2	gg	gg	X
iajs-2806	78	3	]	]	PUNCT
iajs-2806	78	4	without	without	ADP
iajs-2806	78	5	any	any	DET
iajs-2806	78	6	digest	digest	NOUN
iajs-2806	78	7	217bp	217bp	NOUN
iajs-2806	78	8	,	,	PUNCT
iajs-2806	78	9	in	in	ADP
iajs-2806	78	10	the	the	DET
iajs-2806	78	11	heterozygote	heterozygote	NOUN
iajs-2806	78	12	[	[	X
iajs-2806	78	13	ag	ag	X
iajs-2806	78	14	]	]	X
iajs-2806	78	15	three	three	NUM
iajs-2806	78	16	different	different	ADJ
iajs-2806	78	17	fragments	fragment	NOUN
iajs-2806	78	18	with	with	ADP
iajs-2806	78	19	217	217	NUM
iajs-2806	78	20	,	,	PUNCT
iajs-2806	78	21	134	134	NUM
iajs-2806	78	22	and	and	CCONJ
iajs-2806	78	23	83bp	83bp	ADV
iajs-2806	78	24	,	,	PUNCT
iajs-2806	78	25	while	while	SCONJ
iajs-2806	78	26	in	in	ADP
iajs-2806	78	27	the	the	DET
iajs-2806	78	28	homozygote	homozygote	NOUN
iajs-2806	78	29	[	[	X
iajs-2806	78	30	aa	aa	X
iajs-2806	78	31	]	]	X
iajs-2806	78	32	two	two	NUM
iajs-2806	78	33	different	different	ADJ
iajs-2806	78	34	fragments	fragment	NOUN
iajs-2806	78	35	134	134	NUM
iajs-2806	78	36	and	and	CCONJ
iajs-2806	78	37	83bp	83bp	ADJ
iajs-2806	78	38	.	.	PUNCT
iajs-2806	79	1	table	table	NOUN
iajs-2806	79	2	1	1	NUM
iajs-2806	79	3	:	:	PUNCT
iajs-2806	79	4	sequence	sequence	NOUN
iajs-2806	79	5	of	of	ADP
iajs-2806	79	6	the	the	DET
iajs-2806	79	7	il-33	il-33	ADJ
iajs-2806	79	8	snp	snp	ADJ
iajs-2806	79	9	rs1929992	rs1929992	ADJ
iajs-2806	79	10	primers	primer	NOUN
iajs-2806	79	11	utilized	utilize	VERB
iajs-2806	79	12	in	in	ADP
iajs-2806	79	13	this	this	DET
iajs-2806	79	14	study	study	NOUN
iajs-2806	79	15	.	.	PUNCT
iajs-2806	80	1	sequences	sequence	NOUN
iajs-2806	81	1	[	[	X
iajs-2806	81	2	5`→3`	5`→3`	NUM
iajs-2806	81	3	]	]	PUNCT
iajs-2806	81	4	size	size	NOUN
iajs-2806	81	5	references	reference	NOUN
iajs-2806	81	6	forward	forward	ADV
iajs-2806	81	7	:	:	PUNCT
iajs-2806	81	8	5`gaagtcatcatcaacttggaacc-3`	5`gaagtcatcatcaacttggaacc-3`	NUM
iajs-2806	81	9	revers	rever	NOUN
iajs-2806	81	10	:	:	PUNCT
iajs-2806	81	11	5`-ggattggaatcccatggtc-3`	5`-ggattggaatcccatggtc-3`	NUM
iajs-2806	81	12	217bp	217bp	NOUN
iajs-2806	81	13	23	23	NUM
iajs-2806	81	14	ibn	ibn	PROPN
iajs-2806	81	15	al	al	PROPN
iajs-2806	81	16	-	-	PUNCT
iajs-2806	81	17	haitham	haitham	PROPN
iajs-2806	81	18	jour	jour	X
iajs-2806	81	19	.	.	PROPN
iajs-2806	81	20	for	for	ADP
iajs-2806	81	21	pure	pure	ADJ
iajs-2806	81	22	&	&	CCONJ
iajs-2806	81	23	appl	appl	PROPN
iajs-2806	81	24	.	.	PUNCT
iajs-2806	82	1	sci	sci	PROPN
iajs-2806	82	2	.	.	PROPN
iajs-2806	83	1	34	34	NUM
iajs-2806	83	2	(	(	PUNCT
iajs-2806	83	3	1	1	NUM
iajs-2806	83	4	)	)	PUNCT
iajs-2806	83	5	2021	2021	NUM
iajs-2806	83	6	4	4	NUM
iajs-2806	83	7	table	table	NOUN
iajs-2806	83	8	2	2	NUM
iajs-2806	83	9	:	:	PUNCT
iajs-2806	83	10	pcr	pcr	ADJ
iajs-2806	83	11	amplification	amplification	NOUN
iajs-2806	83	12	program	program	NOUN
iajs-2806	83	13	il-33	il-33	VERB
iajs-2806	83	14	gene	gene	NOUN
iajs-2806	83	15	.	.	PUNCT
iajs-2806	84	1	steps	step	NOUN
iajs-2806	84	2	temperature	temperature	NOUN
iajs-2806	84	3	[	[	X
iajs-2806	84	4	ْc	ْc	X
iajs-2806	84	5	]	]	X
iajs-2806	84	6	time	time	NOUN
iajs-2806	84	7	no	no	INTJ
iajs-2806	84	8	.	.	PUNCT
iajs-2806	84	9	of	of	ADP
iajs-2806	84	10	cycles	cycle	NOUN
iajs-2806	84	11	initial	initial	ADJ
iajs-2806	84	12	denaturation	denaturation	NOUN
iajs-2806	84	13	95	95	NUM
iajs-2806	84	14	10	10	NUM
iajs-2806	84	15	minutes	minute	NOUN
iajs-2806	84	16	1	1	NUM
iajs-2806	84	17	denaturation	denaturation	NOUN
iajs-2806	84	18	95	95	NUM
iajs-2806	84	19	30	30	NUM
iajs-2806	84	20	second	second	ADJ
iajs-2806	84	21	35	35	NUM
iajs-2806	84	22	annealing	anneal	VERB
iajs-2806	84	23	57	57	NUM
iajs-2806	84	24	30	30	NUM
iajs-2806	84	25	second	second	ADJ
iajs-2806	84	26	extension	extension	NOUN
iajs-2806	84	27	72	72	NUM
iajs-2806	84	28	30	30	NUM
iajs-2806	84	29	second	second	ADJ
iajs-2806	84	30	final	final	ADJ
iajs-2806	84	31	extension	extension	NOUN
iajs-2806	84	32	72	72	NUM
iajs-2806	84	33	5	5	NUM
iajs-2806	84	34	minutes	minute	NOUN
iajs-2806	84	35	1	1	NUM
iajs-2806	84	36	3	3	NUM
iajs-2806	84	37	.	.	PUNCT
iajs-2806	85	1	statistical	statistical	ADJ
iajs-2806	85	2	analysis	analysis	NOUN
iajs-2806	85	3	the	the	DET
iajs-2806	85	4	statistical	statistical	ADJ
iajs-2806	85	5	analysis	analysis	NOUN
iajs-2806	85	6	systemsas	systemsa	NOUN
iajs-2806	86	1	[	[	X
iajs-2806	86	2	2012	2012	NUM
iajs-2806	86	3	]	]	PUNCT
iajs-2806	86	4	program	program	NOUN
iajs-2806	86	5	was	be	AUX
iajs-2806	86	6	used	use	VERB
iajs-2806	86	7	for	for	ADP
iajs-2806	86	8	outcome	outcome	NOUN
iajs-2806	86	9	of	of	ADP
iajs-2806	86	10	different	different	ADJ
iajs-2806	86	11	factors	factor	NOUN
iajs-2806	86	12	of	of	ADP
iajs-2806	86	13	parameters	parameter	NOUN
iajs-2806	86	14	in	in	ADP
iajs-2806	86	15	this	this	DET
iajs-2806	86	16	study	study	NOUN
iajs-2806	86	17	.	.	PUNCT
iajs-2806	87	1	least	least	ADJ
iajs-2806	87	2	significant	significant	ADJ
iajs-2806	87	3	difference	difference	NOUN
iajs-2806	87	4	–	–	PUNCT
iajs-2806	87	5	lsd	lsd	NOUN
iajs-2806	87	6	test	test	NOUN
iajs-2806	87	7	[	[	X
iajs-2806	87	8	anova	anova	X
iajs-2806	87	9	]	]	X
iajs-2806	87	10	was	be	AUX
iajs-2806	87	11	used	use	VERB
iajs-2806	87	12	to	to	PART
iajs-2806	87	13	significant	significant	ADJ
iajs-2806	87	14	compare	compare	NOUN
iajs-2806	87	15	between	between	ADP
iajs-2806	87	16	means	mean	NOUN
iajs-2806	87	17	in	in	ADP
iajs-2806	87	18	study	study	NOUN
iajs-2806	87	19	parameters	parameter	NOUN
iajs-2806	87	20	[	[	X
iajs-2806	87	21	24	24	NUM
iajs-2806	87	22	]	]	PUNCT
iajs-2806	87	23	.	.	PUNCT
iajs-2806	88	1	winpepi	winpepi	PROPN
iajs-2806	88	2	computer	computer	NOUN
iajs-2806	88	3	programs	program	NOUN
iajs-2806	88	4	[	[	X
iajs-2806	88	5	version	version	NOUN
iajs-2806	88	6	11.63	11.63	NUM
iajs-2806	88	7	]	]	PUNCT
iajs-2806	88	8	was	be	AUX
iajs-2806	88	9	used	use	VERB
iajs-2806	88	10	to	to	PART
iajs-2806	88	11	calculate	calculate	VERB
iajs-2806	88	12	the	the	DET
iajs-2806	88	13	statistical	statistical	ADJ
iajs-2806	88	14	significance	significance	NOUN
iajs-2806	88	15	of	of	ADP
iajs-2806	88	16	p	p	NOUN
iajs-2806	88	17	-	-	PUNCT
iajs-2806	88	18	value	value	NOUN
iajs-2806	88	19	that	that	PRON
iajs-2806	88	20	was	be	AUX
iajs-2806	88	21	calculated	calculate	VERB
iajs-2806	88	22	by	by	ADP
iajs-2806	88	23	odd	odd	ADJ
iajs-2806	88	24	ratio	ratio	NOUN
iajs-2806	88	25	as	as	ADV
iajs-2806	88	26	well	well	ADV
iajs-2806	88	27	as	as	ADP
iajs-2806	88	28	fisher	fisher	PROPN
iajs-2806	88	29	’s	’s	PART
iajs-2806	88	30	exact	exact	ADJ
iajs-2806	88	31	test	test	NOUN
iajs-2806	88	32	.	.	PUNCT
iajs-2806	89	1	hardy	hardy	ADJ
iajs-2806	89	2	-	-	PUNCT
iajs-2806	89	3	weinberg	weinberg	PROPN
iajs-2806	89	4	equilibrium	equilibrium	NOUN
iajs-2806	89	5	was	be	AUX
iajs-2806	89	6	tested	test	VERB
iajs-2806	89	7	by	by	ADP
iajs-2806	89	8	chi	chi	ADJ
iajs-2806	89	9	-	-	PUNCT
iajs-2806	89	10	squared	square	VERB
iajs-2806	89	11	test	test	NOUN
iajs-2806	89	12	that	that	PRON
iajs-2806	89	13	was	be	AUX
iajs-2806	89	14	used	use	VERB
iajs-2806	89	15	oege	oege	NOUN
iajs-2806	89	16	online	online	ADJ
iajs-2806	89	17	encyclopedia	encyclopedia	NOUN
iajs-2806	89	18	for	for	ADP
iajs-2806	89	19	genetic	genetic	ADJ
iajs-2806	89	20	epidemiology	epidemiology	NOUN
iajs-2806	89	21	studies	study	NOUN
iajs-2806	89	22	[	[	X
iajs-2806	89	23	25	25	NUM
iajs-2806	89	24	]	]	PUNCT
iajs-2806	89	25	.	.	PUNCT
iajs-2806	90	1	4	4	X
iajs-2806	90	2	.	.	NOUN
iajs-2806	90	3	results	result	NOUN
iajs-2806	90	4	and	and	CCONJ
iajs-2806	90	5	discussion	discussion	NOUN
iajs-2806	90	6	sixty	sixty	NUM
iajs-2806	90	7	-	-	PUNCT
iajs-2806	90	8	six	six	NUM
iajs-2806	90	9	samples	sample	NOUN
iajs-2806	90	10	have	have	AUX
iajs-2806	90	11	been	be	AUX
iajs-2806	90	12	collected	collect	VERB
iajs-2806	90	13	from	from	ADP
iajs-2806	90	14	patients	patient	NOUN
iajs-2806	90	15	with	with	ADP
iajs-2806	90	16	breast	breast	NOUN
iajs-2806	90	17	cancer	cancer	NOUN
iajs-2806	90	18	.	.	PUNCT
iajs-2806	91	1	the	the	DET
iajs-2806	91	2	median	median	ADJ
iajs-2806	91	3	age	age	NOUN
iajs-2806	92	1	[	[	X
iajs-2806	92	2	<	<	X
iajs-2806	92	3	40	40	NUM
iajs-2806	92	4	,	,	PUNCT
iajs-2806	92	5	40	40	NUM
iajs-2806	92	6	-	-	SYM
iajs-2806	92	7	50	50	NUM
iajs-2806	92	8	,	,	PUNCT
iajs-2806	92	9	>	>	X
iajs-2806	92	10	50	50	NUM
iajs-2806	92	11	]	]	PUNCT
iajs-2806	92	12	and	and	CCONJ
iajs-2806	92	13	the	the	DET
iajs-2806	92	14	number	number	NOUN
iajs-2806	92	15	and	and	CCONJ
iajs-2806	92	16	percentages	percentage	NOUN
iajs-2806	92	17	were	be	AUX
iajs-2806	92	18	14	14	NUM
iajs-2806	93	1	[	[	X
iajs-2806	93	2	21.21	21.21	NUM
iajs-2806	93	3	%	%	NOUN
iajs-2806	93	4	]	]	X
iajs-2806	93	5	,	,	PUNCT
iajs-2806	93	6	34	34	NUM
iajs-2806	94	1	[	[	X
iajs-2806	94	2	51.51	51.51	NUM
iajs-2806	94	3	%	%	NOUN
iajs-2806	94	4	]	]	X
iajs-2806	94	5	,	,	PUNCT
iajs-2806	94	6	18	18	NUM
iajs-2806	94	7	[	[	X
iajs-2806	94	8	27.27	27.27	NUM
iajs-2806	94	9	%	%	NOUN
iajs-2806	94	10	]	]	X
iajs-2806	94	11	,	,	PUNCT
iajs-2806	94	12	respectively	respectively	ADV
iajs-2806	94	13	.	.	PUNCT
iajs-2806	95	1	the	the	DET
iajs-2806	95	2	results	result	NOUN
iajs-2806	95	3	of	of	ADP
iajs-2806	95	4	the	the	DET
iajs-2806	95	5	present	present	ADJ
iajs-2806	95	6	study	study	NOUN
iajs-2806	95	7	showed	show	VERB
iajs-2806	95	8	that	that	SCONJ
iajs-2806	95	9	most	most	ADJ
iajs-2806	95	10	of	of	ADP
iajs-2806	95	11	the	the	DET
iajs-2806	95	12	patients	patient	NOUN
iajs-2806	95	13	were	be	AUX
iajs-2806	95	14	in	in	ADP
iajs-2806	95	15	age	age	NOUN
iajs-2806	95	16	between	between	ADP
iajs-2806	95	17	[	[	X
iajs-2806	95	18	40	40	NUM
iajs-2806	95	19	-	-	SYM
iajs-2806	95	20	50	50	NUM
iajs-2806	95	21	year	year	NOUN
iajs-2806	95	22	]	]	PUNCT
iajs-2806	95	23	which	which	PRON
iajs-2806	95	24	represents	represent	VERB
iajs-2806	95	25	the	the	DET
iajs-2806	95	26	high	high	ADJ
iajs-2806	95	27	frequency	frequency	NOUN
iajs-2806	95	28	group	group	NOUN
iajs-2806	95	29	51.51	51.51	NUM
iajs-2806	95	30	%	%	NOUN
iajs-2806	95	31	.	.	PUNCT
iajs-2806	96	1	the	the	DET
iajs-2806	96	2	result	result	NOUN
iajs-2806	96	3	of	of	ADP
iajs-2806	96	4	the	the	DET
iajs-2806	96	5	present	present	ADJ
iajs-2806	96	6	study	study	NOUN
iajs-2806	96	7	which	which	PRON
iajs-2806	96	8	agreed	agree	VERB
iajs-2806	96	9	with	with	ADP
iajs-2806	96	10	severed	sever	VERB
iajs-2806	96	11	studies	study	NOUN
iajs-2806	96	12	indicated	indicate	VERB
iajs-2806	96	13	that	that	SCONJ
iajs-2806	96	14	there	there	PRON
iajs-2806	96	15	was	be	VERB
iajs-2806	96	16	a	a	DET
iajs-2806	96	17	dramatic	dramatic	ADJ
iajs-2806	96	18	increase	increase	NOUN
iajs-2806	96	19	of	of	ADP
iajs-2806	96	20	breast	breast	NOUN
iajs-2806	96	21	cancer	cancer	NOUN
iajs-2806	96	22	incidence	incidence	NOUN
iajs-2806	96	23	in	in	ADP
iajs-2806	96	24	iraqi	iraqi	ADJ
iajs-2806	96	25	females	female	NOUN
iajs-2806	96	26	over	over	ADP
iajs-2806	96	27	the	the	DET
iajs-2806	96	28	age	age	NOUN
iajs-2806	96	29	40	40	NUM
iajs-2806	96	30	years	year	NOUN
iajs-2806	96	31	[	[	X
iajs-2806	96	32	26	26	NUM
iajs-2806	96	33	,	,	PUNCT
iajs-2806	96	34	27	27	NUM
iajs-2806	96	35	,	,	PUNCT
iajs-2806	96	36	28	28	NUM
iajs-2806	96	37	]	]	PUNCT
iajs-2806	96	38	.	.	PUNCT
iajs-2806	97	1	age	age	NOUN
iajs-2806	97	2	as	as	ADP
iajs-2806	97	3	a	a	DET
iajs-2806	97	4	breast	breast	NOUN
iajs-2806	97	5	cancer	cancer	NOUN
iajs-2806	97	6	risk	risk	NOUN
iajs-2806	97	7	factor	factor	NOUN
iajs-2806	97	8	and	and	CCONJ
iajs-2806	97	9	the	the	DET
iajs-2806	97	10	increasing	increase	VERB
iajs-2806	97	11	incidence	incidence	NOUN
iajs-2806	97	12	of	of	ADP
iajs-2806	97	13	cancer	cancer	NOUN
iajs-2806	97	14	in	in	ADP
iajs-2806	97	15	women	woman	NOUN
iajs-2806	97	16	over	over	ADP
iajs-2806	97	17	than	than	ADP
iajs-2806	97	18	40	40	NUM
iajs-2806	97	19	years	year	NOUN
iajs-2806	97	20	may	may	AUX
iajs-2806	97	21	be	be	AUX
iajs-2806	97	22	due	due	ADJ
iajs-2806	97	23	to	to	ADP
iajs-2806	97	24	increased	increase	VERB
iajs-2806	97	25	chromosome	chromosome	NOUN
iajs-2806	97	26	damage	damage	NOUN
iajs-2806	97	27	as	as	ADP
iajs-2806	97	28	a	a	DET
iajs-2806	97	29	result	result	NOUN
iajs-2806	97	30	of	of	ADP
iajs-2806	97	31	the	the	DET
iajs-2806	97	32	repeated	repeat	VERB
iajs-2806	97	33	divisions	division	NOUN
iajs-2806	97	34	,	,	PUNCT
iajs-2806	97	35	which	which	PRON
iajs-2806	97	36	led	lead	VERB
iajs-2806	97	37	to	to	ADP
iajs-2806	97	38	the	the	DET
iajs-2806	97	39	accumulation	accumulation	NOUN
iajs-2806	97	40	of	of	ADP
iajs-2806	97	41	mutation	mutation	NOUN
iajs-2806	97	42	in	in	ADP
iajs-2806	97	43	the	the	DET
iajs-2806	97	44	dna	dna	NOUN
iajs-2806	97	45	that	that	PRON
iajs-2806	97	46	led	lead	VERB
iajs-2806	97	47	to	to	ADP
iajs-2806	97	48	cancer	cancer	NOUN
iajs-2806	97	49	development	development	NOUN
iajs-2806	97	50	and	and	CCONJ
iajs-2806	97	51	̋the	̋the	DET
iajs-2806	97	52	agerelated	agerelate	VERB
iajs-2806	97	53	increase	increase	NOUN
iajs-2806	97	54	in	in	ADP
iajs-2806	97	55	chromosomal	chromosomal	ADJ
iajs-2806	97	56	damage	damage	NOUN
iajs-2806	97	57	occurred	occur	VERB
iajs-2806	97	58	faster	fast	ADV
iajs-2806	97	59	in	in	ADP
iajs-2806	97	60	women	woman	NOUN
iajs-2806	97	61	than	than	ADP
iajs-2806	97	62	in	in	ADP
iajs-2806	97	63	men	man	NOUN
iajs-2806	97	64	̏	̏	VERB
iajs-2806	97	65	because	because	SCONJ
iajs-2806	97	66	of	of	ADP
iajs-2806	97	67	the	the	DET
iajs-2806	97	68	increase	increase	NOUN
iajs-2806	97	69	level	level	NOUN
iajs-2806	97	70	of	of	ADP
iajs-2806	97	71	aberrations	aberration	NOUN
iajs-2806	97	72	,	,	PUNCT
iajs-2806	97	73	and	and	CCONJ
iajs-2806	97	74	increase	increase	VERB
iajs-2806	97	75	in	in	ADP
iajs-2806	97	76	the	the	DET
iajs-2806	97	77	level	level	NOUN
iajs-2806	97	78	of	of	ADP
iajs-2806	97	79	x	x	PUNCT
iajs-2806	97	80	chromosome	chromosome	NOUN
iajs-2806	97	81	damage	damage	NOUN
iajs-2806	97	82	that	that	PRON
iajs-2806	97	83	was	be	AUX
iajs-2806	97	84	the	the	DET
iajs-2806	97	85	leading	lead	VERB
iajs-2806	97	86	contributor	contributor	NOUN
iajs-2806	97	87	of	of	ADP
iajs-2806	97	88	aging	aging	NOUN
iajs-2806	97	89	in	in	ADP
iajs-2806	97	90	women	woman	NOUN
iajs-2806	97	91	[	[	X
iajs-2806	97	92	29	29	NUM
iajs-2806	97	93	,	,	PUNCT
iajs-2806	97	94	30	30	NUM
iajs-2806	97	95	]	]	PUNCT
iajs-2806	97	96	.	.	PUNCT
iajs-2806	98	1	during	during	ADP
iajs-2806	98	2	the	the	DET
iajs-2806	98	3	period	period	NOUN
iajs-2806	98	4	from	from	ADP
iajs-2806	98	5	1991	1991	NUM
iajs-2806	98	6	to	to	ADP
iajs-2806	98	7	2000	2000	NUM
iajs-2806	98	8	in	in	ADP
iajs-2806	98	9	iraq	iraq	PROPN
iajs-2806	98	10	in	in	ADP
iajs-2806	98	11	the	the	DET
iajs-2806	98	12	basrah	basrah	PROPN
iajs-2806	98	13	city	city	PROPN
iajs-2806	98	14	,	,	PUNCT
iajs-2806	98	15	the	the	DET
iajs-2806	98	16	mean	mean	ADJ
iajs-2806	98	17	age	age	NOUN
iajs-2806	98	18	of	of	ADP
iajs-2806	98	19	women	woman	NOUN
iajs-2806	98	20	with	with	ADP
iajs-2806	98	21	breast	breast	NOUN
iajs-2806	98	22	cancer	cancer	NOUN
iajs-2806	98	23	was	be	AUX
iajs-2806	98	24	45	45	NUM
iajs-2806	98	25	years	year	NOUN
iajs-2806	98	26	and	and	CCONJ
iajs-2806	98	27	no	no	DET
iajs-2806	98	28	change	change	NOUN
iajs-2806	98	29	in	in	ADP
iajs-2806	98	30	the	the	DET
iajs-2806	98	31	age	age	NOUN
iajs-2806	98	32	distribution	distribution	NOUN
iajs-2806	98	33	in	in	ADP
iajs-2806	98	34	the	the	DET
iajs-2806	98	35	10year	10year	ADJ
iajs-2806	98	36	period	period	NOUN
iajs-2806	98	37	[	[	X
iajs-2806	98	38	31	31	NUM
iajs-2806	98	39	]	]	SYM
iajs-2806	98	40	.	.	PUNCT
iajs-2806	99	1	4.1	4.1	NUM
iajs-2806	99	2	.	.	PUNCT
iajs-2806	100	1	interleukin-33	interleukin-33	PROPN
iajs-2806	100	2	[	[	X
iajs-2806	100	3	il-33	il-33	PRON
iajs-2806	100	4	]	]	X
iajs-2806	100	5	concentration	concentration	NOUN
iajs-2806	100	6	in	in	ADP
iajs-2806	100	7	serum	serum	NOUN
iajs-2806	100	8	.	.	PUNCT
iajs-2806	101	1	as	as	SCONJ
iajs-2806	101	2	shown	show	VERB
iajs-2806	101	3	in	in	ADP
iajs-2806	101	4	figure	figure	NOUN
iajs-2806	101	5	1	1	NUM
iajs-2806	101	6	which	which	PRON
iajs-2806	101	7	illustrated	illustrate	VERB
iajs-2806	101	8	the	the	DET
iajs-2806	101	9	il-33	il-33	ADJ
iajs-2806	101	10	serum	serum	NOUN
iajs-2806	101	11	level	level	NOUN
iajs-2806	101	12	for	for	ADP
iajs-2806	101	13	the	the	DET
iajs-2806	101	14	studied	study	VERB
iajs-2806	101	15	groups	group	NOUN
iajs-2806	101	16	as	as	SCONJ
iajs-2806	101	17	compared	compare	VERB
iajs-2806	101	18	with	with	ADP
iajs-2806	101	19	control	control	NOUN
iajs-2806	101	20	,	,	PUNCT
iajs-2806	101	21	the	the	DET
iajs-2806	101	22	results	result	NOUN
iajs-2806	101	23	of	of	ADP
iajs-2806	101	24	the	the	DET
iajs-2806	101	25	mean	mean	NOUN
iajs-2806	101	26	±	±	NUM
iajs-2806	101	27	se	se	X
iajs-2806	101	28	for	for	ADP
iajs-2806	101	29	the	the	DET
iajs-2806	101	30	pt	pt	PROPN
iajs-2806	101	31	and	and	CCONJ
iajs-2806	101	32	utc	utc	PROPN
iajs-2806	101	33	groups	group	NOUN
iajs-2806	101	34	were	be	AUX
iajs-2806	101	35	[	[	X
iajs-2806	101	36	182.22	182.22	NUM
iajs-2806	101	37	±	±	NUM
iajs-2806	101	38	29.86	29.86	NUM
iajs-2806	101	39	,	,	PUNCT
iajs-2806	101	40	129.87	129.87	NUM
iajs-2806	101	41	±	±	NUM
iajs-2806	101	42	45.11	45.11	NUM
iajs-2806	101	43	pg	pg	NOUN
iajs-2806	101	44	/	/	SYM
iajs-2806	101	45	ml	ml	ADP
iajs-2806	101	46	]	]	PUNCT
iajs-2806	101	47	,	,	PUNCT
iajs-2806	101	48	respectively	respectively	ADV
iajs-2806	101	49	,	,	PUNCT
iajs-2806	101	50	as	as	SCONJ
iajs-2806	101	51	compared	compare	VERB
iajs-2806	101	52	to	to	PART
iajs-2806	101	53	control	control	VERB
iajs-2806	101	54	[	[	PUNCT
iajs-2806	101	55	258.08	258.08	NUM
iajs-2806	101	56	±	±	NOUN
iajs-2806	101	57	39.54	39.54	NUM
iajs-2806	101	58	pg	pg	NOUN
iajs-2806	101	59	/	/	SYM
iajs-2806	101	60	ml	ml	ADP
iajs-2806	101	61	]	]	PUNCT
iajs-2806	101	62	where	where	SCONJ
iajs-2806	101	63	there	there	PRON
iajs-2806	101	64	was	be	VERB
iajs-2806	101	65	a	a	DET
iajs-2806	101	66	significant	significant	ADJ
iajs-2806	101	67	difference	difference	NOUN
iajs-2806	101	68	under	under	ADP
iajs-2806	101	69	[	[	X
iajs-2806	101	70	p<0.05	p<0.05	NOUN
iajs-2806	101	71	]	]	PUNCT
iajs-2806	101	72	.	.	PUNCT
iajs-2806	102	1	ibn	ibn	PROPN
iajs-2806	102	2	al	al	PROPN
iajs-2806	102	3	-	-	PUNCT
iajs-2806	102	4	haitham	haitham	PROPN
iajs-2806	102	5	jour	jour	X
iajs-2806	102	6	.	.	PROPN
iajs-2806	102	7	for	for	ADP
iajs-2806	102	8	pure	pure	ADJ
iajs-2806	102	9	&	&	CCONJ
iajs-2806	102	10	appl	appl	PROPN
iajs-2806	102	11	.	.	PUNCT
iajs-2806	103	1	sci	sci	PROPN
iajs-2806	103	2	.	.	PROPN
iajs-2806	104	1	34	34	NUM
iajs-2806	104	2	(	(	PUNCT
iajs-2806	104	3	1	1	NUM
iajs-2806	104	4	)	)	PUNCT
iajs-2806	104	5	2021	2021	NUM
iajs-2806	104	6	5	5	NUM
iajs-2806	104	7	figure	figure	NOUN
iajs-2806	104	8	1	1	NUM
iajs-2806	104	9	:	:	PUNCT
iajs-2806	104	10	comparisons	comparison	NOUN
iajs-2806	104	11	between	between	ADP
iajs-2806	104	12	different	different	ADJ
iajs-2806	104	13	groups	group	NOUN
iajs-2806	104	14	in	in	ADP
iajs-2806	104	15	il-33	il-33	ADJ
iajs-2806	104	16	concentration	concentration	NOUN
iajs-2806	105	1	[	[	X
iajs-2806	105	2	pg	pg	X
iajs-2806	105	3	/	/	SYM
iajs-2806	105	4	ml	ml	ADP
iajs-2806	105	5	]	]	PUNCT
iajs-2806	105	6	.	.	PUNCT
iajs-2806	106	1	the	the	DET
iajs-2806	106	2	results	result	NOUN
iajs-2806	106	3	of	of	ADP
iajs-2806	106	4	the	the	DET
iajs-2806	106	5	current	current	ADJ
iajs-2806	106	6	study	study	NOUN
iajs-2806	106	7	showed	show	VERB
iajs-2806	106	8	a	a	DET
iajs-2806	106	9	low	low	ADJ
iajs-2806	106	10	level	level	NOUN
iajs-2806	106	11	of	of	ADP
iajs-2806	106	12	il-33	il-33	ADJ
iajs-2806	106	13	in	in	ADP
iajs-2806	106	14	serum	serum	NOUN
iajs-2806	106	15	of	of	ADP
iajs-2806	106	16	pt	pt	PROPN
iajs-2806	106	17	,	,	PUNCT
iajs-2806	106	18	followed	follow	VERB
iajs-2806	106	19	by	by	ADP
iajs-2806	106	20	utc	utc	PROPN
iajs-2806	106	21	patients	patient	NOUN
iajs-2806	106	22	compared	compare	VERB
iajs-2806	106	23	to	to	ADP
iajs-2806	106	24	the	the	DET
iajs-2806	106	25	high	high	ADJ
iajs-2806	106	26	level	level	NOUN
iajs-2806	106	27	in	in	ADP
iajs-2806	106	28	the	the	DET
iajs-2806	106	29	serum	serum	NOUN
iajs-2806	106	30	of	of	ADP
iajs-2806	106	31	healthy	healthy	ADJ
iajs-2806	106	32	control	control	NOUN
iajs-2806	106	33	.	.	PUNCT
iajs-2806	107	1	this	this	DET
iajs-2806	107	2	result	result	NOUN
iajs-2806	107	3	agreed	agree	VERB
iajs-2806	107	4	with	with	ADP
iajs-2806	107	5	another	another	DET
iajs-2806	107	6	study	study	NOUN
iajs-2806	107	7	indicated	indicate	VERB
iajs-2806	107	8	that	that	SCONJ
iajs-2806	107	9	il-33	il-33	ADP
iajs-2806	107	10	serum	serum	NOUN
iajs-2806	107	11	levels	level	NOUN
iajs-2806	107	12	was	be	AUX
iajs-2806	107	13	decreased	decrease	VERB
iajs-2806	107	14	after	after	ADP
iajs-2806	107	15	modified	modify	VERB
iajs-2806	107	16	radical	radical	ADJ
iajs-2806	107	17	mastectomy	mastectomy	NOUN
iajs-2806	107	18	in	in	ADP
iajs-2806	107	19	breast	breast	NOUN
iajs-2806	107	20	cancer	cancer	NOUN
iajs-2806	107	21	patients	patient	NOUN
iajs-2806	107	22	[	[	X
iajs-2806	107	23	32	32	NUM
iajs-2806	107	24	]	]	PUNCT
iajs-2806	107	25	.	.	PUNCT
iajs-2806	108	1	while	while	SCONJ
iajs-2806	108	2	it	it	PRON
iajs-2806	108	3	was	be	AUX
iajs-2806	108	4	disagreed	disagree	VERB
iajs-2806	108	5	with	with	ADP
iajs-2806	108	6	other	other	ADJ
iajs-2806	108	7	studies	study	NOUN
iajs-2806	108	8	which	which	PRON
iajs-2806	108	9	found	find	VERB
iajs-2806	108	10	an	an	DET
iajs-2806	108	11	elevating	elevating	NOUN
iajs-2806	108	12	in	in	ADP
iajs-2806	108	13	il-33	il-33	ADJ
iajs-2806	108	14	serum	serum	NOUN
iajs-2806	108	15	level	level	NOUN
iajs-2806	108	16	in	in	ADP
iajs-2806	108	17	breast	breast	NOUN
iajs-2806	108	18	cancer	cancer	NOUN
iajs-2806	108	19	patients	patient	NOUN
iajs-2806	108	20	[	[	X
iajs-2806	108	21	23	23	NUM
iajs-2806	108	22	,	,	PUNCT
iajs-2806	108	23	33	33	NUM
iajs-2806	108	24	,	,	PUNCT
iajs-2806	108	25	34	34	NUM
iajs-2806	108	26	]	]	PUNCT
iajs-2806	108	27	.	.	PUNCT
iajs-2806	109	1	moreover	moreover	ADV
iajs-2806	109	2	saranchova	saranchova	PROPN
iajs-2806	109	3	et	et	PROPN
iajs-2806	109	4	al	al	PROPN
iajs-2806	109	5	.	.	PROPN
iajs-2806	109	6	indicated	indicate	VERB
iajs-2806	109	7	that	that	SCONJ
iajs-2806	109	8	the	the	DET
iajs-2806	109	9	cancer	cancer	NOUN
iajs-2806	109	10	cell	cell	NOUN
iajs-2806	109	11	evolved	evolve	VERB
iajs-2806	109	12	over	over	ADP
iajs-2806	109	13	time	time	NOUN
iajs-2806	109	14	and	and	CCONJ
iajs-2806	109	15	suffered	suffer	VERB
iajs-2806	109	16	genetic	genetic	ADJ
iajs-2806	109	17	changes	change	NOUN
iajs-2806	109	18	and	and	CCONJ
iajs-2806	109	19	it	it	PRON
iajs-2806	109	20	through	through	ADP
iajs-2806	109	21	their	their	PRON
iajs-2806	109	22	developers	developer	NOUN
iajs-2806	109	23	lose	lose	VERB
iajs-2806	109	24	the	the	DET
iajs-2806	109	25	ability	ability	NOUN
iajs-2806	109	26	to	to	PART
iajs-2806	109	27	manufacture	manufacture	VERB
iajs-2806	109	28	il-33	il-33	PUNCT
iajs-2806	109	29	and	and	CCONJ
iajs-2806	109	30	reduce	reduce	VERB
iajs-2806	109	31	its	its	PRON
iajs-2806	109	32	expression	expression	NOUN
iajs-2806	109	33	in	in	ADP
iajs-2806	109	34	many	many	ADJ
iajs-2806	109	35	metastatic	metastatic	ADJ
iajs-2806	109	36	carcinomas	carcinoma	NOUN
iajs-2806	109	37	and	and	CCONJ
iajs-2806	109	38	because	because	SCONJ
iajs-2806	109	39	that	that	DET
iajs-2806	109	40	immune	immune	ADJ
iajs-2806	109	41	system	system	NOUN
iajs-2806	109	42	loses	lose	VERB
iajs-2806	109	43	the	the	DET
iajs-2806	109	44	ability	ability	NOUN
iajs-2806	109	45	to	to	PART
iajs-2806	109	46	distinguish	distinguish	VERB
iajs-2806	109	47	cancer	cancer	NOUN
iajs-2806	109	48	cells	cell	NOUN
iajs-2806	109	49	and	and	CCONJ
iajs-2806	109	50	their	their	PRON
iajs-2806	109	51	start	start	NOUN
iajs-2806	109	52	transformation	transformation	NOUN
iajs-2806	109	53	and	and	CCONJ
iajs-2806	109	54	metastasis	metastasis	NOUN
iajs-2806	109	55	,	,	PUNCT
iajs-2806	109	56	releasing	release	VERB
iajs-2806	109	57	of	of	ADP
iajs-2806	109	58	il-33	il-33	NOUN
iajs-2806	109	59	serum	serum	NOUN
iajs-2806	109	60	level	level	NOUN
iajs-2806	109	61	may	may	AUX
iajs-2806	109	62	help	help	VERB
iajs-2806	109	63	the	the	DET
iajs-2806	109	64	immune	immune	ADJ
iajs-2806	109	65	system	system	NOUN
iajs-2806	109	66	to	to	PART
iajs-2806	109	67	recognition	recognition	VERB
iajs-2806	109	68	malignant	malignant	ADJ
iajs-2806	109	69	tumor	tumor	NOUN
iajs-2806	109	70	cells	cell	NOUN
iajs-2806	109	71	by	by	ADP
iajs-2806	109	72	expression	expression	NOUN
iajs-2806	109	73	of	of	ADP
iajs-2806	109	74	mhc-1	mhc-1	NUM
iajs-2806	109	75	molecules	molecule	NOUN
iajs-2806	109	76	[	[	X
iajs-2806	109	77	35	35	NUM
iajs-2806	109	78	]	]	PUNCT
iajs-2806	109	79	.	.	PUNCT
iajs-2806	110	1	according	accord	VERB
iajs-2806	110	2	to	to	ADP
iajs-2806	110	3	present	present	ADJ
iajs-2806	110	4	result	result	NOUN
iajs-2806	110	5	,	,	PUNCT
iajs-2806	110	6	low	low	ADJ
iajs-2806	110	7	level	level	NOUN
iajs-2806	110	8	of	of	ADP
iajs-2806	110	9	il-33	il-33	ADJ
iajs-2806	110	10	in	in	ADP
iajs-2806	110	11	serum	serum	NOUN
iajs-2806	110	12	of	of	ADP
iajs-2806	110	13	current	current	ADJ
iajs-2806	110	14	patients	patient	NOUN
iajs-2806	110	15	may	may	AUX
iajs-2806	110	16	relate	relate	VERB
iajs-2806	110	17	to	to	ADP
iajs-2806	110	18	some	some	DET
iajs-2806	110	19	limitation	limitation	NOUN
iajs-2806	110	20	of	of	ADP
iajs-2806	110	21	the	the	DET
iajs-2806	110	22	study	study	NOUN
iajs-2806	110	23	which	which	PRON
iajs-2806	110	24	need	need	VERB
iajs-2806	110	25	a	a	DET
iajs-2806	110	26	cohort	cohort	NOUN
iajs-2806	110	27	study	study	NOUN
iajs-2806	110	28	to	to	PART
iajs-2806	110	29	follow	follow	VERB
iajs-2806	110	30	the	the	DET
iajs-2806	110	31	serum	serum	NOUN
iajs-2806	110	32	level	level	NOUN
iajs-2806	110	33	of	of	ADP
iajs-2806	110	34	il-33	il-33	NUM
iajs-2806	110	35	in	in	ADP
iajs-2806	110	36	the	the	DET
iajs-2806	110	37	same	same	ADJ
iajs-2806	110	38	patients	patient	NOUN
iajs-2806	110	39	before	before	ADP
iajs-2806	110	40	and	and	CCONJ
iajs-2806	110	41	after	after	ADP
iajs-2806	110	42	mastectomy	mastectomy	NOUN
iajs-2806	110	43	or	or	CCONJ
iajs-2806	110	44	resection	resection	NOUN
iajs-2806	110	45	surgery	surgery	NOUN
iajs-2806	110	46	and	and	CCONJ
iajs-2806	110	47	then	then	ADV
iajs-2806	110	48	after	after	SCONJ
iajs-2806	110	49	treated	treat	VERB
iajs-2806	110	50	with	with	ADP
iajs-2806	110	51	chemotherapy	chemotherapy	NOUN
iajs-2806	110	52	.	.	PUNCT
iajs-2806	111	1	4.2	4.2	NUM
iajs-2806	111	2	.	.	PUNCT
iajs-2806	112	1	il-33	il-33	VERB
iajs-2806	112	2	gene	gene	NOUN
iajs-2806	112	3	amplification	amplification	NOUN
iajs-2806	112	4	the	the	DET
iajs-2806	112	5	region	region	NOUN
iajs-2806	112	6	of	of	ADP
iajs-2806	112	7	single	single	ADJ
iajs-2806	112	8	nucleotide	nucleotide	ADJ
iajs-2806	112	9	polymorphism	polymorphism	NOUN
iajs-2806	113	1	[	[	X
iajs-2806	113	2	snp	snp	X
iajs-2806	113	3	]	]	X
iajs-2806	113	4	[	[	X
iajs-2806	113	5	rs1929992	rs1929992	X
iajs-2806	113	6	]	]	PUNCT
iajs-2806	113	7	from	from	ADP
iajs-2806	113	8	il-33	il-33	ADJ
iajs-2806	113	9	gene	gene	NOUN
iajs-2806	113	10	was	be	AUX
iajs-2806	113	11	amplified	amplify	VERB
iajs-2806	113	12	from	from	ADP
iajs-2806	113	13	extracted	extract	VERB
iajs-2806	113	14	dna	dna	NOUN
iajs-2806	113	15	for	for	ADP
iajs-2806	113	16	each	each	DET
iajs-2806	113	17	sample	sample	NOUN
iajs-2806	113	18	of	of	ADP
iajs-2806	113	19	patients	patient	NOUN
iajs-2806	113	20	with	with	ADP
iajs-2806	113	21	breast	breast	NOUN
iajs-2806	113	22	cancer	cancer	NOUN
iajs-2806	113	23	and	and	CCONJ
iajs-2806	113	24	healthy	healthy	ADJ
iajs-2806	113	25	control	control	NOUN
iajs-2806	113	26	.	.	PUNCT
iajs-2806	114	1	by	by	ADP
iajs-2806	114	2	using	use	VERB
iajs-2806	114	3	specific	specific	ADJ
iajs-2806	114	4	primer	primer	NOUN
iajs-2806	114	5	,	,	PUNCT
iajs-2806	114	6	the	the	DET
iajs-2806	114	7	polymerase	polymerase	NOUN
iajs-2806	114	8	chain	chain	NOUN
iajs-2806	114	9	reaction	reaction	NOUN
iajs-2806	114	10	[	[	X
iajs-2806	114	11	pcr	pcr	NOUN
iajs-2806	114	12	]	]	PUNCT
iajs-2806	114	13	was	be	AUX
iajs-2806	114	14	performed	perform	VERB
iajs-2806	114	15	under	under	ADP
iajs-2806	114	16	optimum	optimum	ADJ
iajs-2806	114	17	condition	condition	NOUN
iajs-2806	114	18	,	,	PUNCT
iajs-2806	114	19	then	then	ADV
iajs-2806	114	20	pcr	pcr	NOUN
iajs-2806	114	21	product	product	NOUN
iajs-2806	114	22	was	be	AUX
iajs-2806	114	23	electrophoresis	electrophoresis	NOUN
iajs-2806	114	24	on	on	ADP
iajs-2806	114	25	agarose	agarose	NOUN
iajs-2806	114	26	gel	gel	NOUN
iajs-2806	115	1	[	[	X
iajs-2806	115	2	2	2	NUM
iajs-2806	115	3	%	%	NOUN
iajs-2806	115	4	]	]	PUNCT
iajs-2806	115	5	in	in	ADP
iajs-2806	115	6	[	[	X
iajs-2806	115	7	100v	100v	NOUN
iajs-2806	115	8	,	,	PUNCT
iajs-2806	115	9	1	1	NUM
iajs-2806	115	10	hour	hour	NOUN
iajs-2806	115	11	]	]	X
iajs-2806	115	12	the	the	DET
iajs-2806	115	13	results	result	NOUN
iajs-2806	115	14	were	be	AUX
iajs-2806	115	15	a	a	DET
iajs-2806	115	16	single	single	ADJ
iajs-2806	115	17	clear	clear	ADJ
iajs-2806	115	18	band	band	NOUN
iajs-2806	115	19	with	with	ADP
iajs-2806	115	20	molecular	molecular	ADJ
iajs-2806	115	21	size	size	NOUN
iajs-2806	115	22	[	[	X
iajs-2806	115	23	217bp	217bp	X
iajs-2806	115	24	]	]	PUNCT
iajs-2806	115	25	compare	compare	VERB
iajs-2806	115	26	with	with	ADP
iajs-2806	115	27	dna	dna	NOUN
iajs-2806	115	28	ladder	ladder	NOUN
iajs-2806	115	29	figure	figure	NOUN
iajs-2806	115	30	2	2	NUM
iajs-2806	115	31	.	.	PUNCT
iajs-2806	116	1	ibn	ibn	PROPN
iajs-2806	116	2	al	al	PROPN
iajs-2806	116	3	-	-	PUNCT
iajs-2806	116	4	haitham	haitham	PROPN
iajs-2806	116	5	jour	jour	X
iajs-2806	116	6	.	.	PROPN
iajs-2806	116	7	for	for	ADP
iajs-2806	116	8	pure	pure	ADJ
iajs-2806	116	9	&	&	CCONJ
iajs-2806	116	10	appl	appl	PROPN
iajs-2806	116	11	.	.	PUNCT
iajs-2806	117	1	sci	sci	PROPN
iajs-2806	117	2	.	.	PROPN
iajs-2806	118	1	34	34	NUM
iajs-2806	118	2	(	(	PUNCT
iajs-2806	118	3	1	1	NUM
iajs-2806	118	4	)	)	PUNCT
iajs-2806	118	5	2021	2021	NUM
iajs-2806	118	6	6	6	NUM
iajs-2806	118	7	figure	figure	NOUN
iajs-2806	118	8	2	2	NUM
iajs-2806	118	9	:	:	PUNCT
iajs-2806	118	10	gel	gel	NOUN
iajs-2806	118	11	electrophoresis	electrophoresis	NOUN
iajs-2806	118	12	for	for	ADP
iajs-2806	118	13	pcr	pcr	ADJ
iajs-2806	118	14	product	product	NOUN
iajs-2806	118	15	of	of	ADP
iajs-2806	118	16	il-33	il-33	ADJ
iajs-2806	118	17	gene	gene	NOUN
iajs-2806	119	1	[	[	X
iajs-2806	119	2	217bp	217bp	X
iajs-2806	119	3	]	]	PUNCT
iajs-2806	119	4	with	with	ADP
iajs-2806	119	5	dna	dna	NOUN
iajs-2806	119	6	ladder	ladder	NOUN
iajs-2806	119	7	[	[	X
iajs-2806	119	8	m	m	X
iajs-2806	119	9	]	]	X
iajs-2806	119	10	on	on	ADP
iajs-2806	119	11	agarose	agarose	NOUN
iajs-2806	119	12	gel	gel	NOUN
iajs-2806	120	1	[	[	X
iajs-2806	120	2	2	2	NUM
iajs-2806	120	3	%	%	NOUN
iajs-2806	120	4	]	]	PUNCT
iajs-2806	120	5	in	in	ADP
iajs-2806	120	6	[	[	X
iajs-2806	120	7	100v	100v	NOUN
iajs-2806	120	8	,	,	PUNCT
iajs-2806	120	9	1	1	NUM
iajs-2806	120	10	hour	hour	NOUN
iajs-2806	120	11	]	]	PUNCT
iajs-2806	120	12	.	.	PUNCT
iajs-2806	121	1	4.2.1	4.2.1	NOUN
iajs-2806	121	2	.	.	PUNCT
iajs-2806	122	1	genotype	genotype	NOUN
iajs-2806	122	2	of	of	ADP
iajs-2806	122	3	il-33	il-33	ADJ
iajs-2806	122	4	gene	gene	NOUN
iajs-2806	122	5	il-33	il-33	ADP
iajs-2806	122	6	gene	gene	NOUN
iajs-2806	122	7	pcr	pcr	NOUN
iajs-2806	122	8	product	product	NOUN
iajs-2806	122	9	digested	digest	VERB
iajs-2806	122	10	with	with	ADP
iajs-2806	122	11	sspi	sspi	NOUN
iajs-2806	122	12	restriction	restriction	NOUN
iajs-2806	122	13	enzyme	enzyme	NOUN
iajs-2806	122	14	[	[	NOUN
iajs-2806	122	15	sequence	sequence	NOUN
iajs-2806	122	16	of	of	ADP
iajs-2806	122	17	restrictions	restriction	NOUN
iajs-2806	122	18	aat	aat	PROPN
iajs-2806	122	19	/	/	SYM
iajs-2806	122	20	att	att	PROPN
iajs-2806	122	21	in	in	ADP
iajs-2806	122	22	allele	allele	PROPN
iajs-2806	122	23	a	a	X
iajs-2806	122	24	]	]	X
iajs-2806	122	25	.	.	PUNCT
iajs-2806	123	1	the	the	DET
iajs-2806	123	2	pcr	pcr	PROPN
iajs-2806	123	3	-	-	PUNCT
iajs-2806	123	4	rflp	rflp	NOUN
iajs-2806	123	5	product	product	NOUN
iajs-2806	123	6	recognized	recognize	VERB
iajs-2806	123	7	on	on	ADP
iajs-2806	123	8	gel	gel	NOUN
iajs-2806	123	9	electrophoresis	electrophoresis	NOUN
iajs-2806	123	10	as	as	ADP
iajs-2806	123	11	a	a	DET
iajs-2806	123	12	homozygote	homozygote	NOUN
iajs-2806	123	13	[	[	X
iajs-2806	123	14	gg	gg	X
iajs-2806	123	15	]	]	X
iajs-2806	123	16	217bp	217bp	NOUN
iajs-2806	123	17	without	without	ADP
iajs-2806	123	18	any	any	DET
iajs-2806	123	19	digestion	digestion	NOUN
iajs-2806	123	20	,	,	PUNCT
iajs-2806	123	21	in	in	ADP
iajs-2806	123	22	the	the	DET
iajs-2806	123	23	homozygote	homozygote	NOUN
iajs-2806	123	24	[	[	X
iajs-2806	123	25	aa	aa	X
iajs-2806	123	26	]	]	X
iajs-2806	123	27	two	two	NUM
iajs-2806	123	28	different	different	ADJ
iajs-2806	123	29	fragments	fragment	NOUN
iajs-2806	123	30	134bp	134bp	PROPN
iajs-2806	123	31	and	and	CCONJ
iajs-2806	123	32	83bp	83bp	ADV
iajs-2806	123	33	,	,	PUNCT
iajs-2806	123	34	while	while	SCONJ
iajs-2806	123	35	three	three	NUM
iajs-2806	123	36	different	different	ADJ
iajs-2806	123	37	fragments	fragment	NOUN
iajs-2806	123	38	in	in	ADP
iajs-2806	123	39	the	the	DET
iajs-2806	123	40	heterozygous	heterozygous	ADJ
iajs-2806	123	41	form	form	NOUN
iajs-2806	123	42	[	[	X
iajs-2806	123	43	ag	ag	X
iajs-2806	123	44	]	]	X
iajs-2806	123	45	its	its	PRON
iajs-2806	123	46	217bp,134bp	217bp,134bp	NUM
iajs-2806	123	47	,	,	PUNCT
iajs-2806	123	48	83bp	83bp	ADJ
iajs-2806	123	49	were	be	AUX
iajs-2806	123	50	observed	observe	VERB
iajs-2806	123	51	in	in	ADP
iajs-2806	123	52	figure3	figure3	PROPN
iajs-2806	123	53	.	.	PUNCT
iajs-2806	124	1	figure	figure	VERB
iajs-2806	124	2	3	3	NUM
iajs-2806	124	3	:	:	PUNCT
iajs-2806	124	4	gel	gel	NOUN
iajs-2806	124	5	electrophoresis	electrophoresis	NOUN
iajs-2806	124	6	of	of	ADP
iajs-2806	124	7	pcr	pcr	ADJ
iajs-2806	124	8	-	-	PUNCT
iajs-2806	124	9	rflp	rflp	NOUN
iajs-2806	124	10	product	product	NOUN
iajs-2806	124	11	which	which	PRON
iajs-2806	124	12	illustrated	illustrate	VERB
iajs-2806	124	13	genotype	genotype	NOUN
iajs-2806	124	14	of	of	ADP
iajs-2806	124	15	il-33	il-33	ADJ
iajs-2806	124	16	snp	snp	NOUN
iajs-2806	124	17	on	on	ADP
iajs-2806	124	18	agarose	agarose	NOUN
iajs-2806	124	19	[	[	X
iajs-2806	124	20	3	3	NUM
iajs-2806	124	21	%	%	NOUN
iajs-2806	124	22	]	]	PUNCT
iajs-2806	124	23	in	in	ADP
iajs-2806	124	24	[	[	X
iajs-2806	124	25	150v	150v	NUM
iajs-2806	124	26	,	,	PUNCT
iajs-2806	124	27	1hour	1hour	NUM
iajs-2806	124	28	]	]	PUNCT
iajs-2806	124	29	.	.	PUNCT
iajs-2806	125	1	the	the	DET
iajs-2806	125	2	restriction	restriction	NOUN
iajs-2806	125	3	process	process	NOUN
iajs-2806	125	4	showed	show	VERB
iajs-2806	125	5	three	three	NUM
iajs-2806	125	6	types	type	NOUN
iajs-2806	125	7	of	of	ADP
iajs-2806	125	8	genotype	genotype	NOUN
iajs-2806	125	9	aa	aa	PROPN
iajs-2806	126	1	[	[	X
iajs-2806	126	2	134bp	134bp	PROPN
iajs-2806	126	3	,	,	PUNCT
iajs-2806	126	4	83bp	83bp	ADV
iajs-2806	126	5	]	]	X
iajs-2806	126	6	,	,	PUNCT
iajs-2806	126	7	ag	ag	PROPN
iajs-2806	127	1	[	[	X
iajs-2806	127	2	217bp	217bp	NOUN
iajs-2806	127	3	,	,	PUNCT
iajs-2806	127	4	134bp	134bp	PROPN
iajs-2806	127	5	,	,	PUNCT
iajs-2806	127	6	83bp	83bp	ADV
iajs-2806	127	7	]	]	PUNCT
iajs-2806	127	8	and	and	CCONJ
iajs-2806	127	9	gg	gg	X
iajs-2806	127	10	[	[	X
iajs-2806	127	11	217bp	217bp	NOUN
iajs-2806	127	12	]	]	PUNCT
iajs-2806	127	13	.	.	PUNCT
iajs-2806	128	1	genetic	genetic	ADJ
iajs-2806	128	2	polymorphism	polymorphism	NOUN
iajs-2806	128	3	of	of	ADP
iajs-2806	128	4	il-33	il-33	NOUN
iajs-2806	128	5	gene	gene	NOUN
iajs-2806	128	6	[	[	X
iajs-2806	128	7	rs1929992	rs1929992	X
iajs-2806	128	8	]	]	PUNCT
iajs-2806	128	9	that	that	PRON
iajs-2806	128	10	was	be	AUX
iajs-2806	128	11	observed	observe	VERB
iajs-2806	128	12	with	with	ADP
iajs-2806	128	13	three	three	NUM
iajs-2806	128	14	genotypes	genotype	NOUN
iajs-2806	128	15	[	[	X
iajs-2806	128	16	aa	aa	INTJ
iajs-2806	128	17	,	,	PUNCT
iajs-2806	128	18	ag	ag	PROPN
iajs-2806	128	19	,	,	PUNCT
iajs-2806	128	20	gg	gg	NOUN
iajs-2806	128	21	]	]	PUNCT
iajs-2806	128	22	as	as	SCONJ
iajs-2806	128	23	shown	show	VERB
iajs-2806	128	24	in	in	ADP
iajs-2806	128	25	table	table	NOUN
iajs-2806	128	26	3	3	NUM
iajs-2806	128	27	which	which	PRON
iajs-2806	128	28	illustrated	illustrate	VERB
iajs-2806	128	29	the	the	DET
iajs-2806	128	30	distribution	distribution	NOUN
iajs-2806	128	31	of	of	ADP
iajs-2806	128	32	genotypes	genotype	NOUN
iajs-2806	128	33	of	of	ADP
iajs-2806	128	34	il-33	il-33	ADJ
iajs-2806	128	35	in	in	ADP
iajs-2806	128	36	patients	patient	NOUN
iajs-2806	128	37	and	and	CCONJ
iajs-2806	128	38	control	control	NOUN
iajs-2806	128	39	groups	group	NOUN
iajs-2806	128	40	.	.	PUNCT
iajs-2806	129	1	heterozygous	heterozygous	ADJ
iajs-2806	129	2	genotype	genotype	NOUN
iajs-2806	129	3	ag	ag	PROPN
iajs-2806	129	4	showed	show	VERB
iajs-2806	129	5	a	a	DET
iajs-2806	129	6	high	high	ADJ
iajs-2806	129	7	frequency	frequency	NOUN
iajs-2806	129	8	in	in	ADP
iajs-2806	129	9	the	the	DET
iajs-2806	129	10	control	control	NOUN
iajs-2806	129	11	[	[	X
iajs-2806	129	12	76.47	76.47	NUM
iajs-2806	129	13	%	%	NOUN
iajs-2806	129	14	]	]	PUNCT
iajs-2806	129	15	than	than	ADP
iajs-2806	129	16	in	in	ADP
iajs-2806	129	17	patients	patient	NOUN
iajs-2806	129	18	[	[	X
iajs-2806	129	19	58.46	58.46	NUM
iajs-2806	129	20	%	%	NOUN
iajs-2806	129	21	]	]	PUNCT
iajs-2806	129	22	with	with	ADP
iajs-2806	129	23	a	a	DET
iajs-2806	129	24	highly	highly	ADV
iajs-2806	129	25	significant	significant	ADJ
iajs-2806	129	26	difference	difference	NOUN
iajs-2806	129	27	between	between	ADP
iajs-2806	129	28	patients	patient	NOUN
iajs-2806	129	29	and	and	CCONJ
iajs-2806	129	30	the	the	DET
iajs-2806	129	31	control	control	NOUN
iajs-2806	129	32	.	.	PUNCT
iajs-2806	130	1	the	the	DET
iajs-2806	130	2	homozygote	homozygote	NOUN
iajs-2806	130	3	genotype	genotype	NOUN
iajs-2806	130	4	aa	aa	PROPN
iajs-2806	130	5	frequency	frequency	NOUN
iajs-2806	130	6	[	[	X
iajs-2806	130	7	23.08	23.08	NUM
iajs-2806	130	8	%	%	NOUN
iajs-2806	130	9	]	]	PUNCT
iajs-2806	130	10	showed	show	VERB
iajs-2806	130	11	a	a	DET
iajs-2806	130	12	nonsignificant	nonsignificant	ADJ
iajs-2806	130	13	difference	difference	NOUN
iajs-2806	130	14	in	in	ADP
iajs-2806	130	15	patients	patient	NOUN
iajs-2806	130	16	compared	compare	VERB
iajs-2806	130	17	to	to	ADP
iajs-2806	130	18	the	the	DET
iajs-2806	130	19	control	control	NOUN
iajs-2806	130	20	[	[	X
iajs-2806	130	21	17.65	17.65	NUM
iajs-2806	130	22	%	%	NOUN
iajs-2806	130	23	]	]	PUNCT
iajs-2806	130	24	,	,	PUNCT
iajs-2806	130	25	and	and	CCONJ
iajs-2806	130	26	the	the	DET
iajs-2806	130	27	homozygote	homozygote	NOUN
iajs-2806	130	28	ibn	ibn	PROPN
iajs-2806	130	29	al	al	PROPN
iajs-2806	130	30	-	-	PUNCT
iajs-2806	130	31	haitham	haitham	PROPN
iajs-2806	130	32	jour	jour	X
iajs-2806	130	33	.	.	PROPN
iajs-2806	130	34	for	for	ADP
iajs-2806	130	35	pure	pure	ADJ
iajs-2806	130	36	&	&	CCONJ
iajs-2806	130	37	appl	appl	PROPN
iajs-2806	130	38	.	.	PUNCT
iajs-2806	131	1	sci	sci	PROPN
iajs-2806	131	2	.	.	PROPN
iajs-2806	132	1	34	34	NUM
iajs-2806	132	2	(	(	PUNCT
iajs-2806	132	3	1	1	NUM
iajs-2806	132	4	)	)	PUNCT
iajs-2806	132	5	2021	2021	NUM
iajs-2806	132	6	7	7	NUM
iajs-2806	132	7	genotype	genotype	NOUN
iajs-2806	132	8	gg	gg	NOUN
iajs-2806	132	9	frequency	frequency	NOUN
iajs-2806	132	10	[	[	X
iajs-2806	132	11	18.46	18.46	NUM
iajs-2806	132	12	%	%	NOUN
iajs-2806	132	13	]	]	PUNCT
iajs-2806	132	14	had	have	VERB
iajs-2806	132	15	a	a	DET
iajs-2806	132	16	significant	significant	ADJ
iajs-2806	132	17	difference	difference	NOUN
iajs-2806	132	18	in	in	ADP
iajs-2806	132	19	patients	patient	NOUN
iajs-2806	132	20	compared	compare	VERB
iajs-2806	132	21	to	to	PART
iajs-2806	132	22	control	control	VERB
iajs-2806	132	23	[	[	PUNCT
iajs-2806	132	24	5.88	5.88	NUM
iajs-2806	132	25	%	%	NOUN
iajs-2806	132	26	]	]	PUNCT
iajs-2806	132	27	.	.	PUNCT
iajs-2806	133	1	allele	allele	NOUN
iajs-2806	133	2	frequency	frequency	NOUN
iajs-2806	133	3	for	for	ADP
iajs-2806	133	4	a	a	DET
iajs-2806	133	5	allele	allele	NOUN
iajs-2806	133	6	was	be	AUX
iajs-2806	133	7	[	[	X
iajs-2806	133	8	52.31	52.31	NUM
iajs-2806	133	9	%	%	NOUN
iajs-2806	133	10	]	]	PUNCT
iajs-2806	133	11	in	in	ADP
iajs-2806	133	12	patients	patient	NOUN
iajs-2806	133	13	compared	compare	VERB
iajs-2806	133	14	to	to	PART
iajs-2806	133	15	control	control	VERB
iajs-2806	133	16	[	[	X
iajs-2806	133	17	55.88	55.88	NUM
iajs-2806	133	18	%	%	NOUN
iajs-2806	133	19	]	]	PUNCT
iajs-2806	133	20	while	while	SCONJ
iajs-2806	133	21	for	for	ADP
iajs-2806	133	22	the	the	DET
iajs-2806	133	23	g	g	PROPN
iajs-2806	133	24	allele	allele	NOUN
iajs-2806	134	1	[	[	X
iajs-2806	134	2	47.69	47.69	NUM
iajs-2806	134	3	%	%	NOUN
iajs-2806	134	4	]	]	PUNCT
iajs-2806	134	5	in	in	ADP
iajs-2806	134	6	patients	patient	NOUN
iajs-2806	134	7	compared	compare	VERB
iajs-2806	134	8	with	with	ADP
iajs-2806	134	9	control	control	NOUN
iajs-2806	134	10	[	[	X
iajs-2806	134	11	44.12	44.12	NUM
iajs-2806	134	12	%	%	NOUN
iajs-2806	134	13	]	]	PUNCT
iajs-2806	134	14	with	with	ADP
iajs-2806	134	15	no	no	DET
iajs-2806	134	16	significant	significant	ADJ
iajs-2806	134	17	difference	difference	NOUN
iajs-2806	134	18	.	.	PUNCT
iajs-2806	135	1	table	table	NOUN
iajs-2806	135	2	3	3	NUM
iajs-2806	135	3	:	:	PUNCT
iajs-2806	135	4	distribution	distribution	NOUN
iajs-2806	135	5	of	of	ADP
iajs-2806	135	6	genotype	genotype	NOUN
iajs-2806	135	7	of	of	ADP
iajs-2806	135	8	il-33	il-33	ADJ
iajs-2806	135	9	and	and	CCONJ
iajs-2806	135	10	allele	allele	NOUN
iajs-2806	135	11	frequency	frequency	NOUN
iajs-2806	135	12	.	.	PUNCT
iajs-2806	136	1	il-33	il-33	VERB
iajs-2806	136	2	genotype	genotype	NOUN
iajs-2806	136	3	patients	patient	NOUN
iajs-2806	137	1	no	no	INTJ
iajs-2806	138	1	[	[	X
iajs-2806	138	2	%	%	X
iajs-2806	138	3	]	]	X
iajs-2806	138	4	control	control	NOUN
iajs-2806	139	1	no	no	INTJ
iajs-2806	140	1	[	[	X
iajs-2806	140	2	%	%	X
iajs-2806	140	3	]	]	X
iajs-2806	140	4	chi	chi	ADJ
iajs-2806	140	5	-	-	PUNCT
iajs-2806	140	6	square	square	ADJ
iajs-2806	140	7	pvalue	pvalue	NOUN
iajs-2806	140	8	aa	aa	NOUN
iajs-2806	140	9	15	15	NUM
iajs-2806	141	1	[	[	X
iajs-2806	141	2	23.08	23.08	NUM
iajs-2806	141	3	%	%	NOUN
iajs-2806	141	4	]	]	PUNCT
iajs-2806	141	5	6	6	NUM
iajs-2806	142	1	[	[	X
iajs-2806	142	2	17.65	17.65	NUM
iajs-2806	142	3	%	%	NOUN
iajs-2806	142	4	]	]	PUNCT
iajs-2806	142	5	2.41	2.41	NUM
iajs-2806	142	6	ns	ns	NUM
iajs-2806	142	7	0.039	0.039	NUM
iajs-2806	142	8	ag	ag	PROPN
iajs-2806	142	9	38	38	NUM
iajs-2806	142	10	[	[	X
iajs-2806	142	11	58.46	58.46	NUM
iajs-2806	142	12	%	%	NOUN
iajs-2806	142	13	]	]	PUNCT
iajs-2806	142	14	26	26	NUM
iajs-2806	143	1	[	[	X
iajs-2806	143	2	76.47	76.47	NUM
iajs-2806	143	3	%	%	NOUN
iajs-2806	143	4	]	]	PUNCT
iajs-2806	143	5	6.94	6.94	NUM
iajs-2806	143	6	*	*	NOUN
iajs-2806	143	7	*	*	PROPN
iajs-2806	143	8	0.0087	0.0087	NUM
iajs-2806	143	9	gg	gg	NOUN
iajs-2806	143	10	12	12	NUM
iajs-2806	144	1	[	[	X
iajs-2806	144	2	18.46	18.46	NUM
iajs-2806	144	3	%	%	NOUN
iajs-2806	144	4	]	]	PUNCT
iajs-2806	144	5	2	2	NUM
iajs-2806	145	1	[	[	X
iajs-2806	145	2	5.88	5.88	NUM
iajs-2806	145	3	%	%	NOUN
iajs-2806	145	4	]	]	PUNCT
iajs-2806	145	5	5.27	5.27	NUM
iajs-2806	145	6	*	*	SYM
iajs-2806	145	7	0.082	0.082	NUM
iajs-2806	145	8	allele	allele	PROPN
iajs-2806	145	9	frequency	frequency	NOUN
iajs-2806	145	10	a	a	DET
iajs-2806	145	11	68	68	NUM
iajs-2806	145	12	[	[	SYM
iajs-2806	145	13	52.31	52.31	NUM
iajs-2806	145	14	%	%	NOUN
iajs-2806	145	15	]	]	PUNCT
iajs-2806	145	16	38	38	NUM
iajs-2806	145	17	[	[	X
iajs-2806	145	18	55.88	55.88	NUM
iajs-2806	145	19	%	%	NOUN
iajs-2806	145	20	]	]	X
iajs-2806	145	21	0.822ns	0.822ns	NOUN
iajs-2806	145	22	0.239	0.239	NUM
iajs-2806	145	23	g	g	NOUN
iajs-2806	145	24	62	62	NUM
iajs-2806	146	1	[	[	X
iajs-2806	146	2	47.69	47.69	NUM
iajs-2806	146	3	%	%	NOUN
iajs-2806	146	4	]	]	PUNCT
iajs-2806	146	5	30	30	NUM
iajs-2806	147	1	[	[	X
iajs-2806	147	2	44.12	44.12	NUM
iajs-2806	147	3	%	%	NOUN
iajs-2806	147	4	]	]	PUNCT
iajs-2806	147	5	0.822ns	0.822n	NOUN
iajs-2806	147	6	0.239	0.239	NUM
iajs-2806	147	7	*	*	PUNCT
iajs-2806	148	1	[	[	X
iajs-2806	148	2	p<0.05	p<0.05	NOUN
iajs-2806	148	3	]	]	PUNCT
iajs-2806	148	4	:	:	PUNCT
iajs-2806	148	5	significant	significant	ADJ
iajs-2806	148	6	,	,	PUNCT
iajs-2806	148	7	*	*	PUNCT
iajs-2806	148	8	*	*	PUNCT
iajs-2806	149	1	[	[	X
iajs-2806	149	2	p<0.01	p<0.01	PROPN
iajs-2806	149	3	]	]	X
iajs-2806	149	4	:	:	PUNCT
iajs-2806	149	5	highly	highly	ADV
iajs-2806	149	6	significant	significant	ADJ
iajs-2806	149	7	table	table	NOUN
iajs-2806	149	8	4	4	NUM
iajs-2806	149	9	:	:	PUNCT
iajs-2806	149	10	expected	expect	VERB
iajs-2806	149	11	frequencies	frequency	NOUN
iajs-2806	149	12	of	of	ADP
iajs-2806	149	13	genotypes	genotype	NOUN
iajs-2806	149	14	and	and	CCONJ
iajs-2806	149	15	allele	allele	NOUN
iajs-2806	149	16	of	of	ADP
iajs-2806	149	17	the	the	DET
iajs-2806	149	18	il-33	il-33	NOUN
iajs-2806	149	19	using	use	VERB
iajs-2806	149	20	hardyweinberg	hardyweinberg	PROPN
iajs-2806	149	21	equilibrium	equilibrium	NOUN
iajs-2806	149	22	.	.	PUNCT
iajs-2806	150	1	samples	sample	NOUN
iajs-2806	150	2	aa	aa	PROPN
iajs-2806	150	3	ag	ag	PROPN
iajs-2806	150	4	gg	gg	PROPN
iajs-2806	150	5	a	a	DET
iajs-2806	150	6	g	g	NOUN
iajs-2806	150	7	ꭓ2	ꭓ2	ADJ
iajs-2806	150	8	patients	patient	NOUN
iajs-2806	151	1	o.no	o.no	INTJ
iajs-2806	152	1	[	[	X
iajs-2806	152	2	%	%	X
iajs-2806	152	3	]	]	X
iajs-2806	152	4	.	.	PUNCT
iajs-2806	153	1	15	15	NUM
iajs-2806	153	2	23.08	23.08	NUM
iajs-2806	153	3	%	%	NOUN
iajs-2806	153	4	38	38	NUM
iajs-2806	153	5	58.46	58.46	NUM
iajs-2806	153	6	%	%	NOUN
iajs-2806	153	7	12	12	NUM
iajs-2806	153	8	18.46	18.46	NUM
iajs-2806	153	9	%	%	NOUN
iajs-2806	153	10	0.52	0.52	NUM
iajs-2806	153	11	0.48	0.48	NUM
iajs-2806	153	12	1.92	1.92	NUM
iajs-2806	153	13	e.no	e.no	NOUN
iajs-2806	154	1	[	[	X
iajs-2806	154	2	%	%	X
iajs-2806	154	3	]	]	X
iajs-2806	154	4	.	.	PUNCT
iajs-2806	155	1	17.78	17.78	NUM
iajs-2806	155	2	27.35	27.35	NUM
iajs-2806	155	3	%	%	NOUN
iajs-2806	155	4	32.43	32.43	NUM
iajs-2806	155	5	49.89	49.89	NUM
iajs-2806	155	6	%	%	NOUN
iajs-2806	155	7	14.78	14.78	NUM
iajs-2806	155	8	22.73	22.73	NUM
iajs-2806	155	9	%	%	NOUN
iajs-2806	155	10	control	control	NOUN
iajs-2806	156	1	o.no	o.no	INTJ
iajs-2806	157	1	[	[	X
iajs-2806	157	2	%	%	X
iajs-2806	157	3	]	]	X
iajs-2806	157	4	.	.	PUNCT
iajs-2806	158	1	6	6	NUM
iajs-2806	158	2	17.65	17.65	NUM
iajs-2806	158	3	%	%	NOUN
iajs-2806	158	4	26	26	NUM
iajs-2806	158	5	76.47	76.47	NUM
iajs-2806	158	6	%	%	NOUN
iajs-2806	158	7	2	2	NUM
iajs-2806	158	8	5.88	5.88	NUM
iajs-2806	158	9	%	%	NOUN
iajs-2806	158	10	0.56	0.56	NUM
iajs-2806	158	11	0.44	0.44	NUM
iajs-2806	158	12	10.32	10.32	NUM
iajs-2806	158	13	e.no	e.no	PROPN
iajs-2806	159	1	[	[	X
iajs-2806	159	2	%	%	X
iajs-2806	159	3	]	]	X
iajs-2806	159	4	.	.	PUNCT
iajs-2806	160	1	10.62	10.62	NUM
iajs-2806	160	2	31.23	31.23	NUM
iajs-2806	160	3	%	%	NOUN
iajs-2806	160	4	16.76	16.76	NUM
iajs-2806	160	5	49.29	49.29	NUM
iajs-2806	160	6	%	%	NOUN
iajs-2806	160	7	6.62	6.62	NUM
iajs-2806	160	8	19.47	19.47	NUM
iajs-2806	160	9	%	%	NOUN
iajs-2806	160	10	*	*	PUNCT
iajs-2806	160	11	ꭓ2>3.84	ꭓ2>3.84	PROPN
iajs-2806	160	12	:	:	PUNCT
iajs-2806	160	13	the	the	DET
iajs-2806	160	14	expected	expect	VERB
iajs-2806	160	15	frequencies	frequency	NOUN
iajs-2806	160	16	of	of	ADP
iajs-2806	160	17	genotypes	genotype	NOUN
iajs-2806	161	1	,	,	PUNCT
iajs-2806	161	2	results	result	NOUN
iajs-2806	161	3	showed	show	VERB
iajs-2806	161	4	no	no	DET
iajs-2806	161	5	significant	significant	ADJ
iajs-2806	161	6	differences	difference	NOUN
iajs-2806	161	7	in	in	ADP
iajs-2806	161	8	patients	patient	NOUN
iajs-2806	161	9	and	and	CCONJ
iajs-2806	161	10	significant	significant	ADJ
iajs-2806	161	11	difference	difference	NOUN
iajs-2806	161	12	in	in	ADP
iajs-2806	161	13	control	control	NOUN
iajs-2806	161	14	under	under	ADP
iajs-2806	161	15	[	[	X
iajs-2806	161	16	p	p	X
iajs-2806	161	17	<	<	X
iajs-2806	161	18	0.05	0.05	NUM
iajs-2806	161	19	]	]	PUNCT
iajs-2806	161	20	between	between	ADP
iajs-2806	161	21	observed	observed	ADJ
iajs-2806	161	22	and	and	CCONJ
iajs-2806	161	23	expected	expect	VERB
iajs-2806	161	24	frequencies	frequency	NOUN
iajs-2806	161	25	.	.	PUNCT
iajs-2806	162	1	[	[	X
iajs-2806	162	2	o	o	X
iajs-2806	162	3	;	;	PUNCT
iajs-2806	162	4	observed	observe	VERB
iajs-2806	162	5	.	.	PUNCT
iajs-2806	163	1	e	e	X
iajs-2806	163	2	;	;	PUNCT
iajs-2806	163	3	expected	expect	VERB
iajs-2806	163	4	]	]	PUNCT
iajs-2806	163	5	.	.	PUNCT
iajs-2806	164	1	results	result	NOUN
iajs-2806	164	2	of	of	ADP
iajs-2806	164	3	patients	patient	NOUN
iajs-2806	164	4	were	be	AUX
iajs-2806	164	5	agreed	agree	VERB
iajs-2806	164	6	with	with	ADP
iajs-2806	164	7	expected	expect	VERB
iajs-2806	164	8	hardyweinberg	hardyweinberg	PROPN
iajs-2806	164	9	equilibrium	equilibrium	NOUN
iajs-2806	164	10	in	in	ADP
iajs-2806	164	11	patients	patient	NOUN
iajs-2806	164	12	,	,	PUNCT
iajs-2806	164	13	while	while	SCONJ
iajs-2806	164	14	in	in	ADP
iajs-2806	164	15	the	the	DET
iajs-2806	164	16	control	control	NOUN
iajs-2806	164	17	the	the	DET
iajs-2806	164	18	result	result	NOUN
iajs-2806	164	19	was	be	AUX
iajs-2806	164	20	not	not	PART
iajs-2806	164	21	in	in	ADP
iajs-2806	164	22	agreement	agreement	NOUN
iajs-2806	164	23	with	with	ADP
iajs-2806	164	24	expected	expect	VERB
iajs-2806	164	25	hardyweinberg	hardyweinberg	PROPN
iajs-2806	164	26	equilibrium	equilibrium	NOUN
iajs-2806	164	27	,	,	PUNCT
iajs-2806	164	28	and	and	CCONJ
iajs-2806	164	29	there	there	PRON
iajs-2806	164	30	was	be	VERB
iajs-2806	164	31	a	a	DET
iajs-2806	164	32	highly	highly	ADV
iajs-2806	164	33	significant	significant	ADJ
iajs-2806	164	34	difference	difference	NOUN
iajs-2806	164	35	between	between	ADP
iajs-2806	164	36	the	the	DET
iajs-2806	164	37	observed	observe	VERB
iajs-2806	164	38	and	and	CCONJ
iajs-2806	164	39	expected	expect	VERB
iajs-2806	164	40	frequencies	frequency	NOUN
iajs-2806	164	41	[	[	X
iajs-2806	164	42	ꭓ=	ꭓ=	NOUN
iajs-2806	164	43	10.32	10.32	NUM
iajs-2806	164	44	]	]	PUNCT
iajs-2806	164	45	.	.	PUNCT
iajs-2806	165	1	this	this	DET
iajs-2806	165	2	deviate	deviate	NOUN
iajs-2806	165	3	may	may	AUX
iajs-2806	165	4	due	due	ADP
iajs-2806	165	5	to	to	ADP
iajs-2806	165	6	the	the	DET
iajs-2806	165	7	small	small	ADJ
iajs-2806	165	8	sample	sample	NOUN
iajs-2806	165	9	size	size	NOUN
iajs-2806	165	10	overlap	overlap	NOUN
iajs-2806	165	11	marriages	marriage	NOUN
iajs-2806	165	12	deviated	deviate	VERB
iajs-2806	165	13	from	from	ADP
iajs-2806	165	14	hardy	hardy	ADJ
iajs-2806	165	15	-	-	PUNCT
iajs-2806	165	16	weinberg	weinberg	NOUN
iajs-2806	165	17	table	table	NOUN
iajs-2806	165	18	4	4	NUM
iajs-2806	165	19	.	.	PUNCT
iajs-2806	166	1	although	although	SCONJ
iajs-2806	166	2	the	the	DET
iajs-2806	166	3	heterozygous	heterozygous	NOUN
iajs-2806	166	4	represented	represent	VERB
iajs-2806	166	5	the	the	DET
iajs-2806	166	6	most	most	ADV
iajs-2806	166	7	common	common	ADJ
iajs-2806	166	8	type	type	NOUN
iajs-2806	166	9	in	in	ADP
iajs-2806	166	10	patients	patient	NOUN
iajs-2806	166	11	and	and	CCONJ
iajs-2806	166	12	control	control	NOUN
iajs-2806	166	13	groups	group	NOUN
iajs-2806	166	14	so	so	ADV
iajs-2806	166	15	,	,	PUNCT
iajs-2806	166	16	it	it	PRON
iajs-2806	166	17	is	be	AUX
iajs-2806	166	18	common	common	ADJ
iajs-2806	166	19	in	in	ADP
iajs-2806	166	20	the	the	DET
iajs-2806	166	21	iraqi	iraqi	ADJ
iajs-2806	166	22	population	population	NOUN
iajs-2806	166	23	.	.	PUNCT
iajs-2806	167	1	the	the	DET
iajs-2806	167	2	present	present	ADJ
iajs-2806	167	3	study	study	NOUN
iajs-2806	167	4	illustrated	illustrate	VERB
iajs-2806	167	5	that	that	SCONJ
iajs-2806	167	6	the	the	DET
iajs-2806	167	7	genotyping	genotype	VERB
iajs-2806	167	8	distribution	distribution	NOUN
iajs-2806	167	9	of	of	ADP
iajs-2806	167	10	il-33	il-33	NOUN
iajs-2806	167	11	[	[	X
iajs-2806	167	12	rs1929992	rs1929992	ADJ
iajs-2806	167	13	]	]	X
iajs-2806	167	14	gene	gene	NOUN
iajs-2806	167	15	was	be	AUX
iajs-2806	167	16	the	the	DET
iajs-2806	167	17	genotype	genotype	NOUN
iajs-2806	167	18	ag	ag	PROPN
iajs-2806	167	19	,	,	PUNCT
iajs-2806	167	20	which	which	PRON
iajs-2806	167	21	showed	show	VERB
iajs-2806	167	22	the	the	DET
iajs-2806	167	23	highest	high	ADJ
iajs-2806	167	24	percentage	percentage	NOUN
iajs-2806	167	25	in	in	ADP
iajs-2806	167	26	patients	patient	NOUN
iajs-2806	167	27	and	and	CCONJ
iajs-2806	167	28	control	control	NOUN
iajs-2806	167	29	compared	compare	VERB
iajs-2806	167	30	with	with	ADP
iajs-2806	167	31	genotypes	genotype	NOUN
iajs-2806	167	32	aa	aa	NOUN
iajs-2806	167	33	,	,	PUNCT
iajs-2806	167	34	gg	gg	PROPN
iajs-2806	167	35	which	which	PRON
iajs-2806	167	36	recorded	record	VERB
iajs-2806	167	37	the	the	DET
iajs-2806	167	38	lowest	low	ADJ
iajs-2806	167	39	percentage	percentage	NOUN
iajs-2806	167	40	in	in	ADP
iajs-2806	167	41	the	the	DET
iajs-2806	167	42	patient	patient	NOUN
iajs-2806	167	43	and	and	CCONJ
iajs-2806	167	44	control	control	NOUN
iajs-2806	167	45	,	,	PUNCT
iajs-2806	167	46	the	the	DET
iajs-2806	167	47	chisquare	chisquare	NOUN
iajs-2806	167	48	recorded	record	VERB
iajs-2806	167	49	a	a	DET
iajs-2806	167	50	non	non	ADJ
iajs-2806	167	51	-	-	ADJ
iajs-2806	167	52	significant	significant	ADJ
iajs-2806	167	53	difference	difference	NOUN
iajs-2806	167	54	for	for	ADP
iajs-2806	167	55	the	the	DET
iajs-2806	167	56	aa	aa	PROPN
iajs-2806	167	57	genotype	genotype	NOUN
iajs-2806	167	58	in	in	ADP
iajs-2806	167	59	patients	patient	NOUN
iajs-2806	167	60	compared	compare	VERB
iajs-2806	167	61	to	to	ADP
iajs-2806	167	62	controls	control	NOUN
iajs-2806	167	63	while	while	SCONJ
iajs-2806	167	64	genotype	genotype	NOUN
iajs-2806	167	65	ag	ag	PROPN
iajs-2806	167	66	and	and	CCONJ
iajs-2806	167	67	gg	gg	PROPN
iajs-2806	167	68	recorded	record	VERB
iajs-2806	167	69	a	a	DET
iajs-2806	167	70	highly	highly	ADV
iajs-2806	167	71	significant	significant	ADJ
iajs-2806	167	72	difference	difference	NOUN
iajs-2806	167	73	.	.	PUNCT
iajs-2806	168	1	the	the	DET
iajs-2806	168	2	results	result	NOUN
iajs-2806	168	3	of	of	ADP
iajs-2806	168	4	the	the	DET
iajs-2806	168	5	present	present	ADJ
iajs-2806	168	6	study	study	NOUN
iajs-2806	168	7	disagreed	disagree	VERB
iajs-2806	168	8	with	with	ADP
iajs-2806	168	9	the	the	DET
iajs-2806	168	10	previous	previous	ADJ
iajs-2806	168	11	studies	study	NOUN
iajs-2806	168	12	that	that	PRON
iajs-2806	168	13	showed	show	VERB
iajs-2806	168	14	the	the	DET
iajs-2806	168	15	il-33	il-33	ADJ
iajs-2806	168	16	[	[	X
iajs-2806	168	17	rs1929992	rs1929992	ADJ
iajs-2806	168	18	]	]	X
iajs-2806	168	19	gene	gene	NOUN
iajs-2806	168	20	was	be	AUX
iajs-2806	168	21	as	as	SCONJ
iajs-2806	168	22	follows	follow	VERB
iajs-2806	168	23	,	,	PUNCT
iajs-2806	168	24	the	the	DET
iajs-2806	168	25	genotypes	genotype	NOUN
iajs-2806	168	26	ag	ag	PROPN
iajs-2806	168	27	,	,	PUNCT
iajs-2806	168	28	aa	aa	PROPN
iajs-2806	168	29	showed	show	VERB
iajs-2806	168	30	a	a	DET
iajs-2806	168	31	high	high	ADJ
iajs-2806	168	32	percentage	percentage	NOUN
iajs-2806	169	1	[	[	X
iajs-2806	169	2	46	46	NUM
iajs-2806	169	3	%	%	NOUN
iajs-2806	169	4	,	,	PUNCT
iajs-2806	169	5	39	39	NUM
iajs-2806	169	6	%	%	NOUN
iajs-2806	169	7	]	]	X
iajs-2806	169	8	,	,	PUNCT
iajs-2806	169	9	respectively	respectively	ADV
iajs-2806	169	10	,	,	PUNCT
iajs-2806	169	11	in	in	ADP
iajs-2806	169	12	patients	patient	NOUN
iajs-2806	169	13	compared	compare	VERB
iajs-2806	169	14	with	with	ADP
iajs-2806	169	15	genotype	genotype	NOUN
iajs-2806	169	16	gg	gg	NOUN
iajs-2806	169	17	which	which	PRON
iajs-2806	169	18	showed	show	VERB
iajs-2806	169	19	the	the	DET
iajs-2806	169	20	lowest	low	ADJ
iajs-2806	169	21	percentage	percentage	NOUN
iajs-2806	170	1	[	[	X
iajs-2806	170	2	15	15	NUM
iajs-2806	170	3	%	%	NOUN
iajs-2806	170	4	]	]	PUNCT
iajs-2806	170	5	in	in	ADP
iajs-2806	170	6	patients	patient	NOUN
iajs-2806	170	7	.	.	PUNCT
iajs-2806	171	1	while	while	SCONJ
iajs-2806	171	2	in	in	ADP
iajs-2806	171	3	the	the	DET
iajs-2806	171	4	control	control	NOUN
iajs-2806	171	5	the	the	DET
iajs-2806	171	6	genotypes	genotype	NOUN
iajs-2806	171	7	ag	ag	PROPN
iajs-2806	171	8	,	,	PUNCT
iajs-2806	171	9	aa	aa	PROPN
iajs-2806	171	10	showed	show	VERB
iajs-2806	171	11	a	a	DET
iajs-2806	171	12	high	high	ADJ
iajs-2806	171	13	percentage	percentage	NOUN
iajs-2806	172	1	[	[	X
iajs-2806	172	2	38	38	NUM
iajs-2806	172	3	%	%	NOUN
iajs-2806	172	4	,	,	PUNCT
iajs-2806	172	5	49	49	NUM
iajs-2806	172	6	%	%	NOUN
iajs-2806	172	7	]	]	X
iajs-2806	172	8	,	,	PUNCT
iajs-2806	172	9	respectively	respectively	ADV
iajs-2806	172	10	,	,	PUNCT
iajs-2806	172	11	compared	compare	VERB
iajs-2806	172	12	to	to	ADP
iajs-2806	172	13	other	other	ADJ
iajs-2806	172	14	genotype	genotype	NOUN
iajs-2806	172	15	gg	gg	NOUN
iajs-2806	172	16	which	which	PRON
iajs-2806	172	17	showed	show	VERB
iajs-2806	172	18	the	the	DET
iajs-2806	172	19	lowest	low	ADJ
iajs-2806	172	20	percentage	percentage	NOUN
iajs-2806	172	21	[	[	X
iajs-2806	172	22	13	13	NUM
iajs-2806	172	23	%	%	NOUN
iajs-2806	172	24	]	]	PUNCT
iajs-2806	172	25	in	in	ADP
iajs-2806	172	26	control	control	NOUN
iajs-2806	172	27	[	[	X
iajs-2806	172	28	23	23	NUM
iajs-2806	172	29	]	]	PUNCT
iajs-2806	172	30	.	.	PUNCT
iajs-2806	173	1	in	in	ADP
iajs-2806	173	2	the	the	DET
iajs-2806	173	3	statistical	statistical	ADJ
iajs-2806	173	4	evaluations	evaluation	NOUN
iajs-2806	173	5	of	of	ADP
iajs-2806	173	6	il-33	il-33	ADJ
iajs-2806	173	7	gene	gene	NOUN
iajs-2806	173	8	between	between	ADP
iajs-2806	173	9	patients	patient	NOUN
iajs-2806	173	10	and	and	CCONJ
iajs-2806	173	11	control	control	NOUN
iajs-2806	173	12	by	by	ADP
iajs-2806	173	13	using	use	VERB
iajs-2806	173	14	fisher	fisher	PROPN
iajs-2806	173	15	’s	’s	PART
iajs-2806	173	16	test	test	NOUN
iajs-2806	173	17	as	as	SCONJ
iajs-2806	173	18	shown	show	VERB
iajs-2806	173	19	in	in	ADP
iajs-2806	173	20	table	table	NOUN
iajs-2806	173	21	5.the	5.the	DET
iajs-2806	173	22	statistical	statistical	ADJ
iajs-2806	173	23	analysis	analysis	NOUN
iajs-2806	173	24	found	find	VERB
iajs-2806	173	25	that	that	SCONJ
iajs-2806	173	26	,	,	PUNCT
iajs-2806	173	27	in	in	ADP
iajs-2806	173	28	the	the	DET
iajs-2806	173	29	patients	patient	NOUN
iajs-2806	173	30	the	the	DET
iajs-2806	173	31	frequency	frequency	NOUN
iajs-2806	173	32	of	of	ADP
iajs-2806	173	33	genotype	genotype	NOUN
iajs-2806	173	34	aa	aa	PROPN
iajs-2806	173	35	recorded	record	VERB
iajs-2806	173	36	odd	odd	ADJ
iajs-2806	173	37	ratio	ratio	NOUN
iajs-2806	173	38	[	[	X
iajs-2806	173	39	or	or	CCONJ
iajs-2806	173	40	]	]	PUNCT
iajs-2806	174	1	[	[	X
iajs-2806	174	2	1.40	1.40	NUM
iajs-2806	174	3	]	]	PUNCT
iajs-2806	174	4	with	with	ADP
iajs-2806	174	5	a	a	DET
iajs-2806	174	6	confidence	confidence	NOUN
iajs-2806	174	7	intervals	interval	NOUN
iajs-2806	174	8	[	[	X
iajs-2806	174	9	ci	ci	X
iajs-2806	174	10	]	]	X
iajs-2806	174	11	value	value	NOUN
iajs-2806	174	12	between	between	ADP
iajs-2806	174	13	[	[	X
iajs-2806	174	14	0.49	0.49	NUM
iajs-2806	174	15	4.31	4.31	NUM
iajs-2806	174	16	]	]	PUNCT
iajs-2806	174	17	under	under	ADP
iajs-2806	174	18	[	[	X
iajs-2806	174	19	95	95	NUM
iajs-2806	174	20	%	%	NOUN
iajs-2806	174	21	]	]	PUNCT
iajs-2806	174	22	and	and	CCONJ
iajs-2806	174	23	showed	show	VERB
iajs-2806	174	24	etiological	etiological	ADJ
iajs-2806	174	25	[	[	X
iajs-2806	174	26	et	et	NOUN
iajs-2806	174	27	]	]	X
iajs-2806	174	28	fraction	fraction	NOUN
iajs-2806	174	29	of	of	ADP
iajs-2806	174	30	the	the	DET
iajs-2806	174	31	diseases	disease	NOUN
iajs-2806	174	32	ibn	ibn	PROPN
iajs-2806	174	33	al	al	PROPN
iajs-2806	174	34	-	-	PUNCT
iajs-2806	174	35	haitham	haitham	PROPN
iajs-2806	174	36	jour	jour	X
iajs-2806	174	37	.	.	PROPN
iajs-2806	175	1	for	for	ADP
iajs-2806	175	2	pure	pure	ADJ
iajs-2806	175	3	&	&	CCONJ
iajs-2806	175	4	appl	appl	PROPN
iajs-2806	175	5	.	.	PUNCT
iajs-2806	176	1	sci	sci	PROPN
iajs-2806	176	2	.	.	PROPN
iajs-2806	177	1	34	34	NUM
iajs-2806	177	2	(	(	PUNCT
iajs-2806	177	3	1	1	NUM
iajs-2806	177	4	)	)	PUNCT
iajs-2806	177	5	2021	2021	NUM
iajs-2806	177	6	8	8	NUM
iajs-2806	178	1	[	[	X
iajs-2806	178	2	0.066	0.066	NUM
iajs-2806	178	3	]	]	PUNCT
iajs-2806	178	4	and	and	CCONJ
iajs-2806	178	5	it	it	PRON
iajs-2806	178	6	also	also	ADV
iajs-2806	178	7	showed	show	VERB
iajs-2806	178	8	a	a	DET
iajs-2806	178	9	nonsignificant	nonsignificant	ADJ
iajs-2806	178	10	difference	difference	NOUN
iajs-2806	178	11	[	[	X
iajs-2806	178	12	0.525	0.525	NUM
iajs-2806	178	13	]	]	PUNCT
iajs-2806	178	14	according	accord	VERB
iajs-2806	178	15	to	to	ADP
iajs-2806	178	16	fisher	fisher	PROPN
iajs-2806	178	17	’s	’s	PART
iajs-2806	178	18	exact	exact	ADJ
iajs-2806	178	19	probability	probability	NOUN
iajs-2806	178	20	.	.	PUNCT
iajs-2806	179	1	the	the	DET
iajs-2806	179	2	genotype	genotype	NOUN
iajs-2806	179	3	ag	ag	PROPN
iajs-2806	179	4	recorded	record	VERB
iajs-2806	179	5	or	or	CCONJ
iajs-2806	179	6	[	[	X
iajs-2806	179	7	0.43	0.43	NUM
iajs-2806	179	8	]	]	PUNCT
iajs-2806	179	9	with	with	ADP
iajs-2806	179	10	a	a	DET
iajs-2806	179	11	ci	ci	NOUN
iajs-2806	179	12	between	between	ADP
iajs-2806	179	13	[	[	X
iajs-2806	179	14	0.16	0.16	NUM
iajs-2806	179	15	–	–	PUNCT
iajs-2806	179	16	1.10	1.10	NUM
iajs-2806	179	17	]	]	PUNCT
iajs-2806	179	18	under	under	ADP
iajs-2806	179	19	[	[	X
iajs-2806	179	20	95	95	NUM
iajs-2806	179	21	%	%	NOUN
iajs-2806	179	22	]	]	PUNCT
iajs-2806	179	23	and	and	CCONJ
iajs-2806	179	24	showed	show	VERB
iajs-2806	179	25	a	a	DET
iajs-2806	179	26	preventive	preventive	ADJ
iajs-2806	179	27	[	[	X
iajs-2806	179	28	pr	pr	X
iajs-2806	179	29	]	]	X
iajs-2806	179	30	fraction	fraction	NOUN
iajs-2806	180	1	[	[	X
iajs-2806	180	2	when	when	SCONJ
iajs-2806	180	3	or	or	CCONJ
iajs-2806	180	4	less	less	ADJ
iajs-2806	180	5	than	than	ADP
iajs-2806	180	6	one	one	NUM
iajs-2806	180	7	]	]	PUNCT
iajs-2806	180	8	of	of	ADP
iajs-2806	180	9	the	the	DET
iajs-2806	180	10	diseases	disease	NOUN
iajs-2806	180	11	was	be	AUX
iajs-2806	180	12	[	[	X
iajs-2806	180	13	0.434	0.434	NUM
iajs-2806	180	14	]	]	PUNCT
iajs-2806	180	15	and	and	CCONJ
iajs-2806	180	16	it	it	PRON
iajs-2806	180	17	showed	show	VERB
iajs-2806	180	18	a	a	DET
iajs-2806	180	19	nonsignificant	nonsignificant	ADJ
iajs-2806	180	20	difference	difference	NOUN
iajs-2806	180	21	[	[	X
iajs-2806	180	22	0.064	0.064	NUM
iajs-2806	180	23	]	]	PUNCT
iajs-2806	180	24	according	accord	VERB
iajs-2806	180	25	to	to	ADP
iajs-2806	180	26	fisher	fisher	PROPN
iajs-2806	180	27	’s	’s	PART
iajs-2806	180	28	exact	exact	ADJ
iajs-2806	180	29	probability	probability	NOUN
iajs-2806	180	30	.	.	PUNCT
iajs-2806	181	1	the	the	DET
iajs-2806	181	2	frequency	frequency	NOUN
iajs-2806	181	3	of	of	ADP
iajs-2806	181	4	genotype	genotype	NOUN
iajs-2806	181	5	gg	gg	PROPN
iajs-2806	181	6	recorded	record	VERB
iajs-2806	181	7	or	or	CCONJ
iajs-2806	181	8	[	[	X
iajs-2806	181	9	3.62	3.62	NUM
iajs-2806	181	10	]	]	PUNCT
iajs-2806	181	11	with	with	ADP
iajs-2806	181	12	a	a	DET
iajs-2806	181	13	ci	ci	NOUN
iajs-2806	181	14	between	between	ADP
iajs-2806	181	15	[	[	X
iajs-2806	181	16	0.84	0.84	NUM
iajs-2806	181	17	24.94	24.94	NUM
iajs-2806	181	18	]	]	PUNCT
iajs-2806	181	19	under	under	ADP
iajs-2806	181	20	[	[	X
iajs-2806	181	21	95	95	NUM
iajs-2806	181	22	%	%	NOUN
iajs-2806	181	23	]	]	PUNCT
iajs-2806	181	24	and	and	CCONJ
iajs-2806	181	25	showed	show	VERB
iajs-2806	181	26	et	et	NOUN
iajs-2806	181	27	fraction	fraction	NOUN
iajs-2806	181	28	was	be	AUX
iajs-2806	181	29	[	[	X
iajs-2806	181	30	0.134	0.134	NUM
iajs-2806	181	31	]	]	PUNCT
iajs-2806	181	32	with	with	ADP
iajs-2806	181	33	a	a	DET
iajs-2806	181	34	nonsignificant	nonsignificant	ADJ
iajs-2806	181	35	difference	difference	NOUN
iajs-2806	181	36	[	[	X
iajs-2806	181	37	0.079	0.079	NUM
iajs-2806	181	38	]	]	PUNCT
iajs-2806	181	39	according	accord	VERB
iajs-2806	181	40	to	to	ADP
iajs-2806	181	41	fisher	fisher	PROPN
iajs-2806	181	42	’s	’s	PART
iajs-2806	181	43	exact	exact	ADJ
iajs-2806	181	44	probability	probability	NOUN
iajs-2806	181	45	.	.	PUNCT
iajs-2806	182	1	the	the	DET
iajs-2806	182	2	allele	allele	NOUN
iajs-2806	182	3	frequency	frequency	NOUN
iajs-2806	182	4	of	of	ADP
iajs-2806	182	5	a	a	DET
iajs-2806	182	6	showed	show	VERB
iajs-2806	182	7	or	or	CCONJ
iajs-2806	182	8	[	[	X
iajs-2806	182	9	0.87	0.87	NUM
iajs-2806	182	10	]	]	PUNCT
iajs-2806	182	11	with	with	ADP
iajs-2806	182	12	ci	ci	PROPN
iajs-2806	182	13	rang	ring	VERB
iajs-2806	182	14	between	between	ADP
iajs-2806	182	15	[	[	X
iajs-2806	182	16	0.48	0.48	NUM
iajs-2806	182	17	–	–	PUNCT
iajs-2806	182	18	1.57	1.57	NUM
iajs-2806	182	19	]	]	PUNCT
iajs-2806	182	20	under	under	ADP
iajs-2806	182	21	[	[	X
iajs-2806	182	22	95	95	NUM
iajs-2806	182	23	%	%	NOUN
iajs-2806	182	24	]	]	PUNCT
iajs-2806	182	25	and	and	CCONJ
iajs-2806	182	26	pr	pr	X
iajs-2806	182	27	fraction	fraction	NOUN
iajs-2806	182	28	[	[	X
iajs-2806	182	29	0.075	0.075	NUM
iajs-2806	182	30	]	]	PUNCT
iajs-2806	182	31	with	with	ADP
iajs-2806	182	32	a	a	DET
iajs-2806	182	33	non	non	ADJ
iajs-2806	182	34	significant	significant	ADJ
iajs-2806	182	35	difference	difference	NOUN
iajs-2806	182	36	[	[	X
iajs-2806	182	37	0.602	0.602	NUM
iajs-2806	182	38	]	]	PUNCT
iajs-2806	182	39	,	,	PUNCT
iajs-2806	182	40	while	while	SCONJ
iajs-2806	182	41	allele	allele	NOUN
iajs-2806	182	42	g	g	PROPN
iajs-2806	182	43	showed	show	VERB
iajs-2806	182	44	or	or	CCONJ
iajs-2806	182	45	[	[	X
iajs-2806	182	46	1.15	1.15	NUM
iajs-2806	182	47	]	]	PUNCT
iajs-2806	182	48	with	with	ADP
iajs-2806	182	49	ci	ci	PROPN
iajs-2806	182	50	rang	ring	VERB
iajs-2806	182	51	between	between	ADP
iajs-2806	182	52	[	[	X
iajs-2806	182	53	0.64	0.64	NUM
iajs-2806	182	54	2.09	2.09	NUM
iajs-2806	182	55	]	]	PUNCT
iajs-2806	182	56	under	under	ADP
iajs-2806	182	57	[	[	X
iajs-2806	182	58	95	95	NUM
iajs-2806	182	59	%	%	NOUN
iajs-2806	182	60	]	]	PUNCT
iajs-2806	182	61	and	and	CCONJ
iajs-2806	182	62	et	et	NOUN
iajs-2806	182	63	fraction	fraction	NOUN
iajs-2806	183	1	[	[	X
iajs-2806	183	2	0.064	0.064	NUM
iajs-2806	183	3	]	]	PUNCT
iajs-2806	183	4	with	with	ADP
iajs-2806	183	5	a	a	DET
iajs-2806	183	6	nonsignificant	nonsignificant	ADJ
iajs-2806	183	7	difference	difference	NOUN
iajs-2806	184	1	[	[	X
iajs-2806	184	2	0.602	0.602	NUM
iajs-2806	184	3	]	]	PUNCT
iajs-2806	184	4	according	accord	VERB
iajs-2806	184	5	to	to	ADP
iajs-2806	184	6	fisher	fisher	PROPN
iajs-2806	184	7	’s	’s	PART
iajs-2806	184	8	exact	exact	ADJ
iajs-2806	184	9	probability	probability	NOUN
iajs-2806	184	10	.	.	PUNCT
iajs-2806	185	1	table	table	NOUN
iajs-2806	185	2	5	5	NUM
iajs-2806	185	3	:	:	PUNCT
iajs-2806	185	4	the	the	DET
iajs-2806	185	5	statistical	statistical	ADJ
iajs-2806	185	6	evaluations	evaluation	NOUN
iajs-2806	185	7	of	of	ADP
iajs-2806	185	8	il-33	il-33	ADJ
iajs-2806	185	9	gene	gene	NOUN
iajs-2806	185	10	between	between	ADP
iajs-2806	185	11	groups	group	NOUN
iajs-2806	185	12	.	.	PUNCT
iajs-2806	186	1	genotype	genotype	NOUN
iajs-2806	186	2	or	or	CCONJ
iajs-2806	186	3	et	et	NOUN
iajs-2806	186	4	or	or	CCONJ
iajs-2806	186	5	pr	pr	PROPN
iajs-2806	186	6	fisher	fisher	PROPN
iajs-2806	186	7	’s	’s	PART
iajs-2806	186	8	exact	exact	ADJ
iajs-2806	186	9	probability	probability	NOUN
iajs-2806	186	10	ci	ci	NOUN
iajs-2806	186	11	95	95	NUM
iajs-2806	186	12	%	%	NOUN
iajs-2806	186	13	aa	aa	NOUN
iajs-2806	186	14	1.40	1.40	NUM
iajs-2806	186	15	0.066	0.066	NUM
iajs-2806	186	16	0.525	0.525	NUM
iajs-2806	186	17	ns	ns	NUM
iajs-2806	186	18	0.49	0.49	NUM
iajs-2806	186	19	4.31	4.31	NUM
iajs-2806	186	20	ag	ag	PROPN
iajs-2806	186	21	0.43	0.43	NUM
iajs-2806	186	22	0.434	0.434	NUM
iajs-2806	186	23	0.064	0.064	NUM
iajs-2806	186	24	ns	ns	NUM
iajs-2806	186	25	0.16	0.16	NUM
iajs-2806	186	26	1.10	1.10	NUM
iajs-2806	186	27	gg	gg	NOUN
iajs-2806	186	28	3.62	3.62	NUM
iajs-2806	186	29	0.134	0.134	NUM
iajs-2806	186	30	0.079	0.079	NUM
iajs-2806	186	31	ns	ns	NUM
iajs-2806	186	32	0.8424.94	0.8424.94	PROPN
iajs-2806	186	33	allele	allele	NOUN
iajs-2806	186	34	distribution	distribution	NOUN
iajs-2806	186	35	a	a	DET
iajs-2806	186	36	0.87	0.87	NUM
iajs-2806	186	37	0.075	0.075	NUM
iajs-2806	186	38	0.602	0.602	NUM
iajs-2806	186	39	ns	ns	NUM
iajs-2806	186	40	0.48	0.48	NUM
iajs-2806	186	41	1.57	1.57	NUM
iajs-2806	186	42	g	g	PROPN
iajs-2806	186	43	1.15	1.15	NUM
iajs-2806	186	44	0.064	0.064	NUM
iajs-2806	186	45	0.602	0.602	NUM
iajs-2806	186	46	ns	ns	NUM
iajs-2806	186	47	0.64	0.64	NUM
iajs-2806	186	48	2.09	2.09	NUM
iajs-2806	186	49	ns	ns	NUM
iajs-2806	186	50	:	:	PUNCT
iajs-2806	186	51	non	non	ADJ
iajs-2806	186	52	-	-	ADJ
iajs-2806	186	53	significant	significant	ADJ
iajs-2806	186	54	.	.	PUNCT
iajs-2806	187	1	the	the	DET
iajs-2806	187	2	statistical	statistical	ADJ
iajs-2806	187	3	evaluations	evaluation	NOUN
iajs-2806	187	4	of	of	ADP
iajs-2806	187	5	il-33	il-33	ADJ
iajs-2806	187	6	gene	gene	NOUN
iajs-2806	187	7	between	between	ADP
iajs-2806	187	8	patients	patient	NOUN
iajs-2806	187	9	and	and	CCONJ
iajs-2806	187	10	control	control	NOUN
iajs-2806	187	11	by	by	ADP
iajs-2806	187	12	using	use	VERB
iajs-2806	187	13	fisher	fisher	PROPN
iajs-2806	187	14	’s	’s	PART
iajs-2806	187	15	exact	exact	ADJ
iajs-2806	187	16	probability	probability	NOUN
iajs-2806	187	17	showed	show	VERB
iajs-2806	187	18	that	that	SCONJ
iajs-2806	187	19	the	the	DET
iajs-2806	187	20	genotype	genotype	NOUN
iajs-2806	187	21	ag	ag	PROPN
iajs-2806	187	22	was	be	AUX
iajs-2806	187	23	a	a	DET
iajs-2806	187	24	high	high	ADJ
iajs-2806	187	25	frequency	frequency	NOUN
iajs-2806	187	26	in	in	ADP
iajs-2806	187	27	studying	study	VERB
iajs-2806	187	28	groups	group	NOUN
iajs-2806	187	29	and	and	CCONJ
iajs-2806	187	30	recorded	record	VERB
iajs-2806	187	31	odd	odd	ADJ
iajs-2806	187	32	ratio	ratio	NOUN
iajs-2806	187	33	value	value	NOUN
iajs-2806	187	34	[	[	X
iajs-2806	187	35	0.43	0.43	NUM
iajs-2806	187	36	]	]	PUNCT
iajs-2806	187	37	and	and	CCONJ
iajs-2806	187	38	also	also	ADV
iajs-2806	187	39	showed	show	VERB
iajs-2806	187	40	the	the	DET
iajs-2806	187	41	preventive	preventive	ADJ
iajs-2806	187	42	fraction	fraction	NOUN
iajs-2806	187	43	in	in	ADP
iajs-2806	187	44	breast	breast	NOUN
iajs-2806	187	45	cancer	cancer	NOUN
iajs-2806	187	46	patients	patient	NOUN
iajs-2806	187	47	,	,	PUNCT
iajs-2806	187	48	the	the	DET
iajs-2806	187	49	genotypes	genotype	NOUN
iajs-2806	187	50	aa	aa	NOUN
iajs-2806	187	51	,	,	PUNCT
iajs-2806	187	52	gg	gg	NOUN
iajs-2806	187	53	record	record	NOUN
iajs-2806	187	54	as	as	ADP
iajs-2806	187	55	etiological	etiological	ADJ
iajs-2806	187	56	fraction	fraction	NOUN
iajs-2806	187	57	in	in	ADP
iajs-2806	187	58	breast	breast	NOUN
iajs-2806	187	59	cancer	cancer	NOUN
iajs-2806	187	60	patients	patient	NOUN
iajs-2806	187	61	with	with	ADP
iajs-2806	187	62	more	more	ADJ
iajs-2806	187	63	than	than	ADP
iajs-2806	187	64	one	one	NUM
iajs-2806	187	65	odd	odd	ADJ
iajs-2806	187	66	ratio	ratio	NOUN
iajs-2806	187	67	[	[	X
iajs-2806	187	68	1.40	1.40	NUM
iajs-2806	187	69	,	,	PUNCT
iajs-2806	187	70	3.62	3.62	NUM
iajs-2806	187	71	]	]	PUNCT
iajs-2806	187	72	,	,	PUNCT
iajs-2806	187	73	respectively	respectively	ADV
iajs-2806	187	74	;	;	PUNCT
iajs-2806	187	75	the	the	DET
iajs-2806	187	76	frequency	frequency	NOUN
iajs-2806	187	77	of	of	ADP
iajs-2806	187	78	a	a	DET
iajs-2806	187	79	allele	allele	NOUN
iajs-2806	187	80	record	record	VERB
iajs-2806	187	81	preventive	preventive	ADJ
iajs-2806	187	82	fraction	fraction	NOUN
iajs-2806	187	83	with	with	ADP
iajs-2806	187	84	odd	odd	ADJ
iajs-2806	187	85	ratio	ratio	NOUN
iajs-2806	187	86	was	be	AUX
iajs-2806	187	87	less	less	ADJ
iajs-2806	187	88	than	than	ADP
iajs-2806	187	89	one	one	NUM
iajs-2806	187	90	[	[	NOUN
iajs-2806	187	91	0.87	0.87	NUM
iajs-2806	187	92	]	]	PUNCT
iajs-2806	187	93	.	.	PUNCT
iajs-2806	188	1	while	while	SCONJ
iajs-2806	188	2	fluency	fluency	NOUN
iajs-2806	188	3	of	of	ADP
iajs-2806	188	4	g	g	PROPN
iajs-2806	188	5	allele	allele	PROPN
iajs-2806	188	6	recorded	record	VERB
iajs-2806	188	7	an	an	DET
iajs-2806	188	8	etiological	etiological	ADJ
iajs-2806	188	9	fraction	fraction	NOUN
iajs-2806	188	10	with	with	ADP
iajs-2806	188	11	odd	odd	ADJ
iajs-2806	188	12	ratios	ratio	NOUN
iajs-2806	188	13	[	[	X
iajs-2806	188	14	1.15	1.15	NUM
iajs-2806	188	15	]	]	PUNCT
iajs-2806	188	16	with	with	ADP
iajs-2806	188	17	a	a	DET
iajs-2806	188	18	non	non	ADJ
iajs-2806	188	19	-	-	ADJ
iajs-2806	188	20	significant	significant	ADJ
iajs-2806	188	21	difference	difference	NOUN
iajs-2806	188	22	in	in	ADP
iajs-2806	188	23	the	the	DET
iajs-2806	188	24	frequencies	frequency	NOUN
iajs-2806	188	25	of	of	ADP
iajs-2806	188	26	genotypes	genotype	NOUN
iajs-2806	188	27	[	[	X
iajs-2806	188	28	aa	aa	NOUN
iajs-2806	188	29	,	,	PUNCT
iajs-2806	188	30	ag	ag	PROPN
iajs-2806	188	31	,	,	PUNCT
iajs-2806	188	32	gg	gg	NOUN
iajs-2806	188	33	]	]	PUNCT
iajs-2806	188	34	and	and	CCONJ
iajs-2806	188	35	alleles	allele	VERB
iajs-2806	188	36	a	a	PRON
iajs-2806	188	37	and	and	CCONJ
iajs-2806	188	38	g	g	NOUN
iajs-2806	188	39	at	at	ADP
iajs-2806	188	40	il-33	il-33	ADJ
iajs-2806	188	41	snp	snp	ADJ
iajs-2806	188	42	[	[	X
iajs-2806	188	43	rs1929992	rs1929992	X
iajs-2806	188	44	]	]	PUNCT
iajs-2806	188	45	between	between	ADP
iajs-2806	188	46	breast	breast	NOUN
iajs-2806	188	47	cancer	cancer	NOUN
iajs-2806	188	48	patients	patient	NOUN
iajs-2806	188	49	and	and	CCONJ
iajs-2806	188	50	healthy	healthy	ADJ
iajs-2806	188	51	control	control	NOUN
iajs-2806	188	52	.	.	PUNCT
iajs-2806	189	1	this	this	DET
iajs-2806	189	2	result	result	NOUN
iajs-2806	189	3	agreed	agree	VERB
iajs-2806	189	4	with	with	ADP
iajs-2806	189	5	a	a	DET
iajs-2806	189	6	previous	previous	ADJ
iajs-2806	189	7	study	study	NOUN
iajs-2806	189	8	where	where	SCONJ
iajs-2806	189	9	there	there	PRON
iajs-2806	189	10	was	be	VERB
iajs-2806	189	11	no	no	DET
iajs-2806	189	12	any	any	DET
iajs-2806	189	13	association	association	NOUN
iajs-2806	189	14	between	between	ADP
iajs-2806	189	15	breast	breast	NOUN
iajs-2806	189	16	cancer	cancer	NOUN
iajs-2806	189	17	disease	disease	NOUN
iajs-2806	189	18	and	and	CCONJ
iajs-2806	189	19	il-33	il-33	VERB
iajs-2806	189	20	snp	snp	ADJ
iajs-2806	190	1	[	[	X
iajs-2806	190	2	rs1929992	rs1929992	X
iajs-2806	190	3	]	]	X
iajs-2806	191	1	[	[	X
iajs-2806	191	2	23	23	NUM
iajs-2806	191	3	]	]	PUNCT
iajs-2806	191	4	.	.	PUNCT
iajs-2806	192	1	as	as	SCONJ
iajs-2806	192	2	shown	show	VERB
iajs-2806	192	3	of	of	ADP
iajs-2806	192	4	the	the	DET
iajs-2806	192	5	il-33	il-33	NUM
iajs-2806	192	6	,	,	PUNCT
iajs-2806	192	7	polymorphism	polymorphism	NOUN
iajs-2806	192	8	may	may	AUX
iajs-2806	192	9	have	have	VERB
iajs-2806	192	10	no	no	DET
iajs-2806	192	11	influence	influence	NOUN
iajs-2806	192	12	of	of	ADP
iajs-2806	192	13	[	[	X
iajs-2806	192	14	rs1929992	rs1929992	X
iajs-2806	192	15	]	]	PUNCT
iajs-2806	192	16	on	on	ADP
iajs-2806	192	17	breast	breast	NOUN
iajs-2806	192	18	cancer	cancer	NOUN
iajs-2806	192	19	risk	risk	NOUN
iajs-2806	192	20	.	.	PUNCT
iajs-2806	193	1	another	another	DET
iajs-2806	193	2	study	study	NOUN
iajs-2806	193	3	on	on	ADP
iajs-2806	193	4	non	non	ADJ
iajs-2806	193	5	-	-	ADJ
iajs-2806	193	6	malignant	malignant	ADJ
iajs-2806	193	7	disease	disease	NOUN
iajs-2806	193	8	[	[	X
iajs-2806	193	9	36	36	NUM
iajs-2806	193	10	]	]	SYM
iajs-2806	193	11	record	record	NOUN
iajs-2806	193	12	il-33	il-33	ADJ
iajs-2806	193	13	rs1929992	rs1929992	ADJ
iajs-2806	193	14	polymorphism	polymorphism	NOUN
iajs-2806	193	15	may	may	AUX
iajs-2806	193	16	be	be	AUX
iajs-2806	193	17	a	a	DET
iajs-2806	193	18	potential	potential	ADJ
iajs-2806	193	19	biomarker	biomarker	NOUN
iajs-2806	193	20	for	for	ADP
iajs-2806	193	21	susceptibility	susceptibility	NOUN
iajs-2806	193	22	to	to	ADP
iajs-2806	193	23	systemic	systemic	ADJ
iajs-2806	193	24	lupus	lupus	PROPN
iajs-2806	193	25	erythematosus	erythematosus	PROPN
iajs-2806	193	26	.	.	PUNCT
iajs-2806	194	1	according	accord	VERB
iajs-2806	194	2	to	to	ADP
iajs-2806	194	3	the	the	DET
iajs-2806	194	4	present	present	ADJ
iajs-2806	194	5	study	study	NOUN
iajs-2806	194	6	the	the	DET
iajs-2806	194	7	conclusion	conclusion	NOUN
iajs-2806	194	8	was	be	AUX
iajs-2806	194	9	that	that	SCONJ
iajs-2806	194	10	ag	ag	PROPN
iajs-2806	194	11	genotype	genotype	NOUN
iajs-2806	194	12	could	could	AUX
iajs-2806	194	13	be	be	AUX
iajs-2806	194	14	considered	consider	VERB
iajs-2806	194	15	as	as	ADP
iajs-2806	194	16	a	a	DET
iajs-2806	194	17	common	common	ADJ
iajs-2806	194	18	type	type	NOUN
iajs-2806	194	19	in	in	ADP
iajs-2806	194	20	the	the	DET
iajs-2806	194	21	iraqi	iraqi	ADJ
iajs-2806	194	22	population	population	NOUN
iajs-2806	194	23	,	,	PUNCT
iajs-2806	194	24	while	while	SCONJ
iajs-2806	194	25	gg	gg	PROPN
iajs-2806	194	26	was	be	AUX
iajs-2806	194	27	a	a	DET
iajs-2806	194	28	lower	low	ADJ
iajs-2806	194	29	frequency	frequency	NOUN
iajs-2806	194	30	genotype	genotype	NOUN
iajs-2806	194	31	in	in	ADP
iajs-2806	194	32	the	the	DET
iajs-2806	194	33	iraqi	iraqi	ADJ
iajs-2806	194	34	population	population	NOUN
iajs-2806	194	35	.	.	PUNCT
iajs-2806	195	1	4.3	4.3	NUM
iajs-2806	195	2	.	.	PUNCT
iajs-2806	195	3	related	relate	VERB
iajs-2806	195	4	genotype	genotype	NOUN
iajs-2806	195	5	with	with	ADP
iajs-2806	195	6	the	the	DET
iajs-2806	195	7	level	level	NOUN
iajs-2806	195	8	of	of	ADP
iajs-2806	195	9	il-33	il-33	ADJ
iajs-2806	195	10	in	in	ADP
iajs-2806	195	11	serum	serum	NOUN
iajs-2806	195	12	the	the	DET
iajs-2806	195	13	present	present	ADJ
iajs-2806	195	14	study	study	NOUN
iajs-2806	195	15	showed	show	VERB
iajs-2806	195	16	a	a	DET
iajs-2806	195	17	comparison	comparison	NOUN
iajs-2806	195	18	of	of	ADP
iajs-2806	195	19	il-33	il-33	ADJ
iajs-2806	195	20	level	level	NOUN
iajs-2806	195	21	according	accord	VERB
iajs-2806	195	22	of	of	ADP
iajs-2806	195	23	the	the	DET
iajs-2806	195	24	il-33	il-33	ADJ
iajs-2806	195	25	genotype	genotype	NOUN
iajs-2806	195	26	in	in	ADP
iajs-2806	195	27	patients	patient	NOUN
iajs-2806	195	28	and	and	CCONJ
iajs-2806	195	29	control	control	NOUN
iajs-2806	195	30	groups	group	NOUN
iajs-2806	195	31	.	.	PUNCT
iajs-2806	196	1	in	in	ADP
iajs-2806	196	2	patients	patient	NOUN
iajs-2806	196	3	the	the	DET
iajs-2806	196	4	genotype	genotype	NOUN
iajs-2806	196	5	aa	aa	NOUN
iajs-2806	196	6	showed	show	VERB
iajs-2806	196	7	a	a	DET
iajs-2806	196	8	significant	significant	ADJ
iajs-2806	196	9	difference	difference	NOUN
iajs-2806	196	10	with	with	ADP
iajs-2806	196	11	a	a	DET
iajs-2806	196	12	mean	mean	NOUN
iajs-2806	196	13	[	[	X
iajs-2806	196	14	142.27	142.27	NUM
iajs-2806	196	15	±	±	NUM
iajs-2806	196	16	25.83	25.83	NUM
iajs-2806	196	17	]	]	PUNCT
iajs-2806	196	18	compared	compare	VERB
iajs-2806	196	19	to	to	PART
iajs-2806	196	20	control	control	VERB
iajs-2806	196	21	[	[	PUNCT
iajs-2806	196	22	340.07±	340.07±	NUM
iajs-2806	196	23	130.45	130.45	NUM
iajs-2806	196	24	]	]	PUNCT
iajs-2806	196	25	.	.	PUNCT
iajs-2806	197	1	as	as	ADV
iajs-2806	197	2	well	well	ADV
iajs-2806	197	3	as	as	SCONJ
iajs-2806	197	4	genotype	genotype	NOUN
iajs-2806	197	5	ag	ag	PROPN
iajs-2806	197	6	recorded	record	VERB
iajs-2806	197	7	a	a	DET
iajs-2806	197	8	significant	significant	ADJ
iajs-2806	197	9	difference	difference	NOUN
iajs-2806	197	10	in	in	ADP
iajs-2806	197	11	mean	mean	NOUN
iajs-2806	198	1	[	[	X
iajs-2806	198	2	136.82	136.82	NUM
iajs-2806	198	3	±	±	NUM
iajs-2806	198	4	24.21	24.21	NUM
iajs-2806	198	5	]	]	PUNCT
iajs-2806	198	6	compared	compare	VERB
iajs-2806	198	7	to	to	PART
iajs-2806	198	8	control	control	VERB
iajs-2806	198	9	[	[	X
iajs-2806	198	10	242.53	242.53	NUM
iajs-2806	198	11	±	±	NUM
iajs-2806	198	12	41.34	41.34	NUM
iajs-2806	198	13	]	]	PUNCT
iajs-2806	198	14	.	.	PUNCT
iajs-2806	199	1	while	while	SCONJ
iajs-2806	199	2	the	the	DET
iajs-2806	199	3	genotype	genotype	NOUN
iajs-2806	199	4	gg	gg	PROPN
iajs-2806	199	5	showed	show	VERB
iajs-2806	199	6	a	a	DET
iajs-2806	199	7	non	non	ADJ
iajs-2806	199	8	-	-	ADJ
iajs-2806	199	9	significant	significant	ADJ
iajs-2806	199	10	increasing	increase	VERB
iajs-2806	199	11	[	[	X
iajs-2806	199	12	238.27	238.27	NUM
iajs-2806	199	13	±	±	NOUN
iajs-2806	199	14	120.44	120.44	NUM
iajs-2806	199	15	]	]	PUNCT
iajs-2806	199	16	compared	compare	VERB
iajs-2806	199	17	to	to	PART
iajs-2806	199	18	control	control	VERB
iajs-2806	199	19	[	[	PUNCT
iajs-2806	199	20	183.24	183.24	NUM
iajs-2806	199	21	±	±	NUM
iajs-2806	199	22	40.75	40.75	NUM
iajs-2806	199	23	]	]	PUNCT
iajs-2806	199	24	as	as	SCONJ
iajs-2806	199	25	shown	show	VERB
iajs-2806	199	26	in	in	ADP
iajs-2806	199	27	table	table	NOUN
iajs-2806	199	28	6	6	NUM
iajs-2806	199	29	.	.	PUNCT
iajs-2806	200	1	the	the	DET
iajs-2806	200	2	result	result	NOUN
iajs-2806	200	3	of	of	ADP
iajs-2806	200	4	the	the	DET
iajs-2806	200	5	current	current	ADJ
iajs-2806	200	6	study	study	NOUN
iajs-2806	200	7	showed	show	VERB
iajs-2806	200	8	that	that	SCONJ
iajs-2806	200	9	the	the	DET
iajs-2806	200	10	il-33	il-33	ADJ
iajs-2806	200	11	serum	serum	NOUN
iajs-2806	200	12	level	level	NOUN
iajs-2806	200	13	was	be	AUX
iajs-2806	200	14	lowest	low	ADJ
iajs-2806	200	15	in	in	ADP
iajs-2806	200	16	patients	patient	NOUN
iajs-2806	200	17	with	with	ADP
iajs-2806	200	18	genotypes	genotype	NOUN
iajs-2806	200	19	aa	aa	NOUN
iajs-2806	200	20	,	,	PUNCT
iajs-2806	200	21	ag	ag	PROPN
iajs-2806	200	22	with	with	ADP
iajs-2806	200	23	a	a	DET
iajs-2806	200	24	significant	significant	ADJ
iajs-2806	200	25	difference	difference	NOUN
iajs-2806	200	26	as	as	SCONJ
iajs-2806	200	27	compared	compare	VERB
iajs-2806	200	28	to	to	ADP
iajs-2806	200	29	control	control	NOUN
iajs-2806	200	30	than	than	ADP
iajs-2806	200	31	ibn	ibn	PROPN
iajs-2806	200	32	al	al	PROPN
iajs-2806	200	33	-	-	PUNCT
iajs-2806	200	34	haitham	haitham	PROPN
iajs-2806	200	35	jour	jour	X
iajs-2806	200	36	.	.	PROPN
iajs-2806	201	1	for	for	ADP
iajs-2806	201	2	pure	pure	ADJ
iajs-2806	201	3	&	&	CCONJ
iajs-2806	201	4	appl	appl	PROPN
iajs-2806	201	5	.	.	PUNCT
iajs-2806	202	1	sci	sci	PROPN
iajs-2806	202	2	.	.	PROPN
iajs-2806	203	1	34	34	NUM
iajs-2806	203	2	(	(	PUNCT
iajs-2806	203	3	1	1	NUM
iajs-2806	203	4	)	)	PUNCT
iajs-2806	203	5	2021	2021	NUM
iajs-2806	203	6	9	9	NUM
iajs-2806	203	7	patients	patient	NOUN
iajs-2806	203	8	with	with	ADP
iajs-2806	203	9	gg	gg	NOUN
iajs-2806	203	10	genotype	genotype	NOUN
iajs-2806	203	11	and	and	CCONJ
iajs-2806	203	12	this	this	DET
iajs-2806	203	13	result	result	NOUN
iajs-2806	203	14	disagreed	disagree	VERB
iajs-2806	203	15	with	with	ADP
iajs-2806	203	16	the	the	DET
iajs-2806	203	17	previous	previous	ADJ
iajs-2806	203	18	study	study	NOUN
iajs-2806	203	19	,	,	PUNCT
iajs-2806	203	20	which	which	PRON
iajs-2806	203	21	demonstrated	demonstrate	VERB
iajs-2806	203	22	the	the	DET
iajs-2806	203	23	mean	mean	ADJ
iajs-2806	203	24	serum	serum	NOUN
iajs-2806	203	25	level	level	NOUN
iajs-2806	203	26	of	of	ADP
iajs-2806	203	27	il-33	il-33	NOUN
iajs-2806	203	28	was	be	AUX
iajs-2806	203	29	higher	high	ADJ
iajs-2806	203	30	in	in	ADP
iajs-2806	203	31	patients	patient	NOUN
iajs-2806	203	32	with	with	ADP
iajs-2806	203	33	the	the	DET
iajs-2806	203	34	genotypes	genotype	NOUN
iajs-2806	203	35	aa	aa	NOUN
iajs-2806	203	36	,	,	PUNCT
iajs-2806	203	37	ag	ag	PROPN
iajs-2806	203	38	than	than	ADP
iajs-2806	203	39	patients	patient	NOUN
iajs-2806	203	40	with	with	ADP
iajs-2806	203	41	the	the	DET
iajs-2806	203	42	genotype	genotype	NOUN
iajs-2806	203	43	gg	gg	NOUN
iajs-2806	203	44	and	and	CCONJ
iajs-2806	203	45	the	the	DET
iajs-2806	203	46	difference	difference	NOUN
iajs-2806	203	47	not	not	PART
iajs-2806	203	48	significant	significant	ADJ
iajs-2806	203	49	between	between	ADP
iajs-2806	203	50	patients	patient	NOUN
iajs-2806	203	51	and	and	CCONJ
iajs-2806	203	52	control	control	VERB
iajs-2806	203	53	[	[	X
iajs-2806	203	54	23	23	NUM
iajs-2806	203	55	]	]	PUNCT
iajs-2806	203	56	.	.	PUNCT
iajs-2806	204	1	table	table	NOUN
iajs-2806	204	2	6	6	NUM
iajs-2806	204	3	:	:	PUNCT
iajs-2806	204	4	the	the	DET
iajs-2806	204	5	comparison	comparison	NOUN
iajs-2806	204	6	level	level	NOUN
iajs-2806	204	7	of	of	ADP
iajs-2806	204	8	il-33	il-33	ADJ
iajs-2806	204	9	concentration	concentration	NOUN
iajs-2806	204	10	according	accord	VERB
iajs-2806	204	11	to	to	ADP
iajs-2806	204	12	type	type	NOUN
iajs-2806	204	13	of	of	ADP
iajs-2806	204	14	genotype	genotype	NOUN
iajs-2806	204	15	in	in	ADP
iajs-2806	204	16	pt	pt	NOUN
iajs-2806	204	17	patients	patient	NOUN
iajs-2806	204	18	and	and	CCONJ
iajs-2806	204	19	control	control	NOUN
iajs-2806	204	20	.	.	PUNCT
iajs-2806	205	1	il-33	il-33	VERB
iajs-2806	205	2	a	a	DET
iajs-2806	205	3	/	/	SYM
iajs-2806	205	4	g	g	NOUN
iajs-2806	205	5	genotype	genotype	NOUN
iajs-2806	205	6	patients	patient	NOUN
iajs-2806	205	7	mean	mean	VERB
iajs-2806	205	8	±se	±se	PROPN
iajs-2806	205	9	control	control	PROPN
iajs-2806	205	10	mean	mean	VERB
iajs-2806	205	11	±se	±se	NOUN
iajs-2806	205	12	pvalue	pvalue	VERB
iajs-2806	205	13	aa	aa	NOUN
iajs-2806	205	14	142.27	142.27	NUM
iajs-2806	205	15	±	±	NUM
iajs-2806	205	16	25.83	25.83	NUM
iajs-2806	205	17	340.07±	340.07±	NUM
iajs-2806	205	18	130.45	130.45	NUM
iajs-2806	205	19	0.0366	0.0366	NUM
iajs-2806	205	20	*	*	PUNCT
iajs-2806	205	21	ag	ag	PROPN
iajs-2806	205	22	136.82	136.82	NUM
iajs-2806	205	23	±	±	NUM
iajs-2806	205	24	24.21	24.21	NUM
iajs-2806	205	25	242.53	242.53	NUM
iajs-2806	205	26	±	±	NUM
iajs-2806	205	27	41.34	41.34	NUM
iajs-2806	205	28	0.0394	0.0394	NUM
iajs-2806	205	29	*	*	PUNCT
iajs-2806	205	30	gg	gg	PROPN
iajs-2806	205	31	238.27	238.27	NUM
iajs-2806	205	32	±	±	NUM
iajs-2806	205	33	120.44	120.44	NUM
iajs-2806	205	34	183.24	183.24	NUM
iajs-2806	205	35	±	±	NUM
iajs-2806	205	36	40.75	40.75	NUM
iajs-2806	205	37	0.082	0.082	NUM
iajs-2806	205	38	ns	ns	NUM
iajs-2806	205	39	*	*	PUNCT
iajs-2806	206	1	[	[	X
iajs-2806	206	2	p<0.05	p<0.05	NOUN
iajs-2806	206	3	]	]	X
iajs-2806	206	4	,	,	PUNCT
iajs-2806	206	5	ns	ns	NUM
iajs-2806	206	6	:	:	PUNCT
iajs-2806	206	7	non	non	ADJ
iajs-2806	206	8	-	-	ADJ
iajs-2806	206	9	significant	significant	ADJ
iajs-2806	206	10	.	.	PUNCT
iajs-2806	207	1	5	5	X
iajs-2806	207	2	.	.	X
iajs-2806	207	3	conclusion	conclusion	NOUN
iajs-2806	207	4	this	this	DET
iajs-2806	207	5	study	study	NOUN
iajs-2806	207	6	found	find	VERB
iajs-2806	207	7	that	that	SCONJ
iajs-2806	207	8	the	the	DET
iajs-2806	207	9	il-33	il-33	ADJ
iajs-2806	207	10	serum	serum	NOUN
iajs-2806	207	11	level	level	NOUN
iajs-2806	207	12	decreased	decrease	VERB
iajs-2806	207	13	after	after	ADP
iajs-2806	207	14	surgery	surgery	NOUN
iajs-2806	207	15	performed	perform	VERB
iajs-2806	207	16	in	in	ADP
iajs-2806	207	17	patients	patient	NOUN
iajs-2806	207	18	with	with	ADP
iajs-2806	207	19	breast	breast	NOUN
iajs-2806	207	20	cancer	cancer	NOUN
iajs-2806	207	21	.	.	PUNCT
iajs-2806	208	1	no	no	DET
iajs-2806	208	2	association	association	NOUN
iajs-2806	208	3	was	be	AUX
iajs-2806	208	4	found	find	VERB
iajs-2806	208	5	between	between	ADP
iajs-2806	208	6	breast	breast	NOUN
iajs-2806	208	7	cancer	cancer	NOUN
iajs-2806	208	8	development	development	NOUN
iajs-2806	208	9	and	and	CCONJ
iajs-2806	208	10	il-33	il-33	ADJ
iajs-2806	208	11	snp	snp	ADJ
iajs-2806	209	1	[	[	X
iajs-2806	209	2	rs1929992	rs1929992	X
iajs-2806	209	3	]	]	PUNCT
iajs-2806	209	4	in	in	ADP
iajs-2806	209	5	the	the	DET
iajs-2806	209	6	iraqi	iraqi	ADJ
iajs-2806	209	7	population	population	NOUN
iajs-2806	209	8	,	,	PUNCT
iajs-2806	209	9	the	the	DET
iajs-2806	209	10	heterozygous	heterozygous	ADJ
iajs-2806	209	11	genotype	genotype	NOUN
iajs-2806	209	12	ag	ag	PROPN
iajs-2806	209	13	was	be	AUX
iajs-2806	209	14	a	a	DET
iajs-2806	209	15	common	common	ADJ
iajs-2806	209	16	genotype	genotype	NOUN
iajs-2806	209	17	in	in	ADP
iajs-2806	209	18	the	the	DET
iajs-2806	209	19	iraqi	iraqi	ADJ
iajs-2806	209	20	population	population	NOUN
iajs-2806	209	21	.	.	PUNCT
iajs-2806	210	1	the	the	DET
iajs-2806	210	2	g	g	PROPN
iajs-2806	210	3	allele	allele	PROPN
iajs-2806	210	4	was	be	AUX
iajs-2806	210	5	an	an	DET
iajs-2806	210	6	environmental	environmental	ADJ
iajs-2806	210	7	effect	effect	NOUN
iajs-2806	210	8	allele	allele	NOUN
iajs-2806	210	9	,	,	PUNCT
iajs-2806	210	10	while	while	SCONJ
iajs-2806	210	11	allele	allele	NOUN
iajs-2806	210	12	a	a	PRON
iajs-2806	210	13	had	have	VERB
iajs-2806	210	14	preventive	preventive	ADJ
iajs-2806	210	15	fraction	fraction	NOUN
iajs-2806	210	16	,	,	PUNCT
iajs-2806	210	17	which	which	PRON
iajs-2806	210	18	was	be	AUX
iajs-2806	210	19	related	relate	VERB
iajs-2806	210	20	with	with	ADP
iajs-2806	210	21	increasing	increase	VERB
iajs-2806	210	22	level	level	NOUN
iajs-2806	210	23	of	of	ADP
iajs-2806	210	24	il-33	il-33	ADJ
iajs-2806	210	25	for	for	ADP
iajs-2806	210	26	both	both	PRON
iajs-2806	210	27	genotypes	genotype	NOUN
iajs-2806	210	28	aa	aa	NOUN
iajs-2806	210	29	,	,	PUNCT
iajs-2806	210	30	ag	ag	PROPN
iajs-2806	210	31	in	in	ADP
iajs-2806	210	32	healthy	healthy	ADJ
iajs-2806	210	33	control	control	NOUN
iajs-2806	210	34	group	group	NOUN
iajs-2806	210	35	,	,	PUNCT
iajs-2806	210	36	in	in	ADP
iajs-2806	210	37	contrast	contrast	NOUN
iajs-2806	210	38	with	with	ADP
iajs-2806	210	39	gg	gg	NOUN
iajs-2806	210	40	genotype	genotype	NOUN
iajs-2806	210	41	which	which	PRON
iajs-2806	210	42	showed	show	VERB
iajs-2806	210	43	the	the	DET
iajs-2806	210	44	highly	highly	ADV
iajs-2806	210	45	level	level	NOUN
iajs-2806	210	46	in	in	ADP
iajs-2806	210	47	patients	patient	NOUN
iajs-2806	210	48	’	'	PUNCT
iajs-2806	210	49	group	group	NOUN
iajs-2806	210	50	.	.	PUNCT
iajs-2806	211	1	this	this	DET
iajs-2806	211	2	study	study	NOUN
iajs-2806	211	3	needs	need	VERB
iajs-2806	211	4	a	a	DET
iajs-2806	211	5	cohort	cohort	NOUN
iajs-2806	211	6	study	study	NOUN
iajs-2806	211	7	to	to	PART
iajs-2806	211	8	follow	follow	VERB
iajs-2806	211	9	the	the	DET
iajs-2806	211	10	serum	serum	NOUN
iajs-2806	211	11	level	level	NOUN
iajs-2806	211	12	of	of	ADP
iajs-2806	211	13	il-33	il-33	NUM
iajs-2806	211	14	in	in	ADP
iajs-2806	211	15	the	the	DET
iajs-2806	211	16	same	same	ADJ
iajs-2806	211	17	patients	patient	NOUN
iajs-2806	211	18	before	before	ADP
iajs-2806	211	19	and	and	CCONJ
iajs-2806	211	20	after	after	ADP
iajs-2806	211	21	mastectomy	mastectomy	NOUN
iajs-2806	211	22	or	or	CCONJ
iajs-2806	211	23	resection	resection	NOUN
iajs-2806	211	24	surgery	surgery	NOUN
iajs-2806	211	25	and	and	CCONJ
iajs-2806	211	26	then	then	ADV
iajs-2806	211	27	after	after	ADP
iajs-2806	211	28	treating	treat	VERB
iajs-2806	211	29	with	with	ADP
iajs-2806	211	30	chemotherapy	chemotherapy	NOUN
iajs-2806	211	31	.	.	PUNCT
iajs-2806	212	1	references	reference	NOUN
iajs-2806	212	2	1.desantis	1.desantis	NUM
iajs-2806	212	3	,	,	PUNCT
iajs-2806	212	4	c.e	c.e	PROPN
iajs-2806	212	5	.	.	PROPN
iajs-2806	212	6	;	;	PUNCT
iajs-2806	213	1	bray	bray	PROPN
iajs-2806	213	2	,	,	PUNCT
iajs-2806	213	3	f	f	X
iajs-2806	213	4	,	,	PUNCT
iajs-2806	213	5	;	;	PUNCT
iajs-2806	213	6	ferlay	ferlay	NOUN
iajs-2806	213	7	,	,	PUNCT
iajs-2806	213	8	j.	j.	PROPN
iajs-2806	213	9	;	;	PUNCT
iajs-2806	213	10	lortet	lortet	NOUN
iajs-2806	213	11	-	-	PUNCT
iajs-2806	213	12	tieulent	tieulent	NOUN
iajs-2806	213	13	,	,	PUNCT
iajs-2806	213	14	j.	j.	PROPN
iajs-2806	213	15	anderson	anderson	PROPN
iajs-2806	213	16	,	,	PUNCT
iajs-2806	213	17	b.o	b.o	PROPN
iajs-2806	213	18	.	.	PROPN
iajs-2806	213	19	;	;	PUNCT
iajs-2806	213	20	jemal	jemal	ADJ
iajs-2806	213	21	,	,	PUNCT
iajs-2806	213	22	a.	a.	PROPN
iajs-2806	213	23	international	international	ADJ
iajs-2806	213	24	variation	variation	NOUN
iajs-2806	213	25	in	in	ADP
iajs-2806	213	26	female	female	ADJ
iajs-2806	213	27	breast	breast	NOUN
iajs-2806	213	28	cancer	cancer	NOUN
iajs-2806	213	29	incidence	incidence	NOUN
iajs-2806	213	30	and	and	CCONJ
iajs-2806	213	31	mortality	mortality	NOUN
iajs-2806	213	32	rates	rate	NOUN
iajs-2806	213	33	.	.	PUNCT
iajs-2806	214	1	cancer	cancer	NOUN
iajs-2806	214	2	epidemiol	epidemiol	PROPN
iajs-2806	214	3	.	.	PUNCT
iajs-2806	215	1	prevent	prevent	VERB
iajs-2806	215	2	.	.	PUNCT
iajs-2806	216	1	biomarkers	biomarker	NOUN
iajs-2806	216	2	.	.	PUNCT
iajs-2806	217	1	2015	2015	NUM
iajs-2806	217	2	,	,	PUNCT
iajs-2806	217	3	24,10	24,10	NUM
iajs-2806	217	4	,	,	PUNCT
iajs-2806	217	5	1495	1495	NUM
iajs-2806	217	6	-	-	SYM
iajs-2806	217	7	1506	1506	NUM
iajs-2806	217	8	.	.	PUNCT
iajs-2806	218	1	2.ministry	2.ministry	NUM
iajs-2806	218	2	of	of	ADP
iajs-2806	218	3	health	health	NOUN
iajs-2806	218	4	in	in	ADP
iajs-2806	218	5	iraq	iraq	PROPN
iajs-2806	218	6	.	.	PUNCT
iajs-2806	219	1	annual	annual	ADJ
iajs-2806	219	2	statistical	statistical	ADJ
iajs-2806	219	3	report	report	NOUN
iajs-2806	219	4	.	.	PUNCT
iajs-2806	220	1	2017	2017	NUM
iajs-2806	220	2	.	.	PUNCT
iajs-2806	221	1	3.liu	3.liu	NUM
iajs-2806	221	2	,	,	PUNCT
iajs-2806	221	3	j.	j.	PROPN
iajs-2806	221	4	;	;	PUNCT
iajs-2806	221	5	shen	shen	PROPN
iajs-2806	221	6	,	,	PUNCT
iajs-2806	221	7	j.x	j.x	PROPN
iajs-2806	221	8	.	.	PROPN
iajs-2806	221	9	;	;	PUNCT
iajs-2806	221	10	hu	hu	PROPN
iajs-2806	221	11	,	,	PUNCT
iajs-2806	221	12	j.l	j.l	PROPN
iajs-2806	221	13	.	.	PROPN
iajs-2806	221	14	;	;	PUNCT
iajs-2806	221	15	huang	huang	PROPN
iajs-2806	221	16	,	,	PUNCT
iajs-2806	221	17	w.h	w.h	PROPN
iajs-2806	221	18	.	.	PROPN
iajs-2806	221	19	;	;	PUNCT
iajs-2806	221	20	zhang	zhang	PROPN
iajs-2806	221	21	,	,	PUNCT
iajs-2806	221	22	g.j	g.j	PROPN
iajs-2806	221	23	.	.	PROPN
iajs-2806	221	24	significance	significance	NOUN
iajs-2806	221	25	of	of	ADP
iajs-2806	221	26	interleukin-33	interleukin-33	PROPN
iajs-2806	221	27	and	and	CCONJ
iajs-2806	221	28	its	its	PRON
iajs-2806	221	29	related	related	ADJ
iajs-2806	221	30	cytokines	cytokine	NOUN
iajs-2806	221	31	in	in	ADP
iajs-2806	221	32	patients	patient	NOUN
iajs-2806	221	33	with	with	ADP
iajs-2806	221	34	breast	breast	NOUN
iajs-2806	221	35	cancers	cancer	NOUN
iajs-2806	221	36	.	.	PUNCT
iajs-2806	222	1	frontiers	frontier	NOUN
iajs-2806	222	2	immunol	immunol	NOUN
iajs-2806	222	3	.	.	PUNCT
iajs-2806	223	1	2014	2014	NUM
iajs-2806	223	2	,	,	PUNCT
iajs-2806	223	3	7	7	NUM
iajs-2806	223	4	,	,	PUNCT
iajs-2806	223	5	5	5	NUM
iajs-2806	223	6	,	,	PUNCT
iajs-2806	223	7	141	141	NUM
iajs-2806	223	8	.	.	PUNCT
iajs-2806	224	1	4.lefrançais	4.lefrançais	NUM
iajs-2806	224	2	,	,	PUNCT
iajs-2806	224	3	e.	e.	PROPN
iajs-2806	224	4	;	;	PUNCT
iajs-2806	224	5	duval	duval	PROPN
iajs-2806	224	6	,	,	PUNCT
iajs-2806	224	7	a.	a.	NOUN
iajs-2806	224	8	;	;	PUNCT
iajs-2806	224	9	mirey	mirey	PROPN
iajs-2806	224	10	,	,	PUNCT
iajs-2806	224	11	e.	e.	PROPN
iajs-2806	224	12	;	;	PUNCT
iajs-2806	224	13	roga	roga	PROPN
iajs-2806	224	14	,	,	PUNCT
iajs-2806	224	15	s.	s.	PROPN
iajs-2806	224	16	;	;	PUNCT
iajs-2806	224	17	espinosa	espinosa	PROPN
iajs-2806	224	18	,	,	PUNCT
iajs-2806	224	19	e.	e.	PROPN
iajs-2806	224	20	;	;	PUNCT
iajs-2806	224	21	cayrol	cayrol	NOUN
iajs-2806	224	22	,	,	PUNCT
iajs-2806	224	23	c.	c.	PROPN
iajs-2806	224	24	;	;	PUNCT
iajs-2806	224	25	girard	girard	PROPN
iajs-2806	224	26	,	,	PUNCT
iajs-2806	224	27	j.p	j.p	PROPN
iajs-2806	224	28	.	.	PROPN
iajs-2806	224	29	central	central	ADJ
iajs-2806	224	30	domain	domain	NOUN
iajs-2806	224	31	of	of	ADP
iajs-2806	224	32	il-33	il-33	ADJ
iajs-2806	224	33	is	be	AUX
iajs-2806	224	34	cleaved	cleave	VERB
iajs-2806	224	35	by	by	ADP
iajs-2806	224	36	mast	mast	NOUN
iajs-2806	224	37	cell	cell	NOUN
iajs-2806	224	38	proteases	protease	NOUN
iajs-2806	224	39	for	for	ADP
iajs-2806	224	40	potent	potent	ADJ
iajs-2806	224	41	activation	activation	NOUN
iajs-2806	224	42	of	of	ADP
iajs-2806	224	43	group-2	group-2	PROPN
iajs-2806	224	44	innate	innate	ADJ
iajs-2806	224	45	lymphoid	lymphoid	ADJ
iajs-2806	224	46	cells	cell	NOUN
iajs-2806	224	47	.	.	PUNCT
iajs-2806	225	1	proceedings	proceeding	NOUN
iajs-2806	225	2	of	of	ADP
iajs-2806	225	3	the	the	DET
iajs-2806	225	4	national	national	PROPN
iajs-2806	225	5	academy	academy	PROPN
iajs-2806	225	6	of	of	ADP
iajs-2806	225	7	sciences	sciences	PROPN
iajs-2806	225	8	.	.	PUNCT
iajs-2806	225	9	2014	2014	NUM
iajs-2806	225	10	,	,	PUNCT
iajs-2806	225	11	28	28	NUM
iajs-2806	225	12	,	,	PUNCT
iajs-2806	225	13	111	111	NUM
iajs-2806	225	14	,	,	PUNCT
iajs-2806	225	15	43	43	NUM
iajs-2806	225	16	,	,	PUNCT
iajs-2806	225	17	15502	15502	NUM
iajs-2806	225	18	-	-	SYM
iajs-2806	225	19	15507	15507	NUM
iajs-2806	225	20	.	.	PUNCT
iajs-2806	226	1	5.carriere	5.carriere	NUM
iajs-2806	226	2	,	,	PUNCT
iajs-2806	226	3	v.	v.	ADV
iajs-2806	226	4	;	;	PUNCT
iajs-2806	226	5	roussel	roussel	PROPN
iajs-2806	226	6	,	,	PUNCT
iajs-2806	226	7	l.	l.	PROPN
iajs-2806	226	8	;	;	PUNCT
iajs-2806	226	9	ortega	ortega	PROPN
iajs-2806	226	10	,	,	PUNCT
iajs-2806	226	11	n.	n.	PROPN
iajs-2806	226	12	;	;	PUNCT
iajs-2806	226	13	lacorre	lacorre	PROPN
iajs-2806	226	14	,	,	PUNCT
iajs-2806	226	15	d.a	d.a	PROPN
iajs-2806	226	16	.	.	PROPN
iajs-2806	226	17	;	;	PUNCT
iajs-2806	226	18	americh	americh	PROPN
iajs-2806	226	19	,	,	PUNCT
iajs-2806	226	20	l.	l.	PROPN
iajs-2806	226	21	;	;	PUNCT
iajs-2806	226	22	aguilar	aguilar	PROPN
iajs-2806	226	23	,	,	PUNCT
iajs-2806	226	24	l.	l.	PROPN
iajs-2806	226	25	;	;	PUNCT
iajs-2806	226	26	bouche	bouche	X
iajs-2806	226	27	,	,	PUNCT
iajs-2806	226	28	g.	g.	PROPN
iajs-2806	226	29	;	;	PUNCT
iajs-2806	226	30	girard	girard	PROPN
iajs-2806	226	31	,	,	PUNCT
iajs-2806	226	32	j.p	j.p	PROPN
iajs-2806	226	33	.	.	PROPN
iajs-2806	226	34	il-33	il-33	PROPN
iajs-2806	226	35	the	the	DET
iajs-2806	226	36	il-1	il-1	NOUN
iajs-2806	226	37	-	-	PUNCT
iajs-2806	226	38	like	like	ADJ
iajs-2806	226	39	cytokine	cytokine	NOUN
iajs-2806	226	40	ligand	ligand	NOUN
iajs-2806	226	41	for	for	ADP
iajs-2806	226	42	st2	st2	NOUN
iajs-2806	226	43	receptor	receptor	NOUN
iajs-2806	226	44	,	,	PUNCT
iajs-2806	226	45	is	be	AUX
iajs-2806	226	46	a	a	DET
iajs-2806	226	47	chromatin	chromatin	NOUN
iajs-2806	226	48	-	-	PUNCT
iajs-2806	226	49	associated	associate	VERB
iajs-2806	226	50	nuclear	nuclear	ADJ
iajs-2806	226	51	factor	factor	NOUN
iajs-2806	226	52	in	in	ADP
iajs-2806	226	53	vivo	vivo	NOUN
iajs-2806	226	54	.	.	PUNCT
iajs-2806	227	1	proceedings	proceeding	NOUN
iajs-2806	227	2	of	of	ADP
iajs-2806	227	3	the	the	DET
iajs-2806	227	4	national	national	PROPN
iajs-2806	227	5	academy	academy	PROPN
iajs-2806	227	6	of	of	ADP
iajs-2806	227	7	sciences	sciences	PROPN
iajs-2806	227	8	.	.	PUNCT
iajs-2806	228	1	2007	2007	NUM
iajs-2806	228	2	,	,	PUNCT
iajs-2806	228	3	2,104	2,104	NUM
iajs-2806	228	4	,	,	PUNCT
iajs-2806	228	5	1	1	NUM
iajs-2806	228	6	,	,	PUNCT
iajs-2806	228	7	282	282	NUM
iajs-2806	228	8	-	-	SYM
iajs-2806	228	9	287	287	NUM
iajs-2806	228	10	.	.	PUNCT
iajs-2806	229	1	6.schmitz	6.schmitz	NUM
iajs-2806	229	2	,	,	PUNCT
iajs-2806	229	3	j.	j.	PROPN
iajs-2806	229	4	;	;	PUNCT
iajs-2806	229	5	owyang	owyang	PROPN
iajs-2806	229	6	,	,	PUNCT
iajs-2806	229	7	a.	a.	PROPN
iajs-2806	229	8	;	;	PUNCT
iajs-2806	229	9	oldham	oldham	PROPN
iajs-2806	229	10	,	,	PUNCT
iajs-2806	229	11	e.	e.	PROPN
iajs-2806	229	12	;	;	PUNCT
iajs-2806	229	13	song	song	PROPN
iajs-2806	229	14	,	,	PUNCT
iajs-2806	229	15	y.	y.	PROPN
iajs-2806	229	16	;	;	PUNCT
iajs-2806	229	17	murphy	murphy	PROPN
iajs-2806	229	18	,	,	PUNCT
iajs-2806	229	19	e.	e.	PROPN
iajs-2806	229	20	;	;	PUNCT
iajs-2806	229	21	mcclanahan	mcclanahan	PROPN
iajs-2806	229	22	,	,	PUNCT
iajs-2806	229	23	t.k	t.k	PROPN
iajs-2806	229	24	.	.	PROPN
iajs-2806	229	25	;	;	PUNCT
iajs-2806	229	26	zurawski	zurawski	PROPN
iajs-2806	229	27	,	,	PUNCT
iajs-2806	229	28	g.	g.	PROPN
iajs-2806	229	29	;	;	PUNCT
iajs-2806	229	30	moshrefi	moshrefi	PROPN
iajs-2806	229	31	,	,	PUNCT
iajs-2806	229	32	m.	m.	NOUN
iajs-2806	229	33	;	;	PUNCT
iajs-2806	229	34	qin	qin	PROPN
iajs-2806	229	35	.	.	PUNCT
iajs-2806	230	1	j.	j.	PROPN
iajs-2806	230	2	;	;	PUNCT
iajs-2806	230	3	li	li	PROPN
iajs-2806	230	4	,	,	PUNCT
iajs-2806	230	5	x.	x.	PROPN
iajs-2806	230	6	;	;	PUNCT
iajs-2806	230	7	gorman	gorman	PROPN
iajs-2806	230	8	,	,	PUNCT
iajs-2806	230	9	d.m	d.m	PROPN
iajs-2806	230	10	.	.	PROPN
iajs-2806	230	11	il-33	il-33	PROPN
iajs-2806	230	12	,	,	PUNCT
iajs-2806	230	13	an	an	DET
iajs-2806	230	14	interleukin-1	interleukin-1	NOUN
iajs-2806	230	15	-	-	PUNCT
iajs-2806	230	16	like	like	ADJ
iajs-2806	230	17	cytokine	cytokine	NOUN
iajs-2806	230	18	that	that	SCONJ
iajs-2806	230	19	signals	signal	NOUN
iajs-2806	230	20	via	via	ADP
iajs-2806	230	21	the	the	DET
iajs-2806	230	22	il-1	il-1	ADJ
iajs-2806	230	23	receptor	receptor	NOUN
iajs-2806	230	24	-	-	PUNCT
iajs-2806	230	25	related	relate	VERB
iajs-2806	230	26	protein	protein	NOUN
iajs-2806	230	27	st2	st2	NOUN
iajs-2806	230	28	and	and	CCONJ
iajs-2806	230	29	induces	induce	VERB
iajs-2806	230	30	t	t	PROPN
iajs-2806	230	31	helper	helper	NOUN
iajs-2806	230	32	type	type	NOUN
iajs-2806	230	33	2	2	NUM
iajs-2806	230	34	-	-	PUNCT
iajs-2806	230	35	associated	associate	VERB
iajs-2806	230	36	cytokines	cytokine	NOUN
iajs-2806	230	37	.	.	PUNCT
iajs-2806	231	1	immunity	immunity	NOUN
iajs-2806	231	2	.	.	PUNCT
iajs-2806	232	1	2005	2005	NUM
iajs-2806	232	2	,	,	PUNCT
iajs-2806	232	3	1	1	NUM
iajs-2806	232	4	,	,	PUNCT
iajs-2806	232	5	23	23	NUM
iajs-2806	232	6	,	,	PUNCT
iajs-2806	232	7	5	5	NUM
iajs-2806	232	8	,	,	PUNCT
iajs-2806	232	9	479	479	NUM
iajs-2806	232	10	-	-	SYM
iajs-2806	232	11	490	490	NUM
iajs-2806	232	12	.	.	PUNCT
iajs-2806	233	1	7.lópez	7.lópez	NUM
iajs-2806	233	2	-	-	PUNCT
iajs-2806	233	3	mejías	mejías	NOUN
iajs-2806	233	4	,	,	PUNCT
iajs-2806	233	5	r.	r.	PROPN
iajs-2806	233	6	;	;	PUNCT
iajs-2806	233	7	genre	genre	NOUN
iajs-2806	233	8	,	,	PUNCT
iajs-2806	233	9	f.	f.	PROPN
iajs-2806	233	10	;	;	PUNCT
iajs-2806	233	11	remuzgo	remuzgo	PROPN
iajs-2806	233	12	-	-	PUNCT
iajs-2806	233	13	martínez	martínez	PROPN
iajs-2806	233	14	,	,	PUNCT
iajs-2806	233	15	s.	s.	PROPN
iajs-2806	233	16	;	;	PUNCT
iajs-2806	233	17	robustillo	robustillo	PROPN
iajs-2806	233	18	-	-	PUNCT
iajs-2806	233	19	villarino	villarino	NOUN
iajs-2806	233	20	,	,	PUNCT
iajs-2806	233	21	m.	m.	NOUN
iajs-2806	233	22	;	;	PUNCT
iajs-2806	233	23	garcíabermúdez	garcíabermúdez	PROPN
iajs-2806	233	24	,	,	PUNCT
iajs-2806	233	25	m.	m.	NOUN
iajs-2806	233	26	;	;	PUNCT
iajs-2806	233	27	llorca	llorca	PROPN
iajs-2806	233	28	,	,	PUNCT
iajs-2806	233	29	j.	j.	PROPN
iajs-2806	233	30	;	;	PUNCT
iajs-2806	233	31	corrales	corrale	NOUN
iajs-2806	233	32	,	,	PUNCT
iajs-2806	233	33	a.	a.	NOUN
iajs-2806	233	34	;	;	PUNCT
iajs-2806	233	35	gonzález	gonzález	PROPN
iajs-2806	233	36	-	-	PUNCT
iajs-2806	233	37	juanatey	juanatey	PROPN
iajs-2806	233	38	,	,	PUNCT
iajs-2806	233	39	c.	c.	NOUN
iajs-2806	233	40	;	;	PUNCT
iajs-2806	233	41	ubilla	ubilla	PROPN
iajs-2806	233	42	,	,	PUNCT
iajs-2806	233	43	b.	b.	PROPN
iajs-2806	233	44	;	;	PUNCT
iajs-2806	233	45	miranda	miranda	NOUN
iajs-2806	233	46	-	-	PUNCT
iajs-2806	233	47	filloy	filloy	NOUN
iajs-2806	233	48	,	,	PUNCT
iajs-2806	233	49	j.a	j.a	PROPN
iajs-2806	233	50	.	.	PROPN
iajs-2806	233	51	;	;	PUNCT
iajs-2806	233	52	mijares	mijare	NOUN
iajs-2806	233	53	,	,	PUNCT
iajs-2806	233	54	v.	v.	ADP
iajs-2806	233	55	protective	protective	ADJ
iajs-2806	233	56	role	role	NOUN
iajs-2806	233	57	of	of	ADP
iajs-2806	233	58	the	the	DET
iajs-2806	233	59	interleukin	interleukin	NOUN
iajs-2806	233	60	33	33	NUM
iajs-2806	233	61	rs3939286	rs3939286	ADJ
iajs-2806	233	62	gene	gene	NOUN
iajs-2806	233	63	polymorphism	polymorphism	NOUN
iajs-2806	233	64	in	in	ADP
iajs-2806	233	65	the	the	DET
iajs-2806	233	66	development	development	NOUN
iajs-2806	233	67	of	of	ADP
iajs-2806	233	68	subclinical	subclinical	ADJ
iajs-2806	233	69	atherosclerosis	atherosclerosis	NOUN
iajs-2806	233	70	in	in	ADP
iajs-2806	233	71	rheumatoid	rheumatoid	NOUN
iajs-2806	233	72	arthritis	arthritis	NOUN
iajs-2806	233	73	patients	patient	NOUN
iajs-2806	233	74	.	.	PUNCT
iajs-2806	234	1	plos	plos	PROPN
iajs-2806	234	2	one	one	NUM
iajs-2806	234	3	.	.	PUNCT
iajs-2806	235	1	2015,10	2015,10	NOUN
iajs-2806	235	2	,	,	PUNCT
iajs-2806	235	3	11	11	NUM
iajs-2806	235	4	.	.	PUNCT
iajs-2806	236	1	ibn	ibn	PROPN
iajs-2806	236	2	al	al	PROPN
iajs-2806	236	3	-	-	PUNCT
iajs-2806	236	4	haitham	haitham	PROPN
iajs-2806	236	5	jour	jour	X
iajs-2806	236	6	.	.	PROPN
iajs-2806	236	7	for	for	ADP
iajs-2806	236	8	pure	pure	ADJ
iajs-2806	236	9	&	&	CCONJ
iajs-2806	236	10	appl	appl	PROPN
iajs-2806	236	11	.	.	PUNCT
iajs-2806	237	1	sci	sci	PROPN
iajs-2806	237	2	.	.	PROPN
iajs-2806	238	1	34	34	NUM
iajs-2806	238	2	(	(	PUNCT
iajs-2806	238	3	1	1	NUM
iajs-2806	238	4	)	)	PUNCT
iajs-2806	238	5	2021	2021	NUM
iajs-2806	238	6	10	10	NUM
iajs-2806	238	7	8.koca	8.koca	NUM
iajs-2806	238	8	,	,	PUNCT
iajs-2806	238	9	s.s	s.s	PROPN
iajs-2806	238	10	.	.	PROPN
iajs-2806	238	11	;	;	PUNCT
iajs-2806	238	12	pehlivan	pehlivan	PROPN
iajs-2806	238	13	,	,	PUNCT
iajs-2806	238	14	y.	y.	PROPN
iajs-2806	238	15	;	;	PUNCT
iajs-2806	238	16	kara	kara	PROPN
iajs-2806	238	17	,	,	PUNCT
iajs-2806	238	18	m.	m.	NOUN
iajs-2806	238	19	;	;	PUNCT
iajs-2806	238	20	alibaz	alibaz	PROPN
iajs-2806	238	21	-	-	PUNCT
iajs-2806	238	22	oner	oner	PROPN
iajs-2806	238	23	,	,	PUNCT
iajs-2806	238	24	f.	f.	PROPN
iajs-2806	238	25	;	;	PUNCT
iajs-2806	238	26	oztuzcu	oztuzcu	PROPN
iajs-2806	238	27	,	,	PUNCT
iajs-2806	238	28	s.	s.	PROPN
iajs-2806	238	29	;	;	PUNCT
iajs-2806	238	30	yilmaz	yilmaz	PROPN
iajs-2806	238	31	,	,	PUNCT
iajs-2806	238	32	n.	n.	PROPN
iajs-2806	238	33	;	;	PUNCT
iajs-2806	238	34	cetin	cetin	PROPN
iajs-2806	238	35	,	,	PUNCT
iajs-2806	238	36	g.y	g.y	PROPN
iajs-2806	238	37	.	.	PROPN
iajs-2806	238	38	;	;	PUNCT
iajs-2806	238	39	kisacik	kisacik	PROPN
iajs-2806	238	40	,	,	PUNCT
iajs-2806	238	41	b.	b.	PROPN
iajs-2806	238	42	;	;	PUNCT
iajs-2806	238	43	ozgen	ozgen	NOUN
iajs-2806	238	44	,	,	PUNCT
iajs-2806	238	45	m.	m.	NOUN
iajs-2806	238	46	;	;	PUNCT
iajs-2806	238	47	pamuk	pamuk	PROPN
iajs-2806	238	48	,	,	PUNCT
iajs-2806	238	49	o.n	o.n	PROPN
iajs-2806	238	50	.	.	PROPN
iajs-2806	238	51	;	;	PUNCT
iajs-2806	238	52	direskeneli	direskeneli	VERB
iajs-2806	238	53	,	,	PUNCT
iajs-2806	238	54	h.	h.	PROPN
iajs-2806	239	1	the	the	DET
iajs-2806	239	2	il-33	il-33	ADJ
iajs-2806	239	3	gene	gene	NOUN
iajs-2806	239	4	is	be	AUX
iajs-2806	239	5	related	relate	VERB
iajs-2806	239	6	to	to	ADP
iajs-2806	239	7	increased	increase	VERB
iajs-2806	239	8	susceptibility	susceptibility	NOUN
iajs-2806	239	9	to	to	ADP
iajs-2806	239	10	systemic	systemic	ADJ
iajs-2806	239	11	sclerosis	sclerosis	NOUN
iajs-2806	239	12	.	.	PUNCT
iajs-2806	240	1	rheumatol	rheumatol	NOUN
iajs-2806	240	2	.	.	PUNCT
iajs-2806	241	1	int	int	NOUN
iajs-2806	241	2	.	.	PUNCT
iajs-2806	242	1	2016	2016	NUM
iajs-2806	242	2	,	,	PUNCT
iajs-2806	242	3	1	1	NUM
iajs-2806	242	4	,	,	PUNCT
iajs-2806	242	5	36	36	NUM
iajs-2806	242	6	,	,	PUNCT
iajs-2806	242	7	4	4	NUM
iajs-2806	242	8	,	,	PUNCT
iajs-2806	242	9	579	579	NUM
iajs-2806	242	10	-	-	SYM
iajs-2806	242	11	584	584	NUM
iajs-2806	242	12	.	.	NOUN
iajs-2806	243	1	9.baekkevold	9.baekkevold	NUM
iajs-2806	243	2	,	,	PUNCT
iajs-2806	243	3	e.s	e.s	PROPN
iajs-2806	243	4	.	.	PROPN
iajs-2806	243	5	;	;	PUNCT
iajs-2806	243	6	roussigné	roussigné	ADV
iajs-2806	243	7	,	,	PUNCT
iajs-2806	243	8	m.	m.	NOUN
iajs-2806	243	9	;	;	PUNCT
iajs-2806	243	10	yamanaka	yamanaka	PROPN
iajs-2806	243	11	,	,	PUNCT
iajs-2806	243	12	t.	t.	PROPN
iajs-2806	243	13	;	;	PUNCT
iajs-2806	243	14	johansen	johansen	PROPN
iajs-2806	243	15	,	,	PUNCT
iajs-2806	243	16	f.e	f.e	PROPN
iajs-2806	243	17	.	.	PROPN
iajs-2806	243	18	;	;	PUNCT
iajs-2806	243	19	jahnsen	jahnsen	NOUN
iajs-2806	243	20	,	,	PUNCT
iajs-2806	243	21	f.l	f.l	PROPN
iajs-2806	243	22	.	.	PROPN
iajs-2806	243	23	;	;	PUNCT
iajs-2806	243	24	amalric	amalric	PROPN
iajs-2806	243	25	,	,	PUNCT
iajs-2806	243	26	f.	f.	PROPN
iajs-2806	243	27	;	;	PUNCT
iajs-2806	243	28	brandtzaeg	brandtzaeg	NOUN
iajs-2806	243	29	,	,	PUNCT
iajs-2806	243	30	p.	p.	NOUN
iajs-2806	243	31	;	;	PUNCT
iajs-2806	243	32	erard	erard	NOUN
iajs-2806	243	33	,	,	PUNCT
iajs-2806	243	34	m.	m.	NOUN
iajs-2806	243	35	;	;	PUNCT
iajs-2806	243	36	haraldsen	haraldsen	PROPN
iajs-2806	243	37	,	,	PUNCT
iajs-2806	243	38	g.	g.	PROPN
iajs-2806	243	39	;	;	PUNCT
iajs-2806	243	40	girard	girard	PROPN
iajs-2806	243	41	,	,	PUNCT
iajs-2806	243	42	j.p	j.p	PROPN
iajs-2806	243	43	.	.	PROPN
iajs-2806	243	44	molecular	molecular	ADJ
iajs-2806	243	45	characterization	characterization	NOUN
iajs-2806	243	46	of	of	ADP
iajs-2806	243	47	nfhev	nfhev	NOUN
iajs-2806	243	48	,	,	PUNCT
iajs-2806	243	49	a	a	DET
iajs-2806	243	50	nuclear	nuclear	ADJ
iajs-2806	243	51	factor	factor	NOUN
iajs-2806	243	52	preferentially	preferentially	ADV
iajs-2806	243	53	expressed	express	VERB
iajs-2806	243	54	in	in	ADP
iajs-2806	243	55	human	human	ADJ
iajs-2806	243	56	high	high	ADJ
iajs-2806	243	57	endothelial	endothelial	ADJ
iajs-2806	243	58	venules	venule	NOUN
iajs-2806	243	59	.	.	PUNCT
iajs-2806	244	1	amer	amer	PROPN
iajs-2806	244	2	.	.	PUNCT
iajs-2806	244	3	j.	j.	PROPN
iajs-2806	244	4	pathol	pathol	PROPN
iajs-2806	244	5	.	.	PUNCT
iajs-2806	245	1	2003	2003	NUM
iajs-2806	245	2	,	,	PUNCT
iajs-2806	245	3	1	1	NUM
iajs-2806	245	4	,	,	PUNCT
iajs-2806	245	5	163	163	NUM
iajs-2806	245	6	,	,	PUNCT
iajs-2806	245	7	1	1	NUM
iajs-2806	245	8	,	,	PUNCT
iajs-2806	245	9	69	69	NUM
iajs-2806	245	10	-	-	SYM
iajs-2806	245	11	79	79	NUM
iajs-2806	245	12	.	.	PUNCT
iajs-2806	246	1	10.macdonald	10.macdonald	X
iajs-2806	246	2	,	,	PUNCT
iajs-2806	246	3	t.t	t.t	PROPN
iajs-2806	246	4	.	.	PROPN
iajs-2806	246	5	;	;	PUNCT
iajs-2806	246	6	hermoso	hermoso	PROPN
iajs-2806	246	7	ramello	ramello	PROPN
iajs-2806	246	8	,	,	PUNCT
iajs-2806	246	9	m.	m.	NOUN
iajs-2806	246	10	the	the	DET
iajs-2806	246	11	il-33	il-33	PRON
iajs-2806	246	12	/	/	SYM
iajs-2806	246	13	st2	st2	NOUN
iajs-2806	246	14	axis	axis	NOUN
iajs-2806	246	15	:	:	PUNCT
iajs-2806	246	16	role	role	NOUN
iajs-2806	246	17	in	in	ADP
iajs-2806	246	18	health	health	NOUN
iajs-2806	246	19	and	and	CCONJ
iajs-2806	246	20	disease	disease	NOUN
iajs-2806	246	21	.	.	PUNCT
iajs-2806	247	1	cytokine	cytokine	ADJ
iajs-2806	247	2	growth	growth	NOUN
iajs-2806	247	3	factor	factor	NOUN
iajs-2806	247	4	rev	rev	VERB
iajs-2806	247	5	.	.	PROPN
iajs-2806	247	6	2015	2015	NUM
iajs-2806	247	7	,	,	PUNCT
iajs-2806	247	8	26	26	NUM
iajs-2806	247	9	,	,	PUNCT
iajs-2806	247	10	615	615	NUM
iajs-2806	247	11	-	-	SYM
iajs-2806	247	12	623	623	NUM
iajs-2806	247	13	.	.	PUNCT
iajs-2806	248	1	11.cayrol	11.cayrol	NUM
iajs-2806	248	2	,	,	PUNCT
iajs-2806	248	3	c.	c.	NOUN
iajs-2806	248	4	;	;	PUNCT
iajs-2806	248	5	girard	girard	PROPN
iajs-2806	248	6	,	,	PUNCT
iajs-2806	248	7	j.p	j.p	PROPN
iajs-2806	248	8	.	.	PROPN
iajs-2806	248	9	il-33	il-33	PROPN
iajs-2806	248	10	:	:	PUNCT
iajs-2806	248	11	an	an	DET
iajs-2806	248	12	alarmin	alarmin	NOUN
iajs-2806	248	13	cytokine	cytokine	NOUN
iajs-2806	248	14	with	with	ADP
iajs-2806	248	15	crucial	crucial	ADJ
iajs-2806	248	16	roles	role	NOUN
iajs-2806	248	17	in	in	ADP
iajs-2806	248	18	innate	innate	ADJ
iajs-2806	248	19	immunity	immunity	NOUN
iajs-2806	248	20	,	,	PUNCT
iajs-2806	248	21	inflammation	inflammation	NOUN
iajs-2806	248	22	and	and	CCONJ
iajs-2806	248	23	allergy	allergy	NOUN
iajs-2806	248	24	.	.	PUNCT
iajs-2806	249	1	curr	curr	PROPN
iajs-2806	249	2	.	.	PUNCT
iajs-2806	250	1	opin	opin	NOUN
iajs-2806	250	2	.	.	PUNCT
iajs-2806	251	1	immunol	immunol	NOUN
iajs-2806	251	2	.	.	PUNCT
iajs-2806	252	1	2014	2014	NUM
iajs-2806	252	2	,	,	PUNCT
iajs-2806	252	3	1	1	NUM
iajs-2806	252	4	,	,	PUNCT
iajs-2806	252	5	31	31	NUM
iajs-2806	252	6	,	,	PUNCT
iajs-2806	252	7	31	31	NUM
iajs-2806	252	8	-	-	SYM
iajs-2806	252	9	37	37	NUM
iajs-2806	252	10	.	.	PUNCT
iajs-2806	253	1	12.martin	12.martin	NUM
iajs-2806	253	2	,	,	PUNCT
iajs-2806	253	3	n.t	n.t	PROPN
iajs-2806	253	4	.	.	PROPN
iajs-2806	253	5	;	;	PUNCT
iajs-2806	253	6	martin	martin	PROPN
iajs-2806	253	7	,	,	PUNCT
iajs-2806	253	8	m.u	m.u	PROPN
iajs-2806	253	9	.	.	PROPN
iajs-2806	253	10	interleukin	interleukin	NOUN
iajs-2806	253	11	33	33	NUM
iajs-2806	253	12	is	be	AUX
iajs-2806	253	13	a	a	DET
iajs-2806	253	14	guardian	guardian	NOUN
iajs-2806	253	15	of	of	ADP
iajs-2806	253	16	barriers	barrier	NOUN
iajs-2806	253	17	and	and	CCONJ
iajs-2806	253	18	a	a	DET
iajs-2806	253	19	local	local	ADJ
iajs-2806	253	20	alarmin	alarmin	NOUN
iajs-2806	253	21	.	.	PUNCT
iajs-2806	254	1	nat	nat	PROPN
iajs-2806	254	2	.	.	PUNCT
iajs-2806	255	1	immunol	immunol	NOUN
iajs-2806	255	2	.	.	PUNCT
iajs-2806	256	1	2016	2016	NUM
iajs-2806	256	2	,	,	PUNCT
iajs-2806	256	3	17	17	NUM
iajs-2806	256	4	,	,	PUNCT
iajs-2806	256	5	2	2	NUM
iajs-2806	256	6	,	,	PUNCT
iajs-2806	256	7	122	122	NUM
iajs-2806	256	8	.	.	PUNCT
iajs-2806	257	1	13.liew	13.liew	NUM
iajs-2806	257	2	,	,	PUNCT
iajs-2806	257	3	f.y	f.y	PROPN
iajs-2806	257	4	.	.	PROPN
iajs-2806	257	5	il-33	il-33	PROPN
iajs-2806	257	6	:	:	PUNCT
iajs-2806	257	7	a	a	DET
iajs-2806	257	8	janus	janus	PROPN
iajs-2806	257	9	cytokine	cytokine	PROPN
iajs-2806	257	10	.	.	PUNCT
iajs-2806	258	1	ann	ann	PROPN
iajs-2806	258	2	.	.	PUNCT
iajs-2806	259	1	rheumatic	rheumatic	PROPN
iajs-2806	259	2	dis	dis	PROPN
iajs-2806	259	3	.	.	PROPN
iajs-2806	260	1	2012	2012	NUM
iajs-2806	260	2	,	,	PUNCT
iajs-2806	260	3	1	1	NUM
iajs-2806	260	4	,	,	PUNCT
iajs-2806	260	5	71	71	NUM
iajs-2806	260	6	,	,	PUNCT
iajs-2806	260	7	l	l	NOUN
iajs-2806	260	8	2	2	NUM
iajs-2806	260	9	,	,	PUNCT
iajs-2806	260	10	i101	i101	PROPN
iajs-2806	260	11	-	-	PUNCT
iajs-2806	260	12	4	4	NUM
iajs-2806	260	13	.	.	PUNCT
iajs-2806	261	1	14.xiao	14.xiao	NUM
iajs-2806	261	2	,	,	PUNCT
iajs-2806	261	3	p.	p.	NOUN
iajs-2806	261	4	;	;	PUNCT
iajs-2806	261	5	wan	wan	PROPN
iajs-2806	261	6	,	,	PUNCT
iajs-2806	261	7	x.	x.	PROPN
iajs-2806	261	8	;	;	PUNCT
iajs-2806	261	9	cui	cui	PROPN
iajs-2806	261	10	,	,	PUNCT
iajs-2806	261	11	b.	b.	PROPN
iajs-2806	261	12	;	;	PUNCT
iajs-2806	261	13	liu	liu	PROPN
iajs-2806	261	14	,	,	PUNCT
iajs-2806	261	15	y.	y.	PROPN
iajs-2806	261	16	;	;	PUNCT
iajs-2806	261	17	qiu	qiu	PROPN
iajs-2806	261	18	,	,	PUNCT
iajs-2806	261	19	c.	c.	PROPN
iajs-2806	261	20	;	;	PUNCT
iajs-2806	261	21	rong	rong	PROPN
iajs-2806	261	22	,	,	PUNCT
iajs-2806	261	23	j.	j.	PROPN
iajs-2806	261	24	;	;	PUNCT
iajs-2806	261	25	zheng	zheng	PROPN
iajs-2806	261	26	,	,	PUNCT
iajs-2806	261	27	m.	m.	NOUN
iajs-2806	261	28	;	;	PUNCT
iajs-2806	261	29	song	song	NOUN
iajs-2806	261	30	,	,	PUNCT
iajs-2806	261	31	y.	y.	PROPN
iajs-2806	261	32	;	;	PUNCT
iajs-2806	261	33	chen	chen	PROPN
iajs-2806	261	34	,	,	PUNCT
iajs-2806	261	35	l.	l.	PROPN
iajs-2806	261	36	;	;	PUNCT
iajs-2806	261	37	he	he	PRON
iajs-2806	261	38	,	,	PUNCT
iajs-2806	261	39	j.	j.	PROPN
iajs-2806	261	40	;	;	PUNCT
iajs-2806	261	41	tan	tan	PROPN
iajs-2806	261	42	,	,	PUNCT
iajs-2806	261	43	q.	q.	PROPN
iajs-2806	261	44	interleukin	interleukin	NOUN
iajs-2806	261	45	33	33	NUM
iajs-2806	261	46	in	in	ADP
iajs-2806	261	47	tumor	tumor	NOUN
iajs-2806	261	48	microenvironment	microenvironment	NOUN
iajs-2806	261	49	is	be	AUX
iajs-2806	261	50	crucial	crucial	ADJ
iajs-2806	261	51	for	for	ADP
iajs-2806	261	52	the	the	DET
iajs-2806	261	53	accumulation	accumulation	NOUN
iajs-2806	261	54	and	and	CCONJ
iajs-2806	261	55	function	function	NOUN
iajs-2806	261	56	of	of	ADP
iajs-2806	261	57	myeloid	myeloid	NOUN
iajs-2806	261	58	-	-	PUNCT
iajs-2806	261	59	derived	derive	VERB
iajs-2806	261	60	suppressor	suppressor	NOUN
iajs-2806	261	61	cells	cell	NOUN
iajs-2806	261	62	.	.	PUNCT
iajs-2806	262	1	oncoimmunology	oncoimmunology	NOUN
iajs-2806	262	2	.	.	PUNCT
iajs-2806	263	1	2016	2016	NUM
iajs-2806	263	2	,	,	PUNCT
iajs-2806	263	3	2	2	NUM
iajs-2806	263	4	,	,	PUNCT
iajs-2806	263	5	5	5	NUM
iajs-2806	263	6	,	,	PUNCT
iajs-2806	263	7	1	1	NUM
iajs-2806	263	8	,	,	PUNCT
iajs-2806	263	9	e1063772	e1063772	NOUN
iajs-2806	263	10	.	.	PUNCT
iajs-2806	264	1	15.hayakawa	15.hayakawa	NUM
iajs-2806	264	2	,	,	PUNCT
iajs-2806	264	3	h.	h.	PROPN
iajs-2806	264	4	;	;	PUNCT
iajs-2806	264	5	hayakawa	hayakawa	PROPN
iajs-2806	264	6	,	,	PUNCT
iajs-2806	264	7	m.	m.	NOUN
iajs-2806	264	8	;	;	PUNCT
iajs-2806	264	9	kume	kume	PROPN
iajs-2806	264	10	,	,	PUNCT
iajs-2806	264	11	a.	a.	PROPN
iajs-2806	264	12	soluble	soluble	ADJ
iajs-2806	264	13	st2	st2	NOUN
iajs-2806	264	14	blocks	block	NOUN
iajs-2806	264	15	interleukin-33	interleukin-33	PROPN
iajs-2806	264	16	signaling	signal	VERB
iajs-2806	264	17	in	in	ADP
iajs-2806	264	18	allergic	allergic	ADJ
iajs-2806	264	19	airway	airway	NOUN
iajs-2806	264	20	inflammation	inflammation	NOUN
iajs-2806	264	21	.	.	PUNCT
iajs-2806	265	1	j.	j.	PROPN
iajs-2806	265	2	biological	biological	PROPN
iajs-2806	265	3	chem	chem	PROPN
iajs-2806	265	4	.	.	PUNCT
iajs-2806	266	1	2007	2007	NUM
iajs-2806	266	2	,	,	PUNCT
iajs-2806	266	3	282	282	NUM
iajs-2806	266	4	,	,	PUNCT
iajs-2806	266	5	36	36	NUM
iajs-2806	266	6	,	,	PUNCT
iajs-2806	266	7	26369	26369	NUM
iajs-2806	266	8	-	-	SYM
iajs-2806	266	9	26380	26380	NUM
iajs-2806	266	10	.	.	PUNCT
iajs-2806	267	1	16.cui	16.cui	PROPN
iajs-2806	267	2	,	,	PUNCT
iajs-2806	267	3	g.	g.	PROPN
iajs-2806	267	4	;	;	PUNCT
iajs-2806	267	5	qi	qi	PROPN
iajs-2806	267	6	,	,	PUNCT
iajs-2806	267	7	h.	h.	PROPN
iajs-2806	267	8	;	;	PUNCT
iajs-2806	267	9	gundersen	gundersen	PROPN
iajs-2806	267	10	,	,	PUNCT
iajs-2806	267	11	m.d	m.d	PROPN
iajs-2806	267	12	.	.	PROPN
iajs-2806	267	13	;	;	PUNCT
iajs-2806	267	14	yang	yang	PROPN
iajs-2806	267	15	,	,	PUNCT
iajs-2806	267	16	h.	h.	PROPN
iajs-2806	267	17	;	;	PUNCT
iajs-2806	267	18	christiansen	christiansen	PROPN
iajs-2806	267	19	,	,	PUNCT
iajs-2806	267	20	i.	i.	PROPN
iajs-2806	267	21	;	;	PUNCT
iajs-2806	267	22	sørbye	sørbye	PROPN
iajs-2806	267	23	,	,	PUNCT
iajs-2806	267	24	s.w	s.w	PROPN
iajs-2806	267	25	.	.	PROPN
iajs-2806	267	26	;	;	PUNCT
iajs-2806	267	27	goll	goll	PROPN
iajs-2806	267	28	,	,	PUNCT
iajs-2806	267	29	r.	r.	PROPN
iajs-2806	267	30	;	;	PUNCT
iajs-2806	267	31	florholmen	florholman	NOUN
iajs-2806	267	32	,	,	PUNCT
iajs-2806	267	33	j.	j.	PROPN
iajs-2806	267	34	dynamics	dynamic	NOUN
iajs-2806	267	35	of	of	ADP
iajs-2806	267	36	the	the	DET
iajs-2806	267	37	il-33	il-33	PRON
iajs-2806	267	38	/	/	SYM
iajs-2806	267	39	st2	st2	NOUN
iajs-2806	267	40	network	network	NOUN
iajs-2806	267	41	in	in	ADP
iajs-2806	267	42	the	the	DET
iajs-2806	267	43	progression	progression	NOUN
iajs-2806	267	44	of	of	ADP
iajs-2806	267	45	human	human	ADJ
iajs-2806	267	46	colorectal	colorectal	ADJ
iajs-2806	267	47	adenoma	adenoma	NOUN
iajs-2806	267	48	to	to	ADP
iajs-2806	267	49	sporadic	sporadic	ADJ
iajs-2806	267	50	colorectal	colorectal	ADJ
iajs-2806	267	51	cancer	cancer	NOUN
iajs-2806	267	52	.	.	PUNCT
iajs-2806	268	1	cancer	cancer	NOUN
iajs-2806	268	2	immunol	immunol	NOUN
iajs-2806	268	3	.	.	PUNCT
iajs-2806	269	1	immunother	immunother	PROPN
iajs-2806	269	2	.	.	PUNCT
iajs-2806	270	1	2015	2015	NUM
iajs-2806	270	2	,	,	PUNCT
iajs-2806	270	3	1	1	NUM
iajs-2806	270	4	,	,	PUNCT
iajs-2806	270	5	64	64	NUM
iajs-2806	270	6	,	,	PUNCT
iajs-2806	270	7	2	2	NUM
iajs-2806	270	8	,	,	PUNCT
iajs-2806	270	9	181190	181190	NUM
iajs-2806	270	10	.	.	PUNCT
iajs-2806	271	1	17.chapuis	17.chapuis	NUM
iajs-2806	271	2	,	,	PUNCT
iajs-2806	271	3	j.	j.	PROPN
iajs-2806	271	4	;	;	PUNCT
iajs-2806	271	5	hot	hot	ADJ
iajs-2806	271	6	,	,	PUNCT
iajs-2806	271	7	d.	d.	PROPN
iajs-2806	271	8	;	;	PUNCT
iajs-2806	271	9	hansmannel	hansmannel	PROPN
iajs-2806	271	10	,	,	PUNCT
iajs-2806	271	11	f.	f.	PROPN
iajs-2806	271	12	;	;	PUNCT
iajs-2806	271	13	kerdraon	kerdraon	PROPN
iajs-2806	271	14	,	,	PUNCT
iajs-2806	271	15	o.	o.	PROPN
iajs-2806	271	16	;	;	PUNCT
iajs-2806	271	17	ferreira	ferreira	PROPN
iajs-2806	271	18	,	,	PUNCT
iajs-2806	271	19	s.	s.	PROPN
iajs-2806	271	20	;	;	PUNCT
iajs-2806	271	21	hubans	huban	NOUN
iajs-2806	271	22	,	,	PUNCT
iajs-2806	271	23	c.	c.	NOUN
iajs-2806	271	24	;	;	PUNCT
iajs-2806	271	25	maurage	maurage	NOUN
iajs-2806	271	26	,	,	PUNCT
iajs-2806	271	27	c.a	c.a	PROPN
iajs-2806	271	28	.	.	PROPN
iajs-2806	271	29	;	;	PUNCT
iajs-2806	271	30	huot	huot	PROPN
iajs-2806	271	31	,	,	PUNCT
iajs-2806	271	32	l.	l.	PROPN
iajs-2806	271	33	;	;	PUNCT
iajs-2806	271	34	bensemain	bensemain	PROPN
iajs-2806	271	35	,	,	PUNCT
iajs-2806	271	36	f.	f.	PROPN
iajs-2806	271	37	;	;	PUNCT
iajs-2806	271	38	laumet	laumet	PROPN
iajs-2806	271	39	,	,	PUNCT
iajs-2806	271	40	g.	g.	PROPN
iajs-2806	271	41	;	;	PUNCT
iajs-2806	271	42	ayral	ayral	ADJ
iajs-2806	271	43	,	,	PUNCT
iajs-2806	271	44	a.m.	a.m.	NOUN
iajs-2806	271	45	transcriptomic	transcriptomic	ADJ
iajs-2806	271	46	and	and	CCONJ
iajs-2806	271	47	genetic	genetic	ADJ
iajs-2806	271	48	studies	study	NOUN
iajs-2806	271	49	identify	identify	VERB
iajs-2806	271	50	il-33	il-33	ADP
iajs-2806	271	51	as	as	ADP
iajs-2806	271	52	a	a	DET
iajs-2806	271	53	candidate	candidate	NOUN
iajs-2806	271	54	gene	gene	NOUN
iajs-2806	271	55	for	for	ADP
iajs-2806	271	56	alzheimer	alzheimer	PROPN
iajs-2806	271	57	's	's	PART
iajs-2806	271	58	disease	disease	NOUN
iajs-2806	271	59	.	.	PUNCT
iajs-2806	272	1	molecul	molecul	PROPN
iajs-2806	272	2	.	.	PUNCT
iajs-2806	273	1	psychiatry	psychiatry	NOUN
iajs-2806	273	2	.	.	PUNCT
iajs-2806	274	1	2009	2009	NUM
iajs-2806	274	2	,	,	PUNCT
iajs-2806	274	3	14	14	NUM
iajs-2806	274	4	,	,	PUNCT
iajs-2806	274	5	11	11	NUM
iajs-2806	274	6	,	,	PUNCT
iajs-2806	274	7	1004	1004	NUM
iajs-2806	274	8	-	-	SYM
iajs-2806	274	9	1016	1016	NUM
iajs-2806	274	10	.	.	PUNCT
iajs-2806	275	1	17.beltrán	17.beltrán	NUM
iajs-2806	275	2	,	,	PUNCT
iajs-2806	275	3	c.j	c.j	PROPN
iajs-2806	275	4	.	.	PROPN
iajs-2806	275	5	;	;	PUNCT
iajs-2806	275	6	núñez	núñez	PROPN
iajs-2806	275	7	,	,	PUNCT
iajs-2806	275	8	l.e	l.e	PROPN
iajs-2806	275	9	.	.	PROPN
iajs-2806	275	10	;	;	PUNCT
iajs-2806	275	11	díaz	díaz	NOUN
iajs-2806	275	12	-	-	PUNCT
iajs-2806	275	13	jiménez	jiménez	PROPN
iajs-2806	275	14	,	,	PUNCT
iajs-2806	275	15	d.	d.	PROPN
iajs-2806	275	16	;	;	PUNCT
iajs-2806	275	17	farfan	farfan	PROPN
iajs-2806	275	18	,	,	PUNCT
iajs-2806	275	19	n.	n.	NOUN
iajs-2806	275	20	;	;	PUNCT
iajs-2806	275	21	candia	candia	PROPN
iajs-2806	275	22	,	,	PUNCT
iajs-2806	275	23	e.	e.	PROPN
iajs-2806	275	24	;	;	PUNCT
iajs-2806	275	25	heine	heine	PROPN
iajs-2806	275	26	,	,	PUNCT
iajs-2806	275	27	c.	c.	PROPN
iajs-2806	275	28	;	;	PUNCT
iajs-2806	275	29	lópez	lópez	PROPN
iajs-2806	275	30	,	,	PUNCT
iajs-2806	275	31	f.	f.	PROPN
iajs-2806	275	32	;	;	PUNCT
iajs-2806	275	33	gonzález	gonzález	PROPN
iajs-2806	275	34	,	,	PUNCT
iajs-2806	275	35	m.j	m.j	PROPN
iajs-2806	275	36	.	.	PROPN
iajs-2806	275	37	;	;	PUNCT
iajs-2806	275	38	quera	quera	PROPN
iajs-2806	275	39	,	,	PUNCT
iajs-2806	275	40	r.	r.	PROPN
iajs-2806	275	41	;	;	PUNCT
iajs-2806	275	42	hermoso	hermoso	PROPN
iajs-2806	275	43	,	,	PUNCT
iajs-2806	275	44	m.a	m.a	PROPN
iajs-2806	275	45	.	.	PROPN
iajs-2806	275	46	characterization	characterization	NOUN
iajs-2806	275	47	of	of	ADP
iajs-2806	275	48	the	the	DET
iajs-2806	275	49	novel	novel	ADJ
iajs-2806	275	50	st2	st2	NOUN
iajs-2806	275	51	/	/	SYM
iajs-2806	275	52	il-33	il-33	ADJ
iajs-2806	275	53	system	system	NOUN
iajs-2806	275	54	in	in	ADP
iajs-2806	275	55	patients	patient	NOUN
iajs-2806	275	56	with	with	ADP
iajs-2806	275	57	inflammatory	inflammatory	ADJ
iajs-2806	275	58	bowel	bowel	NOUN
iajs-2806	275	59	disease	disease	NOUN
iajs-2806	275	60	.	.	PUNCT
iajs-2806	276	1	inflamm	inflamm	PROPN
iajs-2806	276	2	.	.	PUNCT
iajs-2806	277	1	bowel	bowel	PROPN
iajs-2806	277	2	dis	dis	PROPN
iajs-2806	277	3	.	.	PUNCT
iajs-2806	278	1	2010	2010	NUM
iajs-2806	278	2	,	,	PUNCT
iajs-2806	278	3	1	1	NUM
iajs-2806	278	4	,	,	PUNCT
iajs-2806	278	5	16	16	NUM
iajs-2806	278	6	,	,	PUNCT
iajs-2806	278	7	7	7	NUM
iajs-2806	278	8	,	,	PUNCT
iajs-2806	278	9	10971107	10971107	NUM
iajs-2806	278	10	.	.	PUNCT
iajs-2806	279	1	19.millar	19.millar	NUM
iajs-2806	279	2	,	,	PUNCT
iajs-2806	279	3	n.l	n.l	PROPN
iajs-2806	279	4	.	.	PROPN
iajs-2806	279	5	;	;	PUNCT
iajs-2806	279	6	o’donnell	o’donnell	PROPN
iajs-2806	279	7	,	,	PUNCT
iajs-2806	279	8	c.	c.	PROPN
iajs-2806	279	9	;	;	PUNCT
iajs-2806	279	10	mcinnes	mcinnes	PROPN
iajs-2806	279	11	,	,	PUNCT
iajs-2806	279	12	i.b	i.b	PROPN
iajs-2806	279	13	.	.	PROPN
iajs-2806	279	14	;	;	PUNCT
iajs-2806	279	15	brint	brint	PROPN
iajs-2806	279	16	,	,	PUNCT
iajs-2806	279	17	e.	e.	PROPN
iajs-2806	279	18	wounds	wound	VERB
iajs-2806	279	19	that	that	PRON
iajs-2806	279	20	heal	heal	VERB
iajs-2806	279	21	and	and	CCONJ
iajs-2806	279	22	wounds	wound	NOUN
iajs-2806	279	23	that	that	PRON
iajs-2806	279	24	don’t−	don’t−	VERB
iajs-2806	279	25	the	the	DET
iajs-2806	279	26	role	role	NOUN
iajs-2806	279	27	of	of	ADP
iajs-2806	279	28	the	the	DET
iajs-2806	279	29	il-33	il-33	PRON
iajs-2806	279	30	/	/	SYM
iajs-2806	279	31	st2	st2	NOUN
iajs-2806	279	32	pathway	pathway	NOUN
iajs-2806	279	33	in	in	ADP
iajs-2806	279	34	tissue	tissue	NOUN
iajs-2806	279	35	repair	repair	NOUN
iajs-2806	279	36	and	and	CCONJ
iajs-2806	279	37	tumorigenesis	tumorigenesis	NOUN
iajs-2806	279	38	.	.	PUNCT
iajs-2806	280	1	seminars	seminar	NOUN
iajs-2806	280	2	cell	cell	NOUN
iajs-2806	280	3	develop	develop	VERB
iajs-2806	280	4	.	.	PUNCT
iajs-2806	281	1	biol	biol	PROPN
iajs-2806	281	2	.	.	PUNCT
iajs-2806	282	1	2017	2017	NUM
iajs-2806	282	2	,	,	PUNCT
iajs-2806	282	3	61	61	NUM
iajs-2806	282	4	,	,	PUNCT
iajs-2806	282	5	41	41	NUM
iajs-2806	282	6	-	-	SYM
iajs-2806	282	7	50	50	NUM
iajs-2806	282	8	.	.	PUNCT
iajs-2806	283	1	20.gillibert	20.gillibert	NOUN
iajs-2806	283	2	-	-	PUNCT
iajs-2806	283	3	duplantier	duplantier	NOUN
iajs-2806	283	4	,	,	PUNCT
iajs-2806	283	5	j.	j.	PROPN
iajs-2806	283	6	;	;	PUNCT
iajs-2806	283	7	duthey	duthey	PROPN
iajs-2806	283	8	,	,	PUNCT
iajs-2806	283	9	b.	b.	PROPN
iajs-2806	283	10	;	;	PUNCT
iajs-2806	283	11	sisirak	sisirak	PROPN
iajs-2806	283	12	,	,	PUNCT
iajs-2806	283	13	v.	v.	ADV
iajs-2806	283	14	;	;	PUNCT
iajs-2806	283	15	salaün	salaün	X
iajs-2806	283	16	,	,	PUNCT
iajs-2806	283	17	d.	d.	PROPN
iajs-2806	283	18	;	;	PUNCT
iajs-2806	283	19	gargi	gargi	NOUN
iajs-2806	283	20	,	,	PUNCT
iajs-2806	283	21	t.	t.	PROPN
iajs-2806	283	22	;	;	PUNCT
iajs-2806	283	23	tredan	tredan	PROPN
iajs-2806	283	24	,	,	PUNCT
iajs-2806	283	25	o.	o.	PROPN
iajs-2806	283	26	;	;	PUNCT
iajs-2806	283	27	finetti	finetti	PROPN
iajs-2806	283	28	,	,	PUNCT
iajs-2806	283	29	p.	p.	NOUN
iajs-2806	283	30	;	;	PUNCT
iajs-2806	283	31	bertucci	bertucci	PROPN
iajs-2806	283	32	,	,	PUNCT
iajs-2806	283	33	f.	f.	PROPN
iajs-2806	283	34	;	;	PUNCT
iajs-2806	283	35	birnbaum	birnbaum	PROPN
iajs-2806	283	36	,	,	PUNCT
iajs-2806	283	37	d.	d.	PROPN
iajs-2806	283	38	;	;	PUNCT
iajs-2806	283	39	bendriss	bendriss	ADJ
iajs-2806	283	40	-	-	PUNCT
iajs-2806	283	41	vermare	vermare	PROPN
iajs-2806	283	42	,	,	PUNCT
iajs-2806	283	43	n.	n.	NOUN
iajs-2806	283	44	;	;	PUNCT
iajs-2806	283	45	badache	badache	NOUN
iajs-2806	283	46	,	,	PUNCT
iajs-2806	283	47	a.	a.	NOUN
iajs-2806	283	48	gene	gene	NOUN
iajs-2806	283	49	expression	expression	NOUN
iajs-2806	283	50	profiling	profiling	NOUN
iajs-2806	283	51	identifies	identify	VERB
iajs-2806	283	52	sst2	sst2	NOUN
iajs-2806	283	53	as	as	ADP
iajs-2806	283	54	an	an	DET
iajs-2806	283	55	effector	effector	NOUN
iajs-2806	283	56	of	of	ADP
iajs-2806	283	57	erbb2	erbb2	PROPN
iajs-2806	283	58	-	-	PUNCT
iajs-2806	283	59	driven	drive	VERB
iajs-2806	283	60	breast	breast	NOUN
iajs-2806	283	61	carcinoma	carcinoma	NOUN
iajs-2806	283	62	cell	cell	NOUN
iajs-2806	283	63	motility	motility	NOUN
iajs-2806	283	64	,	,	PUNCT
iajs-2806	283	65	associated	associate	VERB
iajs-2806	283	66	with	with	ADP
iajs-2806	283	67	metastasis	metastasis	NOUN
iajs-2806	283	68	.	.	PUNCT
iajs-2806	284	1	oncogene	oncogene	NOUN
iajs-2806	284	2	.	.	PUNCT
iajs-2806	285	1	2012	2012	NUM
iajs-2806	285	2	,	,	PUNCT
iajs-2806	285	3	31	31	NUM
iajs-2806	285	4	,	,	PUNCT
iajs-2806	285	5	30	30	NUM
iajs-2806	285	6	,	,	PUNCT
iajs-2806	285	7	3516	3516	NUM
iajs-2806	285	8	-	-	SYM
iajs-2806	285	9	3524	3524	NUM
iajs-2806	285	10	.	.	PUNCT
iajs-2806	286	1	21.mertz	21.mertz	NUM
iajs-2806	286	2	,	,	PUNCT
iajs-2806	286	3	k.d	k.d	PROPN
iajs-2806	286	4	.	.	PROPN
iajs-2806	286	5	;	;	PUNCT
iajs-2806	286	6	mager	mager	PROPN
iajs-2806	286	7	,	,	PUNCT
iajs-2806	286	8	l.f	l.f	PROPN
iajs-2806	286	9	.	.	PROPN
iajs-2806	286	10	;	;	PUNCT
iajs-2806	286	11	wasmer	wasmer	PROPN
iajs-2806	286	12	,	,	PUNCT
iajs-2806	286	13	m.h	m.h	PROPN
iajs-2806	286	14	.	.	PROPN
iajs-2806	286	15	;	;	PUNCT
iajs-2806	286	16	thiesler	thiesler	NOUN
iajs-2806	286	17	,	,	PUNCT
iajs-2806	286	18	t.	t.	PROPN
iajs-2806	286	19	;	;	PUNCT
iajs-2806	286	20	koelzer	koelzer	PROPN
iajs-2806	286	21	,	,	PUNCT
iajs-2806	286	22	v.h	v.h	PROPN
iajs-2806	286	23	.	.	PROPN
iajs-2806	286	24	;	;	PUNCT
iajs-2806	286	25	ruzzante	ruzzante	PROPN
iajs-2806	286	26	,	,	PUNCT
iajs-2806	286	27	g.	g.	PROPN
iajs-2806	286	28	;	;	PUNCT
iajs-2806	286	29	joller	joller	PROPN
iajs-2806	286	30	,	,	PUNCT
iajs-2806	286	31	s.	s.	PROPN
iajs-2806	286	32	;	;	PUNCT
iajs-2806	286	33	murdoch	murdoch	PROPN
iajs-2806	286	34	,	,	PUNCT
iajs-2806	286	35	j.r	j.r	PROPN
iajs-2806	286	36	.	.	PROPN
iajs-2806	286	37	;	;	PUNCT
iajs-2806	286	38	brümmendorf	brümmendorf	PROPN
iajs-2806	286	39	,	,	PUNCT
iajs-2806	286	40	t.	t.	PROPN
iajs-2806	286	41	;	;	PUNCT
iajs-2806	286	42	genitsch	genitsch	PROPN
iajs-2806	286	43	,	,	PUNCT
iajs-2806	286	44	v.	v.	PROPN
iajs-2806	286	45	;	;	PUNCT
iajs-2806	286	46	lugli	lugli	NOUN
iajs-2806	286	47	,	,	PUNCT
iajs-2806	286	48	a.	a.	NOUN
iajs-2806	286	49	the	the	DET
iajs-2806	286	50	il-33	il-33	PRON
iajs-2806	286	51	/	/	SYM
iajs-2806	286	52	st2	st2	NOUN
iajs-2806	286	53	pathway	pathway	NOUN
iajs-2806	286	54	contributes	contribute	VERB
iajs-2806	286	55	to	to	ADP
iajs-2806	286	56	intestinal	intestinal	ADJ
iajs-2806	286	57	tumorigenesis	tumorigenesis	NOUN
iajs-2806	286	58	in	in	ADP
iajs-2806	286	59	humans	human	NOUN
iajs-2806	286	60	and	and	CCONJ
iajs-2806	286	61	mice	mouse	NOUN
iajs-2806	286	62	.	.	PUNCT
iajs-2806	287	1	oncoimmunology	oncoimmunology	NOUN
iajs-2806	287	2	.	.	PUNCT
iajs-2806	288	1	2016	2016	NUM
iajs-2806	288	2	,	,	PUNCT
iajs-2806	288	3	2	2	NUM
iajs-2806	288	4	,	,	PUNCT
iajs-2806	288	5	5	5	NUM
iajs-2806	288	6	,	,	PUNCT
iajs-2806	288	7	1	1	NUM
iajs-2806	288	8	,	,	PUNCT
iajs-2806	288	9	e1062966	e1062966	PROPN
iajs-2806	288	10	.	.	PUNCT
iajs-2806	289	1	22.milosavljevic	22.milosavljevic	NUM
iajs-2806	289	2	,	,	PUNCT
iajs-2806	289	3	m.z	m.z	PROPN
iajs-2806	289	4	.	.	PROPN
iajs-2806	289	5	;	;	PUNCT
iajs-2806	289	6	jovanovic	jovanovic	PROPN
iajs-2806	289	7	,	,	PUNCT
iajs-2806	289	8	i.p	i.p	PROPN
iajs-2806	289	9	.	.	PROPN
iajs-2806	289	10	;	;	PUNCT
iajs-2806	289	11	pejnovic	pejnovic	PROPN
iajs-2806	289	12	,	,	PUNCT
iajs-2806	289	13	n.n	n.n	PROPN
iajs-2806	289	14	.	.	PROPN
iajs-2806	289	15	;	;	PUNCT
iajs-2806	289	16	mitrovic	mitrovic	PROPN
iajs-2806	289	17	,	,	PUNCT
iajs-2806	289	18	s.l	s.l	PROPN
iajs-2806	289	19	.	.	PROPN
iajs-2806	289	20	;	;	PUNCT
iajs-2806	289	21	arsenijevic	arsenijevic	PROPN
iajs-2806	289	22	,	,	PUNCT
iajs-2806	289	23	n.n	n.n	PROPN
iajs-2806	289	24	.	.	PROPN
iajs-2806	289	25	;	;	PUNCT
iajs-2806	289	26	markovic	markovic	PROPN
iajs-2806	289	27	,	,	PUNCT
iajs-2806	289	28	b.j	b.j	PROPN
iajs-2806	289	29	.	.	PROPN
iajs-2806	289	30	;	;	PUNCT
iajs-2806	289	31	lukic	lukic	PROPN
iajs-2806	289	32	,	,	PUNCT
iajs-2806	289	33	m.l	m.l	PROPN
iajs-2806	289	34	.	.	NOUN
iajs-2806	289	35	deletion	deletion	NOUN
iajs-2806	289	36	of	of	ADP
iajs-2806	289	37	il-33r	il-33r	ADJ
iajs-2806	289	38	attenuates	attenuate	NOUN
iajs-2806	289	39	vegf	vegf	NOUN
iajs-2806	289	40	expression	expression	NOUN
iajs-2806	289	41	and	and	CCONJ
iajs-2806	289	42	enhances	enhance	VERB
iajs-2806	289	43	necrosis	necrosis	NOUN
iajs-2806	289	44	in	in	ADP
iajs-2806	289	45	mammary	mammary	ADJ
iajs-2806	289	46	carcinoma	carcinoma	NOUN
iajs-2806	289	47	.	.	PUNCT
iajs-2806	290	1	oncotarget	oncotarget	NOUN
iajs-2806	290	2	.	.	PUNCT
iajs-2806	291	1	2016	2016	NUM
iajs-2806	291	2	,	,	PUNCT
iajs-2806	291	3	5	5	NUM
iajs-2806	291	4	,	,	PUNCT
iajs-2806	291	5	7	7	NUM
iajs-2806	291	6	,	,	PUNCT
iajs-2806	291	7	14	14	NUM
iajs-2806	291	8	,	,	PUNCT
iajs-2806	291	9	18106	18106	NUM
iajs-2806	291	10	.	.	PUNCT
iajs-2806	292	1	23.jafarzadeh	23.jafarzadeh	NUM
iajs-2806	292	2	,	,	PUNCT
iajs-2806	292	3	a.	a.	NOUN
iajs-2806	292	4	;	;	PUNCT
iajs-2806	292	5	minaee	minaee	X
iajs-2806	292	6	,	,	PUNCT
iajs-2806	292	7	k.	k.	PROPN
iajs-2806	292	8	;	;	PUNCT
iajs-2806	292	9	farsinejad	farsinejad	PROPN
iajs-2806	292	10	,	,	PUNCT
iajs-2806	292	11	a.r	a.r	PROPN
iajs-2806	292	12	.	.	PROPN
iajs-2806	292	13	;	;	PUNCT
iajs-2806	292	14	nemati	nemati	PROPN
iajs-2806	292	15	,	,	PUNCT
iajs-2806	292	16	m.	m.	NOUN
iajs-2806	292	17	;	;	PUNCT
iajs-2806	292	18	khosravimashizi	khosravimashizi	PROPN
iajs-2806	292	19	,	,	PUNCT
iajs-2806	292	20	a.	a.	NOUN
iajs-2806	292	21	;	;	PUNCT
iajs-2806	292	22	daneshvar	daneshvar	NOUN
iajs-2806	292	23	,	,	PUNCT
iajs-2806	292	24	h.	h.	PROPN
iajs-2806	292	25	;	;	PUNCT
iajs-2806	292	26	mohammadi	mohammadi	PROPN
iajs-2806	292	27	,	,	PUNCT
iajs-2806	292	28	m.m	m.m	PROPN
iajs-2806	292	29	.	.	PROPN
iajs-2806	292	30	;	;	PUNCT
iajs-2806	292	31	sheikhi	sheikhi	PROPN
iajs-2806	292	32	,	,	PUNCT
iajs-2806	292	33	a.	a.	NOUN
iajs-2806	292	34	;	;	PUNCT
iajs-2806	292	35	ghaderi	ghaderi	NOUN
iajs-2806	292	36	,	,	PUNCT
iajs-2806	292	37	a.	a.	NOUN
iajs-2806	292	38	evaluation	evaluation	NOUN
iajs-2806	292	39	of	of	ADP
iajs-2806	292	40	the	the	DET
iajs-2806	292	41	circulating	circulate	VERB
iajs-2806	292	42	ibn	ibn	PROPN
iajs-2806	292	43	al	al	PROPN
iajs-2806	292	44	-	-	PUNCT
iajs-2806	292	45	haitham	haitham	PROPN
iajs-2806	292	46	jour	jour	X
iajs-2806	292	47	.	.	PROPN
iajs-2806	293	1	for	for	ADP
iajs-2806	293	2	pure	pure	ADJ
iajs-2806	293	3	&	&	CCONJ
iajs-2806	293	4	appl	appl	PROPN
iajs-2806	293	5	.	.	PUNCT
iajs-2806	294	1	sci	sci	PROPN
iajs-2806	294	2	.	.	PROPN
iajs-2806	295	1	34	34	NUM
iajs-2806	295	2	(	(	PUNCT
iajs-2806	295	3	1	1	NUM
iajs-2806	295	4	)	)	PUNCT
iajs-2806	295	5	2021	2021	NUM
iajs-2806	295	6	11	11	NUM
iajs-2806	295	7	levels	level	NOUN
iajs-2806	295	8	of	of	ADP
iajs-2806	295	9	il-12	il-12	NOUN
iajs-2806	295	10	and	and	CCONJ
iajs-2806	295	11	il-33	il-33	ADJ
iajs-2806	295	12	in	in	ADP
iajs-2806	295	13	patients	patient	NOUN
iajs-2806	295	14	with	with	ADP
iajs-2806	295	15	breast	breast	NOUN
iajs-2806	295	16	cancer	cancer	NOUN
iajs-2806	295	17	:	:	PUNCT
iajs-2806	295	18	influences	influence	NOUN
iajs-2806	295	19	of	of	ADP
iajs-2806	295	20	the	the	DET
iajs-2806	295	21	tumor	tumor	NOUN
iajs-2806	295	22	stages	stage	NOUN
iajs-2806	295	23	and	and	CCONJ
iajs-2806	295	24	cytokine	cytokine	VERB
iajs-2806	295	25	gene	gene	NOUN
iajs-2806	295	26	polymorphisms	polymorphism	NOUN
iajs-2806	295	27	.	.	PUNCT
iajs-2806	296	1	iranian	iranian	PROPN
iajs-2806	296	2	j.	j.	PROPN
iajs-2806	296	3	basic	basic	PROPN
iajs-2806	296	4	med	med	PROPN
iajs-2806	296	5	.	.	PUNCT
iajs-2806	297	1	sci	sci	PROPN
iajs-2806	297	2	.	.	PROPN
iajs-2806	297	3	2015	2015	NUM
iajs-2806	297	4	,	,	PUNCT
iajs-2806	297	5	18	18	NUM
iajs-2806	297	6	,	,	PUNCT
iajs-2806	297	7	12	12	NUM
iajs-2806	297	8	,	,	PUNCT
iajs-2806	297	9	1189	1189	NUM
iajs-2806	297	10	.	.	PUNCT
iajs-2806	298	1	24.cary	24.cary	NUM
iajs-2806	298	2	,	,	PUNCT
iajs-2806	298	3	n.	n.	ADJ
iajs-2806	298	4	statistical	statistical	ADJ
iajs-2806	298	5	analysis	analysis	NOUN
iajs-2806	298	6	system	system	NOUN
iajs-2806	298	7	,	,	PUNCT
iajs-2806	298	8	user	user	NOUN
iajs-2806	298	9	's	's	PART
iajs-2806	298	10	guide	guide	NOUN
iajs-2806	298	11	.	.	PUNCT
iajs-2806	299	1	statistical	statistical	ADJ
iajs-2806	299	2	.	.	PUNCT
iajs-2806	300	1	version	version	NOUN
iajs-2806	300	2	9.sas	9.sas	PROPN
iajs-2806	300	3	.	.	PUNCT
iajs-2806	300	4	inst	inst	PROPN
iajs-2806	300	5	.	.	PROPN
iajs-2806	300	6	inc	inc	PROPN
iajs-2806	300	7	.	.	PROPN
iajs-2806	300	8	usa	usa	PROPN
iajs-2806	301	1	.	.	PROPN
iajs-2806	301	2	2012	2012	NUM
iajs-2806	301	3	.	.	PUNCT
iajs-2806	302	1	25.rodriguez	25.rodriguez	NUM
iajs-2806	302	2	,	,	PUNCT
iajs-2806	302	3	s.	s.	PROPN
iajs-2806	302	4	;	;	PUNCT
iajs-2806	302	5	gaunt	gaunt	ADJ
iajs-2806	302	6	,	,	PUNCT
iajs-2806	302	7	t.r	t.r	PROPN
iajs-2806	302	8	.	.	PROPN
iajs-2806	302	9	;	;	PUNCT
iajs-2806	302	10	day	day	NOUN
iajs-2806	302	11	,	,	PUNCT
iajs-2806	302	12	i.n	i.n	PROPN
iajs-2806	302	13	.	.	PROPN
iajs-2806	302	14	hardy	hardy	PROPN
iajs-2806	302	15	-	-	PUNCT
iajs-2806	302	16	weinberg	weinberg	PROPN
iajs-2806	302	17	equilibrium	equilibrium	NOUN
iajs-2806	302	18	testing	testing	NOUN
iajs-2806	302	19	of	of	ADP
iajs-2806	302	20	biological	biological	ADJ
iajs-2806	302	21	ascertainment	ascertainment	NOUN
iajs-2806	302	22	for	for	ADP
iajs-2806	302	23	mendelian	mendelian	ADJ
iajs-2806	302	24	randomization	randomization	NOUN
iajs-2806	302	25	studies	study	NOUN
iajs-2806	302	26	.	.	PUNCT
iajs-2806	303	1	amer	amer	PROPN
iajs-2806	303	2	.	.	PUNCT
iajs-2806	304	1	j.	j.	PROPN
iajs-2806	304	2	epidemiol	epidemiol	PROPN
iajs-2806	304	3	.	.	PROPN
iajs-2806	304	4	2009	2009	NUM
iajs-2806	304	5	,	,	PUNCT
iajs-2806	304	6	15	15	NUM
iajs-2806	304	7	,	,	PUNCT
iajs-2806	304	8	169	169	NUM
iajs-2806	304	9	,	,	PUNCT
iajs-2806	304	10	4	4	NUM
iajs-2806	304	11	,	,	PUNCT
iajs-2806	304	12	505	505	NUM
iajs-2806	304	13	-	-	SYM
iajs-2806	304	14	14	14	NUM
iajs-2806	304	15	.	.	PUNCT
iajs-2806	305	1	26.bahir	26.bahir	NUM
iajs-2806	305	2	,	,	PUNCT
iajs-2806	305	3	b.	b.	PROPN
iajs-2806	305	4	h.	h.	PROPN
iajs-2806	305	5	,	,	PUNCT
iajs-2806	305	6	al	al	PROPN
iajs-2806	305	7	-	-	PUNCT
iajs-2806	305	8	naqeeb	naqeeb	PROPN
iajs-2806	305	9	,	,	PUNCT
iajs-2806	305	10	a.a	a.a	PROPN
iajs-2806	305	11	.	.	PROPN
iajs-2806	305	12	,	,	PUNCT
iajs-2806	305	13	and	and	CCONJ
iajs-2806	305	14	niazy	niazy	ADV
iajs-2806	305	15	,	,	PUNCT
iajs-2806	305	16	s.	s.	PROPN
iajs-2806	305	17	m.	m.	PROPN
iajs-2806	305	18	risk	risk	NOUN
iajs-2806	305	19	factors	factor	NOUN
iajs-2806	305	20	for	for	ADP
iajs-2806	305	21	breast	breast	NOUN
iajs-2806	305	22	cancer	cancer	NOUN
iajs-2806	305	23	in	in	ADP
iajs-2806	305	24	a	a	DET
iajs-2806	305	25	sample	sample	NOUN
iajs-2806	305	26	of	of	ADP
iajs-2806	305	27	women	woman	NOUN
iajs-2806	305	28	.	.	PUNCT
iajs-2806	306	1	iraqi	iraqi	ADJ
iajs-2806	306	2	j.	j.	PROPN
iajs-2806	306	3	comm	comm	PROPN
iajs-2806	306	4	.	.	PUNCT
iajs-2806	307	1	2012	2012	NUM
iajs-2806	307	2	,	,	PUNCT
iajs-2806	307	3	1	1	NUM
iajs-2806	307	4	,	,	PUNCT
iajs-2806	307	5	4	4	NUM
iajs-2806	307	6	-	-	SYM
iajs-2806	307	7	8	8	NUM
iajs-2806	307	8	.	.	PUNCT
iajs-2806	308	1	27.mahmoud	27.mahmoud	NUM
iajs-2806	308	2	,	,	PUNCT
iajs-2806	308	3	m.m	m.m	PROPN
iajs-2806	308	4	.	.	PROPN
iajs-2806	308	5	breast	breast	NOUN
iajs-2806	308	6	cancer	cancer	NOUN
iajs-2806	308	7	in	in	ADP
iajs-2806	308	8	kirkuk	kirkuk	PROPN
iajs-2806	308	9	city	city	PROPN
iajs-2806	308	10	,	,	PUNCT
iajs-2806	308	11	hormone	hormone	NOUN
iajs-2806	308	12	receptors	receptor	NOUN
iajs-2806	308	13	status	status	NOUN
iajs-2806	308	14	(	(	PUNCT
iajs-2806	308	15	estrogen	estrogen	NOUN
iajs-2806	308	16	and	and	CCONJ
iajs-2806	308	17	progesterone	progesterone	NOUN
iajs-2806	308	18	)	)	PUNCT
iajs-2806	308	19	and	and	CCONJ
iajs-2806	308	20	her-2	her-2	CCONJ
iajs-2806	308	21	/	/	SYM
iajs-2806	308	22	neu	neu	NOUN
iajs-2806	308	23	and	and	CCONJ
iajs-2806	308	24	their	their	PRON
iajs-2806	308	25	correlation	correlation	NOUN
iajs-2806	308	26	with	with	ADP
iajs-2806	308	27	other	other	ADJ
iajs-2806	308	28	pathologic	pathologic	ADJ
iajs-2806	308	29	prognostic	prognostic	ADJ
iajs-2806	308	30	variables	variable	NOUN
iajs-2806	308	31	.	.	PUNCT
iajs-2806	309	1	diyala	diyala	PROPN
iajs-2806	309	2	j.	j.	PROPN
iajs-2806	309	3	med	med	PROPN
iajs-2806	309	4	.	.	PROPN
iajs-2806	309	5	2014	2014	NUM
iajs-2806	309	6	,	,	PUNCT
iajs-2806	309	7	6	6	NUM
iajs-2806	309	8	,	,	PUNCT
iajs-2806	309	9	1	1	NUM
iajs-2806	309	10	,	,	PUNCT
iajs-2806	309	11	1	1	NUM
iajs-2806	309	12	-	-	SYM
iajs-2806	309	13	4	4	NUM
iajs-2806	309	14	.	.	PUNCT
iajs-2806	310	1	28.alwan	28.alwan	NUM
iajs-2806	310	2	,	,	PUNCT
iajs-2806	310	3	n.a	n.a	PROPN
iajs-2806	310	4	.	.	PROPN
iajs-2806	310	5	;	;	PUNCT
iajs-2806	310	6	mualla	mualla	PROPN
iajs-2806	310	7	,	,	PUNCT
iajs-2806	310	8	f.h	f.h	PROPN
iajs-2806	310	9	.	.	PROPN
iajs-2806	310	10	;	;	PUNCT
iajs-2806	310	11	ali	ali	PROPN
iajs-2806	310	12	,	,	PUNCT
iajs-2806	310	13	s.	s.	PROPN
iajs-2806	310	14	;	;	PUNCT
iajs-2806	310	15	kathum	kathum	PROPN
iajs-2806	310	16	,	,	PUNCT
iajs-2806	310	17	m.n	m.n	PROPN
iajs-2806	310	18	.	.	PROPN
iajs-2806	310	19	;	;	PUNCT
iajs-2806	310	20	tawfiq	tawfiq	PROPN
iajs-2806	310	21	,	,	PUNCT
iajs-2806	310	22	f.n	f.n	PROPN
iajs-2806	310	23	.	.	PROPN
iajs-2806	310	24	and	and	CCONJ
iajs-2806	310	25	nadhir	nadhir	ADJ
iajs-2806	310	26	,	,	PUNCT
iajs-2806	310	27	s.	s.	PROPN
iajs-2806	310	28	clinical	clinical	ADJ
iajs-2806	310	29	and	and	CCONJ
iajs-2806	310	30	pathological	pathological	ADJ
iajs-2806	310	31	characteristics	characteristic	NOUN
iajs-2806	310	32	of	of	ADP
iajs-2806	310	33	triple	triple	ADJ
iajs-2806	310	34	positive	positive	ADJ
iajs-2806	310	35	breast	breast	NOUN
iajs-2806	310	36	cancer	cancer	NOUN
iajs-2806	310	37	among	among	ADP
iajs-2806	310	38	iraqi	iraqi	ADJ
iajs-2806	310	39	patients	patient	NOUN
iajs-2806	310	40	.	.	PUNCT
iajs-2806	311	1	gulf	gulf	PROPN
iajs-2806	311	2	j.	j.	PROPN
iajs-2806	311	3	oncol	oncol	PROPN
iajs-2806	311	4	.	.	PUNCT
iajs-2806	312	1	2017	2017	NUM
iajs-2806	312	2	,	,	PUNCT
iajs-2806	312	3	1	1	NUM
iajs-2806	312	4	,	,	PUNCT
iajs-2806	312	5	51	51	NUM
iajs-2806	312	6	-	-	SYM
iajs-2806	312	7	60	60	NUM
iajs-2806	312	8	.	.	PUNCT
iajs-2806	313	1	29.wojda	29.wojda	NUM
iajs-2806	313	2	,	,	PUNCT
iajs-2806	313	3	a.	a.	NOUN
iajs-2806	313	4	;	;	PUNCT
iajs-2806	313	5	ziętkiewicz	ziętkiewicz	PROPN
iajs-2806	313	6	,	,	PUNCT
iajs-2806	313	7	e.	e.	PROPN
iajs-2806	313	8	;	;	PUNCT
iajs-2806	313	9	mossakowska	mossakowska	PROPN
iajs-2806	313	10	,	,	PUNCT
iajs-2806	313	11	m.	m.	NOUN
iajs-2806	313	12	;	;	PUNCT
iajs-2806	313	13	pawłowski	pawłowski	NOUN
iajs-2806	313	14	,	,	PUNCT
iajs-2806	313	15	w.	w.	PROPN
iajs-2806	313	16	;	;	PUNCT
iajs-2806	313	17	skrzypczak	skrzypczak	PROPN
iajs-2806	313	18	,	,	PUNCT
iajs-2806	313	19	k.	k.	PROPN
iajs-2806	313	20	;	;	PUNCT
iajs-2806	313	21	witt	witt	PROPN
iajs-2806	313	22	,	,	PUNCT
iajs-2806	313	23	m.	m.	NOUN
iajs-2806	313	24	correlation	correlation	NOUN
iajs-2806	313	25	between	between	ADP
iajs-2806	313	26	the	the	DET
iajs-2806	313	27	level	level	NOUN
iajs-2806	313	28	of	of	ADP
iajs-2806	313	29	cytogenetic	cytogenetic	ADJ
iajs-2806	313	30	aberrations	aberration	NOUN
iajs-2806	313	31	in	in	ADP
iajs-2806	313	32	cultured	cultured	ADJ
iajs-2806	313	33	human	human	ADJ
iajs-2806	313	34	lymphocytes	lymphocyte	NOUN
iajs-2806	313	35	and	and	CCONJ
iajs-2806	313	36	the	the	DET
iajs-2806	313	37	age	age	NOUN
iajs-2806	313	38	and	and	CCONJ
iajs-2806	313	39	gender	gender	NOUN
iajs-2806	313	40	of	of	ADP
iajs-2806	313	41	donors	donor	NOUN
iajs-2806	313	42	.	.	PUNCT
iajs-2806	314	1	j.	j.	PROPN
iajs-2806	314	2	gerontol	gerontol	PROPN
iajs-2806	314	3	.	.	PUNCT
iajs-2806	315	1	series	series	PROPN
iajs-2806	315	2	a	a	PRON
iajs-2806	315	3	:	:	PUNCT
iajs-2806	315	4	biological	biological	ADJ
iajs-2806	315	5	sci	sci	PROPN
iajs-2806	315	6	.	.	PROPN
iajs-2806	315	7	med	med	PROPN
iajs-2806	315	8	.	.	PUNCT
iajs-2806	316	1	sci	sci	PROPN
iajs-2806	316	2	.	.	PROPN
iajs-2806	316	3	2006	2006	NUM
iajs-2806	316	4	,	,	PUNCT
iajs-2806	316	5	1	1	NUM
iajs-2806	316	6	,	,	PUNCT
iajs-2806	316	7	61	61	NUM
iajs-2806	316	8	,	,	PUNCT
iajs-2806	316	9	8	8	NUM
iajs-2806	316	10	,	,	PUNCT
iajs-2806	316	11	763	763	NUM
iajs-2806	316	12	-	-	SYM
iajs-2806	316	13	772	772	NUM
iajs-2806	316	14	.	.	PUNCT
iajs-2806	317	1	30.orta	30.orta	NUM
iajs-2806	317	2	,	,	PUNCT
iajs-2806	317	3	t.	t.	PROPN
iajs-2806	317	4	;	;	PUNCT
iajs-2806	317	5	günebakan	günebakan	PROPN
iajs-2806	317	6	,	,	PUNCT
iajs-2806	317	7	s.	s.	PROPN
iajs-2806	317	8	the	the	DET
iajs-2806	317	9	effect	effect	NOUN
iajs-2806	317	10	of	of	ADP
iajs-2806	317	11	aging	age	VERB
iajs-2806	317	12	on	on	ADP
iajs-2806	317	13	micronuclei	micronucleus	NOUN
iajs-2806	317	14	frequency	frequency	NOUN
iajs-2806	317	15	and	and	CCONJ
iajs-2806	317	16	proliferation	proliferation	NOUN
iajs-2806	317	17	in	in	ADP
iajs-2806	317	18	human	human	ADJ
iajs-2806	317	19	peripheral	peripheral	ADJ
iajs-2806	317	20	blood	blood	NOUN
iajs-2806	317	21	lymphocytes	lymphocyte	VERB
iajs-2806	317	22	.	.	PUNCT
iajs-2806	318	1	indian	indian	PROPN
iajs-2806	318	2	journal	journal	PROPN
iajs-2806	318	3	of	of	ADP
iajs-2806	318	4	human	human	ADJ
iajs-2806	318	5	genetics	genetic	NOUN
iajs-2806	318	6	.	.	PUNCT
iajs-2806	319	1	2012	2012	NUM
iajs-2806	319	2	,	,	PUNCT
iajs-2806	319	3	18	18	NUM
iajs-2806	319	4	,	,	PUNCT
iajs-2806	319	5	1	1	NUM
iajs-2806	319	6	,	,	PUNCT
iajs-2806	319	7	95	95	NUM
iajs-2806	319	8	.	.	PUNCT
iajs-2806	320	1	31	31	NUM
iajs-2806	320	2	.	.	PUNCT
iajs-2806	321	1	al	al	PROPN
iajs-2806	321	2	saady	saady	PROPN
iajs-2806	321	3	,	,	PUNCT
iajs-2806	321	4	r.	r.	NOUN
iajs-2806	321	5	age	age	NOUN
iajs-2806	321	6	distribution	distribution	NOUN
iajs-2806	321	7	of	of	ADP
iajs-2806	321	8	female	female	ADJ
iajs-2806	321	9	breast	breast	NOUN
iajs-2806	321	10	cancer	cancer	NOUN
iajs-2806	321	11	in	in	ADP
iajs-2806	321	12	basrah	basrah	PROPN
iajs-2806	321	13	10	10	NUM
iajs-2806	321	14	years	year	NOUN
iajs-2806	321	15	study	study	NOUN
iajs-2806	321	16	.	.	PUNCT
iajs-2806	322	1	basrah	basrah	PROPN
iajs-2806	322	2	j.	j.	PROPN
iajs-2806	322	3	surgery	surgery	PROPN
iajs-2806	322	4	.	.	PUNCT
iajs-2806	323	1	2005	2005	NUM
iajs-2806	323	2	,	,	PUNCT
iajs-2806	323	3	28	28	NUM
iajs-2806	323	4	,	,	PUNCT
iajs-2806	323	5	11	11	NUM
iajs-2806	323	6	,	,	PUNCT
iajs-2806	323	7	1	1	NUM
iajs-2806	323	8	,	,	PUNCT
iajs-2806	323	9	89	89	NUM
iajs-2806	323	10	-	-	SYM
iajs-2806	323	11	93	93	NUM
iajs-2806	323	12	.	.	PUNCT
iajs-2806	324	1	32.lu	32.lu	NUM
iajs-2806	324	2	,	,	PUNCT
iajs-2806	324	3	d.p	d.p	PROPN
iajs-2806	324	4	.	.	PROPN
iajs-2806	324	5	;	;	PUNCT
iajs-2806	325	1	zhou	zhou	PROPN
iajs-2806	325	2	,	,	PUNCT
iajs-2806	325	3	x.y	x.y	PROPN
iajs-2806	325	4	.	.	PROPN
iajs-2806	325	5	;	;	PUNCT
iajs-2806	325	6	yao	yao	PROPN
iajs-2806	325	7	,	,	PUNCT
iajs-2806	325	8	l.t	l.t	PROPN
iajs-2806	325	9	.	.	PROPN
iajs-2806	325	10	;	;	PUNCT
iajs-2806	325	11	liu	liu	PROPN
iajs-2806	325	12	,	,	PUNCT
iajs-2806	325	13	c.g	c.g	PROPN
iajs-2806	325	14	.	.	PROPN
iajs-2806	325	15	;	;	PUNCT
iajs-2806	325	16	ma	ma	PROPN
iajs-2806	325	17	,	,	PUNCT
iajs-2806	325	18	w.	w.	PROPN
iajs-2806	325	19	;	;	PUNCT
iajs-2806	325	20	jin	jin	PROPN
iajs-2806	325	21	,	,	PUNCT
iajs-2806	325	22	f.	f.	PROPN
iajs-2806	325	23	;	;	PUNCT
iajs-2806	325	24	wu	wu	PROPN
iajs-2806	325	25	,	,	PUNCT
iajs-2806	325	26	y.f	y.f	PROPN
iajs-2806	325	27	.	.	PUNCT
iajs-2806	325	28	serum	serum	PROPN
iajs-2806	325	29	soluble	soluble	ADJ
iajs-2806	325	30	st2	st2	NOUN
iajs-2806	325	31	is	be	AUX
iajs-2806	325	32	associated	associate	VERB
iajs-2806	325	33	with	with	ADP
iajs-2806	325	34	er	er	INTJ
iajs-2806	325	35	-	-	PUNCT
iajs-2806	325	36	positive	positive	ADJ
iajs-2806	325	37	breast	breast	NOUN
iajs-2806	325	38	cancer	cancer	NOUN
iajs-2806	325	39	.	.	PUNCT
iajs-2806	326	1	bmc	bmc	NOUN
iajs-2806	326	2	cancer	cancer	NOUN
iajs-2806	326	3	.	.	PUNCT
iajs-2806	327	1	2014	2014	NUM
iajs-2806	327	2	,	,	PUNCT
iajs-2806	327	3	1	1	NUM
iajs-2806	327	4	,	,	PUNCT
iajs-2806	327	5	14	14	NUM
iajs-2806	327	6	,	,	PUNCT
iajs-2806	327	7	1	1	NUM
iajs-2806	327	8	,	,	PUNCT
iajs-2806	327	9	198	198	NUM
iajs-2806	327	10	.	.	PUNCT
iajs-2806	328	1	33.yang	33.yang	NUM
iajs-2806	328	2	,	,	PUNCT
iajs-2806	328	3	z.p	z.p	PROPN
iajs-2806	328	4	.	.	PROPN
iajs-2806	328	5	;	;	PUNCT
iajs-2806	328	6	ling	ling	PROPN
iajs-2806	328	7	,	,	PUNCT
iajs-2806	328	8	d.y	d.y	PROPN
iajs-2806	328	9	.	.	PROPN
iajs-2806	328	10	;	;	PUNCT
iajs-2806	328	11	xie	xie	PROPN
iajs-2806	328	12	,	,	PUNCT
iajs-2806	328	13	y.h	y.h	PROPN
iajs-2806	328	14	.	.	PROPN
iajs-2806	328	15	;	;	PUNCT
iajs-2806	328	16	wu	wu	PROPN
iajs-2806	328	17	,	,	PUNCT
iajs-2806	328	18	w.x	w.x	PROPN
iajs-2806	328	19	.	.	PROPN
iajs-2806	328	20	;	;	PUNCT
iajs-2806	328	21	li	li	PROPN
iajs-2806	328	22	,	,	PUNCT
iajs-2806	328	23	j.r	j.r	PROPN
iajs-2806	328	24	.	.	PROPN
iajs-2806	328	25	;	;	PUNCT
iajs-2806	328	26	jiang	jiang	PROPN
iajs-2806	328	27	,	,	PUNCT
iajs-2806	328	28	j.	j.	PROPN
iajs-2806	328	29	;	;	PUNCT
iajs-2806	328	30	zheng	zheng	PROPN
iajs-2806	328	31	,	,	PUNCT
iajs-2806	328	32	j.l	j.l	PROPN
iajs-2806	328	33	.	.	PROPN
iajs-2806	328	34	;	;	PUNCT
iajs-2806	328	35	fan	fan	PROPN
iajs-2806	328	36	,	,	PUNCT
iajs-2806	328	37	y.h	y.h	PROPN
iajs-2806	328	38	.	.	PROPN
iajs-2806	328	39	;	;	PUNCT
iajs-2806	328	40	zhang	zhang	PROPN
iajs-2806	328	41	,	,	PUNCT
iajs-2806	328	42	y.	y.	PROPN
iajs-2806	328	43	the	the	DET
iajs-2806	328	44	association	association	NOUN
iajs-2806	328	45	of	of	ADP
iajs-2806	328	46	serum	serum	NOUN
iajs-2806	328	47	il-33	il-33	ADJ
iajs-2806	328	48	and	and	CCONJ
iajs-2806	328	49	sst2	sst2	NOUN
iajs-2806	328	50	with	with	ADP
iajs-2806	328	51	breast	breast	NOUN
iajs-2806	328	52	cancer	cancer	NOUN
iajs-2806	328	53	.	.	PUNCT
iajs-2806	329	1	dis	dis	PROPN
iajs-2806	329	2	.	.	PUNCT
iajs-2806	330	1	markers	marker	NOUN
iajs-2806	330	2	.	.	PUNCT
iajs-2806	331	1	2015	2015	NUM
iajs-2806	331	2	.	.	PUNCT
iajs-2806	332	1	2015,1	2015,1	NUM
iajs-2806	332	2	-	-	SYM
iajs-2806	332	3	6	6	NUM
iajs-2806	332	4	.	.	NUM
iajs-2806	332	5	34.hu	34.hu	NUM
iajs-2806	332	6	,	,	PUNCT
iajs-2806	332	7	h.	h.	PROPN
iajs-2806	332	8	;	;	PUNCT
iajs-2806	332	9	sun	sun	PROPN
iajs-2806	332	10	,	,	PUNCT
iajs-2806	332	11	j.	j.	PROPN
iajs-2806	332	12	;	;	PUNCT
iajs-2806	332	13	wang	wang	PROPN
iajs-2806	332	14	,	,	PUNCT
iajs-2806	332	15	c.	c.	PROPN
iajs-2806	332	16	;	;	PUNCT
iajs-2806	332	17	bu	bu	PROPN
iajs-2806	332	18	,	,	PUNCT
iajs-2806	332	19	x.	x.	PROPN
iajs-2806	332	20	;	;	PUNCT
iajs-2806	333	1	liu	liu	PROPN
iajs-2806	333	2	,	,	PUNCT
iajs-2806	333	3	x.	x.	PROPN
iajs-2806	333	4	;	;	PUNCT
iajs-2806	333	5	mao	mao	PROPN
iajs-2806	333	6	,	,	PUNCT
iajs-2806	333	7	y.	y.	PROPN
iajs-2806	333	8	;	;	PUNCT
iajs-2806	333	9	wang	wang	PROPN
iajs-2806	333	10	,	,	PUNCT
iajs-2806	333	11	h.	h.	PROPN
iajs-2806	333	12	il-33	il-33	VERB
iajs-2806	333	13	facilitates	facilitate	VERB
iajs-2806	333	14	endocrine	endocrine	ADJ
iajs-2806	333	15	resistance	resistance	NOUN
iajs-2806	333	16	of	of	ADP
iajs-2806	333	17	breast	breast	NOUN
iajs-2806	333	18	cancer	cancer	NOUN
iajs-2806	333	19	by	by	ADP
iajs-2806	333	20	inducing	induce	VERB
iajs-2806	333	21	cancer	cancer	NOUN
iajs-2806	333	22	stem	stem	NOUN
iajs-2806	333	23	cell	cell	NOUN
iajs-2806	333	24	properties	property	NOUN
iajs-2806	333	25	.	.	PUNCT
iajs-2806	334	1	biochem	biochem	PROPN
iajs-2806	334	2	.	.	PUNCT
iajs-2806	335	1	biophys	biophy	NOUN
iajs-2806	335	2	.	.	PUNCT
iajs-2806	336	1	res	re	NOUN
iajs-2806	336	2	.	.	PUNCT
iajs-2806	337	1	commun	commun	PROPN
iajs-2806	337	2	.	.	PROPN
iajs-2806	338	1	2017	2017	NUM
iajs-2806	338	2	,	,	PUNCT
iajs-2806	338	3	8	8	NUM
iajs-2806	338	4	,	,	PUNCT
iajs-2806	338	5	485	485	NUM
iajs-2806	338	6	,	,	PUNCT
iajs-2806	338	7	3	3	NUM
iajs-2806	338	8	,	,	PUNCT
iajs-2806	338	9	643	643	NUM
iajs-2806	338	10	-	-	SYM
iajs-2806	338	11	650	650	NUM
iajs-2806	338	12	.	.	PUNCT
iajs-2806	339	1	35.saranchova	35.saranchova	NUM
iajs-2806	339	2	,	,	PUNCT
iajs-2806	339	3	i.	i.	PROPN
iajs-2806	339	4	;	;	PUNCT
iajs-2806	339	5	han	han	PROPN
iajs-2806	339	6	,	,	PUNCT
iajs-2806	339	7	j.	j.	PROPN
iajs-2806	339	8	;	;	PUNCT
iajs-2806	339	9	huang	huang	PROPN
iajs-2806	339	10	,	,	PUNCT
iajs-2806	339	11	h.	h.	PROPN
iajs-2806	339	12	;	;	PUNCT
iajs-2806	339	13	fenninger	fenninger	NOUN
iajs-2806	339	14	,	,	PUNCT
iajs-2806	339	15	f.	f.	PROPN
iajs-2806	339	16	;	;	PUNCT
iajs-2806	339	17	choi	choi	NOUN
iajs-2806	339	18	,	,	PUNCT
iajs-2806	339	19	k.b	k.b	PROPN
iajs-2806	339	20	.	.	PROPN
iajs-2806	339	21	;	;	PUNCT
iajs-2806	339	22	munro	munro	PROPN
iajs-2806	339	23	,	,	PUNCT
iajs-2806	339	24	l.	l.	PROPN
iajs-2806	339	25	;	;	PUNCT
iajs-2806	339	26	pfeifer	pfeifer	PROPN
iajs-2806	339	27	,	,	PUNCT
iajs-2806	339	28	c.	c.	PROPN
iajs-2806	339	29	;	;	PUNCT
iajs-2806	339	30	welch	welch	PROPN
iajs-2806	339	31	,	,	PUNCT
iajs-2806	339	32	i.	i.	PROPN
iajs-2806	339	33	;	;	PUNCT
iajs-2806	339	34	wyatt	wyatt	PROPN
iajs-2806	339	35	,	,	PUNCT
iajs-2806	339	36	a.w	a.w	PROPN
iajs-2806	339	37	.	.	PROPN
iajs-2806	339	38	;	;	PUNCT
iajs-2806	339	39	fazli	fazli	PROPN
iajs-2806	339	40	,	,	PUNCT
iajs-2806	339	41	l.	l.	PROPN
iajs-2806	339	42	;	;	PUNCT
iajs-2806	339	43	gleave	gleave	PROPN
iajs-2806	339	44	,	,	PUNCT
iajs-2806	339	45	m.e	m.e	PROPN
iajs-2806	339	46	.	.	PROPN
iajs-2806	339	47	discovery	discovery	PROPN
iajs-2806	339	48	of	of	ADP
iajs-2806	339	49	a	a	DET
iajs-2806	339	50	metastatic	metastatic	ADJ
iajs-2806	339	51	immune	immune	ADJ
iajs-2806	339	52	escape	escape	NOUN
iajs-2806	339	53	mechanism	mechanism	NOUN
iajs-2806	339	54	initiated	initiate	VERB
iajs-2806	339	55	by	by	ADP
iajs-2806	339	56	the	the	DET
iajs-2806	339	57	loss	loss	NOUN
iajs-2806	339	58	of	of	ADP
iajs-2806	339	59	expression	expression	NOUN
iajs-2806	339	60	of	of	ADP
iajs-2806	339	61	the	the	DET
iajs-2806	339	62	tumour	tumour	NOUN
iajs-2806	339	63	biomarker	biomarker	NOUN
iajs-2806	340	1	interleukin-33	interleukin-33	PROPN
iajs-2806	340	2	.	.	PUNCT
iajs-2806	340	3	sci	sci	PROPN
iajs-2806	340	4	.	.	PROPN
iajs-2806	341	1	reports	report	NOUN
iajs-2806	341	2	.	.	PUNCT
iajs-2806	342	1	2016	2016	NUM
iajs-2806	342	2	,	,	PUNCT
iajs-2806	342	3	13	13	NUM
iajs-2806	342	4	,	,	PUNCT
iajs-2806	342	5	6	6	NUM
iajs-2806	342	6	,	,	PUNCT
iajs-2806	342	7	1	1	NUM
iajs-2806	342	8	,	,	PUNCT
iajs-2806	342	9	1	1	NUM
iajs-2806	342	10	-	-	SYM
iajs-2806	342	11	4	4	NUM
iajs-2806	342	12	.	.	PUNCT
iajs-2806	343	1	36.xu	36.xu	NUM
iajs-2806	343	2	,	,	PUNCT
iajs-2806	343	3	w.	w.	PROPN
iajs-2806	343	4	;	;	PUNCT
iajs-2806	343	5	liu	liu	PROPN
iajs-2806	343	6	,	,	PUNCT
iajs-2806	343	7	y.	y.	PROPN
iajs-2806	343	8	;	;	PUNCT
iajs-2806	343	9	ye	ye	PROPN
iajs-2806	343	10	,	,	PUNCT
iajs-2806	343	11	d.	d.	PROPN
iajs-2806	343	12	association	association	PROPN
iajs-2806	343	13	between	between	ADP
iajs-2806	343	14	il-33	il-33	ADJ
iajs-2806	343	15	gene	gene	NOUN
iajs-2806	343	16	polymorphisms	polymorphism	NOUN
iajs-2806	343	17	(	(	PUNCT
iajs-2806	343	18	rs1929992	rs1929992	ADJ
iajs-2806	343	19	,	,	PUNCT
iajs-2806	343	20	rs7044343	rs7044343	NOUN
iajs-2806	343	21	)	)	PUNCT
iajs-2806	343	22	and	and	CCONJ
iajs-2806	343	23	systemic	systemic	ADJ
iajs-2806	343	24	lupus	lupus	NOUN
iajs-2806	343	25	erythematosus	erythematosus	NOUN
iajs-2806	343	26	in	in	ADP
iajs-2806	343	27	a	a	DET
iajs-2806	343	28	chinese	chinese	ADJ
iajs-2806	343	29	han	han	PROPN
iajs-2806	343	30	population	population	PROPN
iajs-2806	343	31	.	.	PUNCT
iajs-2806	344	1	immunol	immunol	NOUN
iajs-2806	344	2	.	.	PUNCT
iajs-2806	345	1	investigat	investigat	NOUN
iajs-2806	345	2	.	.	PUNCT
iajs-2806	346	1	2016	2016	NUM
iajs-2806	346	2	,	,	PUNCT
iajs-2806	346	3	2	2	NUM
iajs-2806	346	4	,	,	PUNCT
iajs-2806	346	5	45	45	NUM
iajs-2806	346	6	,	,	PUNCT
iajs-2806	346	7	7	7	NUM
iajs-2806	346	8	,	,	PUNCT
iajs-2806	346	9	575	575	NUM
iajs-2806	346	10	-	-	SYM
iajs-2806	346	11	583	583	NUM
iajs-2806	346	12	.	.	PUNCT